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Abstract 
The development of a whole organism from a single fertilised egg is a tightly orchestrated 
process at the molecular level.  Signalling pathways stimulate the expression of transcription 
factors that in turn coordinate the activation, repression or priming of genes through multi-
protein complex assembly and chromatin remodelling at regulatory regions during key 
developmental transitions.  
This project focuses on the role of the chromatin modifier Jmjd2c/Kdm4c in embryonic stem 
cell (ESC) pluripotency. Jmjd2c is a member of Jmjd2 H3K9-demethylase family, which is highly 
expressed in ESCs and during early mouse development, and was proposed to contribute to ESC 
identity. Here, Jmjd2c-depleted ESCs were generated and found to sustain an undifferentiated 
state. In contrast, these cells fail to execute multi-lineage differentiation, as evidenced by their 
inability to fully activate appropriate gene expression programs, but readily adopt an extra-
embryonic endoderm-like phenotype under appropriate conditions. Moreover, Jmjd2c-knockout 
ESCs can transit to an early epiblast stage and be stably converted into epiblast stem cells 
(cEpiSCs) that harbour an immature state as highlighted by a lack of transcriptional gene priming 
for germ layer markers.  
In order to unfold the mechanistic basis for the observed differentiation defect, genome-wide 
distribution of Jmjd2c was analysed by ChIP-sequencing. This revealed prominent binding to the 
TSS of active and bivalently marked genes, concordant with recent reports. Remarkably, 
acquisition of multi-lineage priming in ESCs was accompanied by Jmjd2c recruitment at poised 
enhancers of lineage-affiliated genes. Surprisingly, these regions were co-occupied by the H3K9-
methyltransferase G9a/Ehmt2, which physically interacts with Jmjd2c and Mediator, within 
chromatin-bound complexes. Critically, the absence of Jmjd2c in cEpiSCs was sufficient to 
destabilize the assembly of enhancer protein complexes, suggesting a scaffolding role 
independent of its H3K9-demethylase activity. Collectively, this study uncovered a novel role for 
Jmjd2c in regulating gene expression at exit of the pluripotent state.  
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OSN    Oct4-Sox2-Nanog 
P    P-value 
PBS    Phosphate buffered saline 
PCR    Polymerase chain reaction 
PE    Parietal endoderm 
PFA    Paraformaldehyde 
PGC    Primordial germ cell 
PHD   Plant homeodomain 
PM   Paraxial mesoderm 
PMSF    Phenylmethanesulfonylfluoride 
polyA   Poly adenylation  
POU   Pit-Oct-Unc 
PRC1   Polycomb repressive complex 1 
PRC2   Polycomb repressive compelx 2 
PrE    Primitive endoderm 
Puro   Puromycin 
PVDF    Polyvinylidene fluoride 
qPCR    Quantitative PCR 
RAF   Rapidly Accelerated Fibrosarcoma    
RIPA    Radio Immuno Precipitation Assay 
RNA    Ribonucleic acid 
RNAi    RNA interference 
RNAPII   RNA polymerase II 
RT-PCR    Reverse transcription PCR 
sA    Splice acceptor 
SCNT   Somatic cellular nuclear transfer 
SD    Standard deviation 
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SDS    Sodium dodecyl sulfate 
SDS-PAGE   Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
shRNA    Small hairpin RNA 
SEM    Standard error of the mean 
Ser2/5P    Phosphorylated serine 2/5 
siRNA    Small interfering RNA 
SN    Supernatant  
SRY   sex-determining region Y 
STAT   Signal Transducer and Activator of Transcription 
SV40   Simian virus 40 
TBE   Tris-borate-EDTA 
TBS-T    Tris-buffered saline with 0.1% Tween-20 
TE    Trophectoderm 
TET   Ten-eleven translocation 
TGF    Transforming growth factor  
TrxG    Trithorax group 
TS    Trophoblast stem (cell) 
TSS    Transcription start site 
USCS   University of California Santa Cruz 
v/v    Volume/volume 
w/v    Weight/volume 
XEN    Extra-embryonic endoderm cell
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I.1 Preface 
For the purpose of this work, the mouse organism was used as a model system. In particular, 
the similarity between mouse and human early embryonic development are significant, making 
this a useful model to address several question regarding the regulation of this process. 
Generating a whole organism from a single fertilised egg is a remarkable process. Thus, at a 
molecular level this process must be perfectly well-orchestrated in order to ensure proper 
generation of specializes tissues.  
This project focuses on the specific role of the chromatin modifier Jmjd2c in early embryonic 
development, using mouse embryo-derived stem cells and in vitro differentiation assays as tools 
to dissect the impact of this protein in the early cell fate choices. In this Chapter, the mouse 
embryonic development will be described with a specific focus on the pre-implantation and early 
post-implantation stages. Furthermore, the ability to derive stem cell lines from the mouse 
blastocysts and the knowledge we have thus far gained on the complex extrinsic signaling cues 
and gene regulatory mechanisms that coordinate cell fate choices, using in vivo and in vitro 
systems, will be discussed. Finally, for the scope of this project, attention will be given to our 
current understanding on the mechanisms of epigenetic regulation and long-range interactions 
that govern and safeguard gene expression upon embryonic lineage commitment. 
 
I.2 The mouse as a model system 
Over the past century, the mouse has been recognised as a leading mammalian model system 
for the study of molecular and cellular processes relevant to human biology. Because of the high 
degree of similarly between genetic and physiological circuitries, mice are a prime model for the 
study of the immune, nervous, cardiovascular, endocrine, skeletal, reproductive and further 
complex physiological processes shared among mammals. Moreover, with the completion of the 
full mapping of the Human and Mouse genomes (Lander, 2011; McPherson et al., 2001; Mouse 
Genome Sequencing et al., 2002; Waterston et al., 2002), we now know that despite 75 million 
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years since the divergence of the human and mouse lineages, about 99% of the mouse genes share 
a homolog in the human genome.  
The rapid advances in sequencing technologies have had an enormous impact on the in-
depth sequencing and decoding of genomic information. Still, we are far from knowing how all 
genes operate and which processes they regulate in a physiological scenery. A great effort to 
answer these question has been attained by genetic manipulation and phenotyping of mouse 
models (Bult et al., 2013). 
Here, the isolation and propagation of pluripotent mouse embryonic stem cells (ESCs) in the 
early 1980s has triggered a major advance in mouse genetics with the emergence of gene 
targeting technology (Evans and Kaufman, 1981; Thomas and Capecchi, 1987). Thus, 
international consortia have ever since been established employing genetic engineering tools that 
permit deleting (knockout) or inserting altered versions of the same gene (knockin), for 
interrogation of virtually any gene function in whole-organisms (Skarnes et al., 2011).  
Beyond being easily manipulated, the mouse has physiological processes highly similar to 
humans and a short breeding cycle. Thus, studying the mouse embryonic development 
overcomes ethical and technical obstacles encountered in the study of human embryology. 
Mammalian development is an extraordinary well regulated phenomena where the fusion of two 
highly specialized cells – egg and sperm – generate a complex multicellular organism. The study 
of early mouse development and derived stem cells, which has deserved much attention in the 
past decades, has provided instrumental insights into the molecular and cellular circuitry behind 
the earliest cell fate choices, a knowledge which has been invaluable not just for developmental 
biology, but also for regenerative medicine.  
 
I.3 - Early mammalian development 
1.3.1 Mouse pre-implantation embryo development 
In mammals, fertilization occurring between two haploid gametes – egg and sperm – forms 
a diploid zygote. This totipotent cell contains the genetic information from both entities and holds 
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the ability to give rise to all cells of the developing organism. Through a series of sequential cell 
divisions that characterize the early stages of embryonic development up to uterine implantation, 
the blastocyst is formed, comprising three distinct cell populations: the trophectoderm (TE) that 
will contribute to the placenta formation, the primitive endoderm (PrE) that will give rise to the 
yolk sac, and the primitive ectoderm, or epiblast (Epi), comprising pluripotent progenitors that 
will generate the proper embryo (Fig.1.1A) (Bedzhov et al., 2014).  
The specification and formation of these distinct blastocyst lineages is accomplished after 
the two major events of cell fate decisions occurring at embryonic day (E) 2.5 and E3.5. First, two 
rounds of asymmetric cell divisions between 8 to 16, and 16 to 32-cell stage, lead to the 
segregation of two distinct populations in morula-stage embryos depending on their location: 
polar cells located on the outside will go on to form the TE, whereas inner apolar cells will form 
the inner cell mass (ICM; Fig.1.1A) (Morris et al., 2010). This process is highly dependent on cell 
polarity, position and cell–cell signalling, being also influenced by molecular heterogeneity 
between blastomeres (Bedzhov et al., 2014). Although epigenetic asymmetry arises early on 
between maternal and paternal gametes, its role in pre-patterning of blastomeres still remains to 
be elucidated (Takaoka and Hamada, 2014). By the 32-cell stage the embryo cavitates with full 
specification of the TE, the orientation of which will define the embryonic–abembryonic axis of 
the embryo. The second event of cell decision occurs at the 32 to 64-cell transition where the ICM 
further segregates into the PrE and the epiblast by E4.5 (Fig.1.1A). Cell lineage tracing techniques 
have unveiled that before this segregation, ICM blastomeres are already engaged into either PrE 
or Epi, and this bias occurs in a heterogeneous “salt and pepper” manner, concomitant with 
acquisition of exclusive expression of PrE and Epi-specific markers Gata6 and Nanog, respectively 
(Chazaud et al., 2006; Rossant et al., 2003).  Moreover, this bias is also thought to be influenced 
by both the timing of internalization within the morula (Krupa et al., 2014), and the expression of 
Fgfr2 or Fgf4, with cells expressing Fgf4 correlating with cells internalized earlier, and hence, 
Nanog-expressing epiblast progenitors, and Fgfr2 cells internalized later corresponding to Gata6-
expressing PrE progenitors (Fig.1.1B) (Morris et al., 2013).  
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Figure 1.1 Pre-implantation development of the mouse embryo 
A. After fertilization, the zygote forms and divides through the early cleavage stages of mammalian 
development up to the morula (E3.0). Embryonic and extra-embryonic lineages cells are specified by two 
cell fate decisions. First, waves of cell divisions segregate inside (pink) and outside (green) layers of cells 
with outside cells later giving rise to extra-embryonic trophectoderm (TE), while inside cells tend to 
preferentially form the pluripotent inner cell mass (ICM). Secondly, at the early blastocyst stage (E3.5) the 
ICM segregated into the extra-embryonic primitive endoderm (PrE; blue) and the epiblast (Epi; orange) 
progenitors, with further maturation and compartmentalization of these lineages at the late-blastocyst 
stage (E4.5), just before implantation. Cell fate decisions are influenced by their inner-outer location and 
molecular heterogeneity between individual blastomeres since the 4-cell stage (E2.0) as represented by 
the different colours. B. Epiblast progenitor (orange) cells, which are internalized earlier, express Fgf4 and 
Nanog, while PrE progenitors (blue) cells, internalized later, express higher levels of Fgf4 receptor Fgfr2 
and Gata6. Nanog and Gata6 reciprocally inhibit their expression, with Fgf signalling also contributing the 
maintenance of Gata6 by inhibition of Nanog-mediated repression. Adapted from (Bedzhov et al., 2014).   
 
As the embryo development progresses, the developmental potency of cells becomes 
restricted. Early cleavage state embryos are totipotent, as they are able to form both embryonic 
and extra-embryonic lineages of the developing embryo. As the TE and PrE emerge, these extra-
embryonic cells  have become multipotent as they are limited to form the placenta and yolk sac, 
respectively, where the pluripotent epiblast will give rise to the three germ layers (endoderm, 
mesoderm and ectoderm) and germ cells upon gastrulation, ultimately forming the proper 
embryo. However, despite early commitment, a small percentage of ICM cells isolated from the 
early blastocyst can still contribute to TE when aggregated into morula, showing that some level 
of plasticity is retained at this stage (Morgani and Brickman, 2014). Upon the second lineage 
E0.5                  E2.0                   E3.0                       E3.5                             E4.5
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decision cell plasticity in the ICM/epiblast is then lost (Boroviak and Nichols, 2014). ICM plasticity 
has been suggested to provide a back-up mechanism for preserving the appropriate balance 
between the number of ICM and PrE cells, vital for subsequent post-implantation development 
(Bedzhov et al., 2014). 
 
1.3.2 Mouse early post-implantation development 
Upon implantation, the blastocyst attaches the zona pelucida where the TE invasion merges 
the blastocyst to the maternal uterine wall, forming the ectoplacental cone (EPC). Embryo growth 
and morphogenesis arise upon successful implantation, being a crucial step for proper 
development. Thus, following implantation, the epiblast undergoes a major rearrangement with 
the emergence of a single layered epithelium that forms an organized a rosette-like cylinder, 
enclosing a pro-amniotic cavity, in a manner highly influenced by polarization (Bedzhov and 
Zernicka-Goetz, 2014). The TE-derived extra-embryonic ectoderm (ExE) and the Epi become 
surrounded by PrE-derived parietal endoderm (PE) and visceral endoderm (VE) layer (Fig.1.2). 
The VE has a crucial role in anterior-posterior patterning of the embryo. In particular, a sub-
population emerging at the tip of the egg cylinder migrates to the distal side of the embryo to 
form the anterior visceral endoderm (AVE), influencing the patterning of the newly formed 
primitive streak – the site of gastrulation, which emerges on its opposite side (Stower and 
Srinivas, 2014; Tam and Loebel, 2007). Correct formation and placement of the primitive streak 
is dependent on reciprocal signalling cues between Epi, ExE, and AVE, respectively.  BMP4 
signalling from the ExE stimulates gene expression programs and Wnt3a production in the 
posterior epiblast, in addition contributing to primitive germ cell (PGC) specification 
(Gunesdogan et al., 2014). Conversely, Wnt-mediated Nodal signalling from the posterior epiblast 
safeguards BMP4 signalling activity from the ExE.  Additionally, asymmetry in Nodal signalling 
guides AVE migration towards the site of expression of its antagonists, which is necessary for pre-
streak positioning (Stower and Srinivas, 2014).  
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Figure 1.2 Early post-implantation development of the mouse embryo 
Before implantation (E4.5), three distinct lineages in the early embryo have been segregated: 
trophectoderm (TE, green), primitive endoderm (PrE, blue) and epiblast (Epi, orange). Upon implantation 
(E.5.5), the polar TE (side attached to the Epi), invades the maternal tissues forming an ectoplacental cone 
(EPC, light green) and extra-embryonic ectoderm (ExE, green). The PrE colonizes the mural TE (opposite 
side of Epi) and segregates into parietal endoderm (PE, light blue) and visceral endoderm (VE, dark blue), 
surrounding the epiblast, primordial germ cells (PGC, pink) and the pro-amniotic cavity (grey).  Upon 
gastrulation, the anterior visceral endoderm (AVE) is established, and epiblast cells are recruited to the 
posterior region (primitive streak), where they will form mesoderm (Meso, brown) and definitive 
endoderm (DE, purple).  Epiblast cells retained at the anterior side will form the ectoderm (Ect, orange). 
Signalling gradients (BMP, Nodal) and activity of Fgf and Wnt pathways will influence the emergence of 
subsequent sub-populations in the primitive strike (Arnold and Robertson, 2009; Mendjan et al., 2014; Tam 
and Loebel, 2007). 
 
Upon gastrulation, epiblast cells ingress into the primitive streak, where they develop the 
mesoderm layer and additionally are integrated into the surrounding VE layer as definitive 
endoderm (DE). Thus, prior to this point, epiblast cells transiently exist in a mesendoderm state, 
having the potential to become either mesoderm or endoderm. Cells that are retained in the 
epiblast anterior site give rise to the ectoderm, and later on the surface ectoderm, which includes 
the epidermis and the neural tissues (Tam and Loebel, 2007). 
E4.5                                 E5.5                                     E6.5
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Mesoderm cells are subsequently compartmentalised depending on the time and location of 
ingression within the strike. The earliest and most posterior compartment forms the extra-
embryonic mesoderm (yolk sac vasculature and blood), followed by the lateral plate (circulatory 
system and gut wall), paraxial (somites) and cardiac mesoderm in the intermediate and anterior 
regions. Finally, at the anterior tip, the axial mesoderm (notochord) is formed as well as the DE 
(gut tube and organs). Notably, the emergence and specification of definitive endoderm and 
mesoderm sub-populations is regulated by Fgf and Wnt signalling, as well as by reciprocal 
gradients of BMP and Nodal along the anterior-posterior axis of the streak (Fig.1.2) (Arnold & 
Robertson, 2009; Tam and Loebel, 2007). 
 
I.4 Derivation of stem cell populations  
1.4.1 Isolation of stem cell populations from the early embryo 
A milestone in the developmental biology field has been the ability to isolate cell populations 
from the early blastocyst and stably culture these in vitro, while maintaining the developmental 
potency of their cognate lineages (Rossant, 2008). Blastocyst-derived stem cells provide powerful 
tools not only to study the precise molecular mechanisms underlying lineage commitment in the 
early embryo, but also hold great promise for the regenerative medicine and disease modeling 
fields. 
Since the 1950s, sporadically acquired teratocarcinomas in mice have been studied in 
regards to their transplant ability. This property was attributed to the presence of embryonal 
carcinoma (EC) cells, a proliferative undifferentiated group of cells which not only could 
regenerate all of the cell types forming teratocarcinomas, but also self-renew in vitro. The capture 
and identification of culture conditions (serum and a feeder layer of mitotically inactivated 
fibroblasts) under which this population could retain its pluripotency in vitro was a critical 
landmark for the later derivation of embryonic stem cells (ESCs) (Kahan and Ephrussi, 1970; 
Martin and Evans, 1975). In the early 1980s, two groups independently derived ESCs from pre-
implantation blastocysts. These cells could be expanded indefinitely while retaining their ability 
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to self-renew and to contribute to the germline in addition to forming all somatic cell types when 
re-introduced back into an embryo environment (Fig.1.3) (Evans and Kaufman, 1981; Martin, 
1981). Later on, their self-renewal requirements for serum and feeders were found to be 
substitutable by BMP4 and Leukemia inhibitory factors (LIF), revealing these as key signaling 
pathways in promoting self-renewal and blocking differentiation cues (Niwa et al., 1998; Ying et 
al., 2003a).  
Although ESCs are commonly derived from the ICM of early blastocysts, they have also been 
successfully established from any pre-implantation stage and even from single blastomeres 
(Chung et al., 2006; Tesar, 2005), acquiring very similar characteristics. This suggested that the 
derivation process allows cells to progress to a common developmental stage in which in vitro 
self-renewal can arise. Moreover, when challenged to differentiate either in vivo or in vitro, ESCs 
proved capable of also contributing to extra-embryonic lineages, hence suggesting that ESC 
cultures might be functionally heterogeneous as they encompass individual cells that are primed 
for an Epi or PrE fate (Morgani and Brickman, 2014).  Consequently, the true in vivo counterpart 
of cultured ESCs has been and remains an object of debate (Fig.1.3) (Plusa and Hadjantonakis, 
2014).  
More recently, derivation of pluripotent stem cell lines from the epiblast of post-implantation 
stage embryos has also been achieved (Fig.1.3) (Brons et al., 2007; Tesar et al., 2007). Although 
epiblast stem cells (EpiSC) are self-renewing and possess similar pluripotent properties of ESCs, 
they are unable to contribute to chimaeras when introduced into a host blastocyst (Guo et al., 
2009), unless when implanted in the post-implantation stage (Huang et al., 2012). Moreover, 
signaling pathway requirements for the maintenance of their self-renewal ability are different 
from ESCs, involving Activin/Nodal and Fgf signaling as opposed to BMP4 and LIF signaling 
pathways (Shen, 2007). Thus, it is considered that ESCs represent an immature or so-called naïve 
state of pluripotency, which resembles that of the pre-implantation epiblast and is characterized 
by the ability to give rise to all somatic cell types and germline competency. Conversely, EpiSCs 
are considered to represent a more advanced state of pluripotency, which is primed for 
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differentiation, as seen in the post-implantation epiblast lineage in vivo (Huang et al., 2012). 
Similarly to ESCs, derivation of EpiSCs from post-implantation E5.5 to E8.5 allows cells to 
progress to a common self-renewing stage in vitro (Kojima et al., 2014). 
In the late 1990s, the first human ESCs were derived from pre-implantation embryos 
donated through in vitro fertilization (IVF) programs (Thomson et al., 1998). Like mouse ESCs, 
hESCs can contribute to teratoma formation when injected into mice, but due to ethical and 
practical reasons their ability to form chimeras cannot be tested. Yet, striking differences in 
morphology, growth factor requirement and epigenetic profiles between hESCs and mESCs later 
revealed that hESCs might in fact be more closely related to the primed mouse EpiSC state 
(Fig.1.3) , and hence might have a different embryonic origin from mouse ESCs (Tesar et al., 2007). 
These differences prompt the still ongoing quest for discovery of conditions that allow derivation 
and/or conversion of hESCs into a “naïve” state of pluripotency (Fonseca et al., 2015).  
Another pluripotent stem cell population has been derived from the mouse embryo. The 
Embryonic Germ (EG) cells can be established from primordial germ cells (PGCs) in the 
developing gonads of E8.5 to E11.5 post-implantation embryos and re-acquire the expression of 
pluripotency genes and similarly contribute to chimera formation (Labosky et al., 1994; Matsui 
et al., 1992; Resnick et al., 1992).  
In addition to pluripotent stem cell lines derived from the ICM/epiblast, extra-embryonic 
stem cell lines have also been successfully established. Here, extra-embryonic endoderm (XEN) 
stem cells derived from the PrE and trophoblast stem (TS) cells derived from the TE, have a 
restricted developmental potency as they can only contribute to the parietal endoderm or 
trophoblast lineages, respectively, when injected back into the embryo (Fig.1.3) (Kunath et al., 
2005; Tanaka et al., 1998). Unlike ESCs, TS cells rely on Fgf and Nodal signaling for their self-
renewal, whereas XEN require Fgf signaling for derivation only (Rossant, 2008). 
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Figure 1.3 Stem cell populations derived from blastocyst-stage embryos  
Schematic representation of the association between derived stem cell cultures and their in vivo 
counterparts. Three stem cells lines can be derived from the mouse pre-implantation blastocyst 
outgrowths: trophoblast stem cells (TS) fare derived from the trophectoderm (TE), embryonic stem cells 
(ESC) and extra-embryonic endoderm (XEN) are derived from the inner cell mass (dotted line) and 
represent the epiblast (Epi) and the primitive endoderm (PrE) lineages, respectively (full line). Epiblast 
stem cells (EpiSCs) are derived from post-implantation epiblasts. Human embryonic stem cells (hESC) are 
also derived from the ICM of pre-implantation blastocysts (dotted line) but are thought to represent the 
post-implantation epiblast in culture (full line). Markers indicated underneath are transcription factors 
associated with each of the respective lineages.  
 
1.4.2 Pluripotent stem cell heterogeneity and plasticity  
The establishment of embryonic and extra-embryonic cell lines have provided powerful tools 
for the dissection of the molecular mechanisms underlying lineage choices in the early embryo. 
In particular, the plasticity of ESCs has been exploited as an in vitro system to uncover regulatory 
switches between pluripotent naïve and primed states, different differentiated (ectoderm, 
endoderm and mesoderm) states, or even across embryonic and extra-embryonic fates (e.g. ESC 
conversion into TS or XEN cell states).  
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Standard conditions (serum and LIF) utilised to isolate and culture undifferentiated ESCs 
derived from the ICM have been proposed to support distinct cell sub-populations based on the 
observed fluctuations in the expression of a variety of pluripotency-associated factors (Torres-
Padilla and Chambers, 2014). In particular, oscillations in the expression of Rex1 associated with 
Oct4 defined an ICM-like (Rex1+) versus an early primitive ectoderm-like (Rex1-) sub-population 
in culture. Moreover, the later could differentiate more efficiently to somatic lineages and showed 
poor ability to contribute to chimera formation (Toyooka et al., 2008). Similarly, Nanog’s 
expression is found to be highly heterogeneous in the presence of serum and to associate with a 
naïve pluripotency state (Chambers et al., 2003; Kalmar et al., 2009). Cells with low levels of 
Nanog correlate with moderate expression of primitive-endoderm markers such as Gata4 and 
Hex1 (Canham et al., 2010; Singh et al., 2007) and the epiblast marker Fgf5 (Kalmar et al., 2009). 
Additionally, Nanog-low cells also exhibit a more pronounced differentiation potential when 
exposed to differentiation cues in vitro.  
 Moreover, fluctuations in the expression of non-pluripotency markers, which include 
lineage-affiliated markers, has also been identified in culture (Fig.1.4). One example is the 
aforementioned extra-embryonic associated factor Hex1, in which sub-populations with higher 
levels of expression were shown to increase the contribution into extra-embryonic endoderm 
when introduced back in early blastocysts (Canham et al., 2010). Another example is Otx2 – a 
transcription factor essential for brain development, which was found to be required to maintain 
the ESC metastable state, by promoting commitment to differentiation and essential for ESC 
transition into EpiSCs (Acampora et al., 2013). 
Heterogeneity has long been defined as a hallmark of ESCs, where the constant switch 
between metastable states might provide a mechanism that safeguards the rapid response to 
differentiation cues while retaining the self-renewal ability. However, the degree of heterogeneity 
has been proposed to be associated with the uncontrolled signalling environment that might be 
provided by the serum in culture. Thus, efforts to identify novel chemically defined derivation 
and culture conditions have led to the discovery of 2 key inhibitors  (2i) for Erk and Gsk3 
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pathways, which robustly block differentiation signals and lock ESCs in a so-called “ground” state 
of pluripotency (Ying et al., 2008). This translates into a more homogeneous colony morphology, 
transcriptome and epigenetic features, with reduced transcriptional gene priming for lineage-
affiliated genes (Fig.1.4). Nevertheless, despite higher homogeneity in the expression of 
pluripotency markers, ESCs cultured in 2i still express heterogeneous levels of extra-embryonic 
markers such as Hex1, Gata6 and even Cdx2, and gain enhanced capacity of contributing to extra-
embryonic tissues (Fig.1.4) (Canham et al., 2010; Morgani et al., 2013). Thus, heterogeneity is 
likely to be not only an extrinsic factor, but also an intrinsic feature of uncommitted ESCs, the 
extent of which can be manipulated by the culture conditions.  
 
Figure 1.4 Equilibrium of ESCs sub-states in different culture conditions  
Schematic representation of potential cell sub-types that coexist in 2i/LIF (yellow shade) and serum/LIF 
ESC cultures (purple shade). ICM-like “naïve” ESCs are represented in purple expressing high levels of 
pluripotency-associated factors Nanog and Rex1. Totipotent cells expressing low levels of TS marker Cdx2 
in 2i/LIF are represented in green. PrE precursors are indicated in blue, expressing low levels of markers 
such as Hex1 and Gata6. Epi precursors are indicates in orange, expressing low levels of post-implantation 
Epi markers of Fgf5 and Eomes. Moreover, in serum/LIF conditions, background expression of lineage-
affiliated genes is also detected Adapted from Morgani et al., 2013.   
 
Cell heterogeneity is also a defining feature of “primed” post-implantation derived EpiSC 
cultures. Sub-states have been identified by the heterogeneous levels of the pluripotency marker 
Oct4. Here, using an engineered EpiSC population expressing a GFP-coupled Oct4 transgene, it 
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was found that a sub-population expresses high levels of Oct4, which correlated with a 
transcriptome and epigenetic features that resembled those of most immature (E5.5) post-
implantation epiblast, notably devoid of transcriptional gene priming for germ layer markers. 
Remarkably, this minor fraction could readily contribute to chimera formation and could revert 
back to an ESC state more efficiently. EpiSCs expressing lower levels of Oct4-GFP were found to 
have a transcriptional profile aligned with later stage of epiblast maturation, and concordantly, 
could not form chimeras when injected into a host blastocyst. As seen in ESC cultures, these two 
EpiSC sub-populations can be interconverted (Han et al., 2010), and the degree of Oct4 
heterogeneity in culture can be attenuated by addition of Fgf4 in culture (Joo et al., 2014).  
Furthermore, PGCs derived from post-implantation epiblasts are unipotent in the sense that 
their developmental fate is uniquely biased towards the formation of germ cells. However, and as 
mentioned above, these cells can also generate in culture pluripotent ES-like cells (Matsui et al., 
1992). ESCs converted into an early epiblast-like cell (EpiLC) state can also generate functional 
PG-like cells in response to BMP4 and cytokines, whereas this process proved inefficient when 
using embryo-derived EpiSC cultures (Hayashi et al., 2011).  Thus, the ability to generate 
pluripotent PGC-like cells from EpiLCs corroborates with the ability of immature EpiSCs to revert 
back into naïve ESCs in contrast to more advanced EpiSCs, as identified by high and low Oct4, 
respectively (Han et al., 2010).   
ESCs and EpiSCs have different signalling requirements and these cell populations cannot 
spontaneously interconvert in culture. However, manipulation of signalling pathways can induce 
ESCs to differentiate into EpiSC cultures. ESCs cultures under the effect of Activin/Nodal and Fgf 
signalling, readily acquire an EpiSC phenotype and transcriptome (Guo et al., 2009; Jouneau et al., 
2012) , and can be stably propagated. However, culturing EpiSCs in ground-state ESCs conditions 
does not revert them back to an ICM-like state, unless by forced expression of the pluripotency 
marker Klf4 (Guo et al., 2009). Notably, the difficulty in reverting EpiSCs into ICM-like state is a 
feature attributed to the epigenetic barrier that separates these two pluripotent states. 
Nevertheless, EpiSCs were found able to revert into an ESC-like state without genetic 
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manipulation though at low frequency, by derivation and/or propagation on feeders and 
exposure to LIF-Stat signalling and serum (Fig.1.5) (Bao et al., 2009; Veillard et al., 2014), or by 
treatment with a cocktail of Lsd1, Alk5, Mek, Fgf and Gsk3 inhibitors (Zhou et al., 2010).  
 
1.4.3 Generation of extra-embryonic stem cell populations 
Mouse ESCs can also be directed to generate extra-embryonic lineages in vitro by genetic 
manipulation. Notably, over-expression of key TE or PrE-associated transcription factors, or 
down-regulation of transcription factors that safeguard the pluripotent state, can induce lineage 
switching between ESCs and TS or XEN cells lines. Notably, the pluripotency triad Oct4, Nanog 
and Sox2 was proposed to be at the heart of a multi-factor gene network that cooperates to 
sustain the pluripotent state by stimulating expression of downstream self-renewal genes while 
repressing differentiation-associated genes in ESCs (Yeo and Ng, 2013). Depletion of Oct4 in the 
embryo causes malformation of the pluripotent ICM, with concomitant differentiation into TE 
tissues (Nichols et al., 1998). Similarly, depletion of Oct4 in ESCs impairs the undifferentiated 
state and favors the formation of TS-like cells under appropriate culture conditions, due to de-
repression of the TE marker Cdx2 (Niwa et al., 2000). Concordantly, over-expression of Cdx2 in 
ESCs concomitantly inhibits Oct4 expression allowing the production of self-renewing TS-like 
cells, concordant with their mutual exclusive expression in TE versus ICM in the blastocyst (Niwa 
et al., 2005). Additionally, Sox2 cooperates with Oct4 to inhibit TE differentiation, by maintaining 
appropriate levels of Oct4. Concordantly, Sox2-depleted blastocysts cannot generate a pluripotent 
ICM, and depleted ESCs acquire a TS-like phenotype (Avilion et al., 2003; Masui et al., 2007). While 
Oct4/Sox2 and Cdx2 associate with and specify the ICM and TE, Nanog and Gata6 specifically 
mark Epi and PrE lineages, respectively (Chazaud et al., 2006). Differentiation into PrE is 
prevented by Nanog via transcriptional repression of Gata6 and other PrE-associated markers 
(Lavial et al., 2012; Singh et al., 2007). Conversely, PrE differentiation in ESCs can be 
accomplished by over-expression of Gata6 or deletion of Nanog, both in vitro and in vivo (Fujikura 
et al., 2002; Shimosato et al., 2007). However, although Nanog depleted pre-implantation 
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embryos do not form a pluripotent ICM, depleted ESCs can be established and maintain their 
pluripotency, highlighting a role in acquisition rather than maintenance of pluripotency 
(Chambers et al., 2003; Mitsui et al., 2003).  
Without gene manipulation, conversion of ESCs into a TS and XEN-like state can also be 
accomplished and/or inhibited by exposure to extrinsic signalling factors. In particular, LIF and 
BMP4 signalling molecules cooperate to support ESC self-renewal state by inhibiting trophoblast 
and neural differentiation (Qi et al., 2004; Ying et al., 2003a). Thus, in defined conditions, removal 
of LIF and treatment with BMP4 promotes direct activation of Cdx2, with concomitant activation 
of other TS cell markers (Fig.1.5) (Hayashi et al., 2010). Moreover, retinoic acid treatment of ESCs 
in monolayer (Artus et al., 2011; Capo-Chichi et al., 2005; Soprano et al., 2007) or cell aggregation 
into embryoid bodies in the absence of LIF has been shown to promote the emergence of PrE-like 
derivatives (Fig.1.5) (Coucouvanis et al., 1995). However, generation of a self-renewing XEN-like 
population from ESCs can only be achieved upon combined retinoic acid and Activin treatment 
(Fig.1.5) (Niakan et al., 2010; Niakan et al., 2013).   
 
1.4.4 Multi-lineage differentiation of pluripotent stem cells 
The remarkable ability of ESCs to derive a broad spectrum of cell types from the three germ 
layers has been extensively studied and continuously optimized (Keller, 2005). In particular, ESCs 
culture in suspension in the absence of LIF has been exploited as an in vitro system that mimics 
early segregation events in the mouse blastocyst and promotes the emergence of multi-lineage 
progenitors. These progenitors can then be further induced into mature cell types and/or 
propagated in monolayer systems. Moreover, direct differentiation of ESC in monolayer and on 
specific extra-cellular matrixes offer an alternative and efficient platform to differentiate these 
cells into specific and relevant lineages with key identified signalling pathways, as summarised 
in Fig.1.5. Overall, generation of in vitro systems that model transitions between pluripotent and 
somatic states provide important tools to investigate the molecular events underlying not only 
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the shut-down of the pluripotency network, but also the signalling requirements and specific gene 
function upon lineage commitment.  
 
 
Figure 1.5 In vitro differentiation of pluripotent stem cells  
Schematic representation of signalling pathways that can be manipulated in order to direct the fate of ESCs 
into extra-embryonic (blue shade), epiblast (yellow shade) and epiblast-derived lineages (orange shade) 
as depicted. ESCs rely on LIF and BMP4 (or serum) for the maintenance of their identity. Removal of LIF 
and BMP4 treatment directs ESCs towards a TS-like state, whereas treatment with all-trans retinoic acid 
(atRA) and Activin induces formation of self-renewing XEN cells. Embryo-derived EpiSCs sustain their 
pluripotent state through Nodal/Activin and Fgf signalling, hence culturing ESCs under these conditions 
promotes their conversion into an EpiSC-like state.  Moreover, EpiSCs can sporadically revert back to an 
ESC state by exposure to LIF and serum on feeders. Culture of ESCs in suspension in the absence of LIF 
promotes emergence of progenitors of both embryonic lineages and extra-embryonic PrE, mimicking the 
early segregation events in the blastocyst. ESCs, EpiSCs and embryoid bodies (EB) can be further induced 
to differentiate into cell types representative of the three germ layers that arise upon gastrulation in the 
post-implantation epiblast. Mesoderm (Meso) and definitive endoderm (DE) can be induced by BMP4 and 
Fgf signalling, but DE requires additional Activin. Induction of ectoderm (Ect), in particular neuroectoderm 
commitment, is associated with active Fgf signalling. Adapted from (Keller, 2005). 
       
1.4.5 Somatic reprogramming to pluripotency 
For decades, cell differentiation was assumed to proceed in a one-way route (Waddington, 
1957). However, this view has been challenged by the discovery that somatic cells are more 
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versatile than previously thought, and can be manipulated to re-acquire pluripotency through a 
process now commonly known as reprogramming.  
Pioneer experiments in the 1950s showed that using somatic cellular nuclear transfer 
(SCNT) (Gurdon, 1962), where the genetic information from a somatic cell is transferred into an 
unfertilized and enucleated oocyte, a full organism could be de novo generated from an adult, 
differentiated cell (Fig.1.6A). These cloning experiments initially performed in frogs thus 
uncovered that adult cells indeed retained the genetic information necessary to develop an entire 
organism, and that unlike previously hypothesised, differentiation did not occur with progressive 
loss of genetic information during development, which we now know is attributed to epigenetic 
regulation. It was only in the late 1990s that SCNT could then be replicated in mammals with the 
cloning of “Dolly” the sheep (Wilmut et al., 1997). It these pioneer experiments, it became 
apparent that the factors required for reprogramming were present in the host cell. Supporting 
evidence came from cell fusion experiments, where two cells are fused together in order to 
generate a multinucleated heterokarion (or hybrid if cell division occurs) (Fig.1.6B). Here, the fast 
dividing cell (dominant) induces changes in the gene expression profile of the second cell 
(recessive). This technique has since been applied to a number of somatic cell types 
reprogrammed by fusion with ESCs (Pereira et al., 2008; Tada et al., 2001; Ying et al., 2002).  
Altering the fate of a cell by forced expression of tissue-specific transcription factors has long 
been explored, but it was not until 2006 that the same procedure was found to be applicable to 
the reversion of somatic cells to a pluripotent state. In a ground-breaking study, mouse embryonic 
and adult fibroblasts were transduced with a combination of retroviral vectors encoding four key 
ESC transcription factors: Oct4, Sox2, Klf4 and c-Myc, commonly referred as to OSKM or Yamanaka 
factors (Takahashi and Yamanaka, 2006). This successfully induced a stable self-renewal state 
with acquisition of a multi-lineage developmental potency similar to ESCs (Fig.1.6C). This new 
type of induced pluripotent stem cells (iPSC) has since been exploited for its potential in 
autologous transplantation in regenerative medicine, disease modelling and drug screening 
studies. Moreover, the iPSC technology has since been continuously optimized for identification 
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of faster, safer and more efficient approaches, which include combination of signalling and 
epigenetic modifiers (Ohnuki and Takahashi, 2015).  
 
Figure 1.6 Multiple routes to reprogramming   
A. Nuclear transfer: the nucleus of a somatic cell is transplanted into an enucleated oocyte where it is 
reprogrammed. Upon transfer back to the uterus of the host species a full organism can be generated, or 
ESCs can be derived from the blastocyst. B. Cell fusion: two distinct cell types (eg. an ESC and a somatic cell) 
are fused together. Without proliferation, a multinucleated heterokaryon is formed, and the nuclear ratio 
in the fusion reprograms the heterokarion to the desired cell type. With cell proliferation (dashed line), the 
cells become hybrids and, on division, nuclei fusion occurs. If both cells are from the same species, their 
karyotype will remain euploid, but if they belong to different species the hybrid cells become aneuploid. C. 
Transcription factors: by introduction of the four genes Oct4 (O), Sox2 (S), Klf4 (K) and c-Myc (M) the 
pluripotent state can be induced in somatic cells, generating induced pluripotent stem cells (iPSC). Adapted 
from (Yamanaka and Blau, 2010). 
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I.5 Regulation of the pluripotent state  
The ease of manipulating embryo-derived pluripotent stem cell lines in culture has provided 
an extraordinary tool to decipher the molecular mechanisms that govern self-renewal and the 
remarkable long-term maintenance of multi-lineage developmental potency. Over the past 
decade, accumulating evidence highlighted that not one, but multiple factors, cooperate to sustain 
the unique ESC identity. As will be described in this section, the integrated action of multiple 
signalling pathways with complex gene regulatory networks, elegantly reinforced by chromatin 
and DNA modifiers, safeguard the self-renewing state while priming gene expression for efficient 
response to differentiation stimuli.  
 
1.5.1 Extrinsic signalling pathways  
Embryo development, as well as in vitro culture of ESCs, requires the action of extrinsic 
growth factors to preserve the pluripotent state. In turn, growth factors influence different 
intrinsic signalling pathways that will ultimately regulate the transcription factor network that 
sustains ESC identity.  
 
1.5.1.1 LIF-mediated signalling pathways 
Originally, ESC culture was found to rely on serum and a layer of feeder cells that consisted 
of mitotically inactivated mouse embryonic fibroblasts (MEF). It was later uncovered that the key 
component produced by MEFs was LIF, a member of the Interleukin-6 family cytokines, which 
sustained pluripotency by inhibiting differentiation through the JAK/STAT signalling pathway 
(Niwa et al., 1998). The LIF-mediated activation of this pathway occurs through the 
heterodimerization of the LIF receptor with the membrane protein gp130. This process leads to 
trans-phosphorylation and activation of JAK1 tyrosine kinase (Janus kinase), which 
phosphorylates gp130 and subsequently promotes STAT3 (Signal Transducers and Activators of 
Transcription 3) recruitment (Yoshida et al., 1994). Thus, STAT3 is in turn phosphorylated by 
JAK1 and forms a homodimer, which translocates into the nucleus where it potentiates ESC-
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specific gene expression (Niwa et al., 1998; Raz et al., 1999). Notably, STAT3 binds genomic 
regions co-occupied by the key transcription factors Nanog, Oct4 and Sox2 in the vicinity of genes 
specifically expressed in ESCs (Chen et al., 2008; Kidder et al., 2008). Removal of LIF, or 
knockdown of STAT3 target genes, results into the activation of a variety of endodermal and 
mesodermal-affiliated genes, proposing that the LIF/STAT3 action is essential for the silencing of 
differentiation markers via activation of key ESC-specific genes (Bourillot et al., 2009). Further 
evidence that STAT3 is a key player in this pathway comes from the observation that constitutive 
STAT3 activation confers LIF independency in ESCs (Matsuda et al., 1999). 
  
Moreover, two other pathways are induced upon LIF stimuli: PI3K and MAPK pathways. 
Activation of PI3K (PI3-kinase) is achieved through association between JAK1 and the subunit 
p54 of Pi3K, leading to activation of the serine/threonine kinase AKT (protein kinase B). In turn, 
AKT stimulates a number of other pathways, involved in cell cycle regulation (e.g. mTOR) and 
metabolism, as well inhibiting the WNT signalling via GSK3 (glycogen synthase kinase 3) 
(Vanhaesebroeck et al., 2001). Similarly to STAT3, inhibition of Pi3K leads to ESC differentiation, 
and LIF unresponsiveness, whereas constitutive activation of AKT sustains self-renewal without 
requirement of LIF (Paling et al., 2004). Activation of the MAPK/ERK pathway occurs through 
recruitment of the phosphatase SHP2 to the gp130, which in turn activates RAS/RAF components 
of this pathway (Schiemann et al., 1997). Activation of this pathway is linked to induction of 
differentiation, however, this is counterbalanced by activation of SOCS3 by STAT3, which down-
regulates ERK signalling by competition for the anchoring site of gp130 (Lehmann et al., 2003). 
Ultimately, the balance of the competing pathways activated by LIF sustains the pluripotent state 
in mouse ESCs. 
 
1.5.1.2 TGF-β-mediated signalling pathways 
The TGF-β superfamily is composed by a wide range of molecules, including TGF-β, Activin, 
Nodal, GDFs (growth and differentiation factors) and BMPs (bone morphogenetic proteins), 
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which regulate multiple cellular processes. The canonical pathway occurs via activation of SMAD 
proteins, leading to their nuclear translocation and target gene activation (Wrana et al., 1992).  
Binding of BMP ligands to type II receptors leads to activation of type I receptors by 
phosphorylation. In turn, type I receptors phosphorylate SMAD1, 5 and 8, which stimulate gene 
expression. In particular, BMP4, has been found to substitute serum in the maintenance of 
pluripotency by inhibiting neural differentiation via activation of the Id genes, and inhibition of 
the MAPK/ERK pathway (Qi et al., 2004; Ying et al., 2003a). Additionally, it promotes proliferation 
by stimulation of WNT expression (Lee et al., 2009). Moreover, BMP4 also plays a role during 
differentiation into the mesoderm and hematopoietic lineages, and, together with Activin, induces 
cardiac development (Laflamme et al., 2007; Sadlon et al., 2004). This cooperative action is linked 
with the activity of SMADs in regulating Oct4 expression, which is involved in cardiac lineage 
specification (Zeineddine et al., 2006). However, BMP4-alone induces extra-embryonic 
differentiation in human ESCs and mouse EpiSC (Brons et al., 2007; Vallier et al., 2009b; Vallier et 
al., 2009c), while high BPM4 concentrations in mouse EpiSCs self-renewing conditions can induce 
differentiation into germ cells (Hayashi and Surani, 2009; Tesar et al., 2007).  
 
Activin and Nodal signalling comprise another branch of the canonical TGF-β pathway, which 
has been widely associated with the self-renewal maintenance of primed, LIF-irresponsive, 
mouse EpiSCs and human ESCs. This occurs via SMAD2/3-mediated activation of Nanog and, 
consequently, inhibition of neuronal differentiation (Vallier et al., 2009a). In mouse ESCs, 
however, it appears to have no impact on the undifferentiated identity but instead was found to 
be associated with cell proliferation (Ogawa et al., 2007).  
 
1.5.1.3 FGF-mediated signalling pathways 
FGF (Fibroblast growth factor) signalling has a key role in lineage segregation in the early 
mouse blastocyst. In particular, Fgf4 is produced by ICM cells and ICM-derived ESCs, and its 
expression is enhanced by the pluripotency-associated factors Oct4 and Sox2 (Yuan et al., 1995). 
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In the blastocyst, Fgf4 action is required for proper trophectoderm and primitive endoderm 
formation, where its receptor Fgfr2 is expressed (Feldman et al., 1995; Haffner-Krausz et al., 
1999). Concordantly, addition of exogenous Fgf4 is required for derivation and/or maintenance 
of extra-embryonic derived stem cells in vitro (Kunath et al., 2005; Tanaka et al., 1998). Although 
ESCs produce Fgf4 in an autocrine fashion, this is dispensable for sustaining their self-renewal 
state, but instead promotes lineage commitment (Kunath et al., 2007; Stavridis et al., 2007) 
FGF signalling occurs upon ligand-receptor interactions, leading to auto-phosphorylation of 
tyrosine residues of Fgfr2. In turn, this activates the mediators Grb2 and, consequently, the 
Pi3K/AKT and MEK/ERK pathways, which will contribute to induction of self-renewal and 
differentiation of mouse ESCs, respectively. Hence, chemical inhibition of MEK with PD0325901 
supports the self-renewal state, but is insufficient to sustain it unless combined with a GSK3 
inhibitor (Ying et al., 2008).     
In mouse EpiSCs and human ESCs, maintenance of the self-renewal state requires active FGF 
signalling by addition of exogenous Fgf2 (Brons et al., 2007). However, and unlike human ESCs, 
FGF signalling in mouse EpiSCs is not essential for SMAD2/3-mediated activation of Nanog, but is 
rather required to prevent spontaneous neuronal differentiation and reversion to an ESC-like 
state (Greber et al., 2010). 
 
1.5.1.4 WNT-mediated signalling pathways 
The WNT signalling pathway has key roles in a wide range of cellular processes like 
proliferation, adhesion, morphology and migration (Bejsovec, 2005). It encompasses more than 
30 extracellular ligands that can either operate via a canonical pathway, which involves β-
catenin-mediated gene expression, or via a β-catenin-independent non-canonical pathway, which 
involves activation of many other signalling cascades (Widelitz, 2005).  Upon ligand binding, 
activation of the two receptors Frizzled and LRP (low-density lipoprotein receptor protein) leads 
to inhibition of the GSK3-mediated destruction of β-catenin. Accumulated β-catenin translocates 
into the nucleus and promotes the expression of pluripotency factors including Oct4, Nanog, 
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Tfcp2l1 and Esrrb, through degradation of the repressor Tcf3 (Wray et al., 2011). Here, Esrrb is 
considered a key downstream target of GSK3 pathway as depletion of Esrrb abrogates the effect 
of Tcf3 inhibition and impairs ESC self-renewal (Martello et al., 2012). A parallel effect of Tcf3 
degradation is the activation of Nr5a2, which stabilizes the expression of Oct4, Nanog and Tbx3 
(Fuhrmann et al., 2001).  
In ESC cultures, the accumulation of β-catenin can be promoted by chemical inhibition of the 
GSK3 pathway with CHIR99021, but alone is not sufficient to promote self-renewal. Thus, 
activation of the β-catenin signalling by GSK3 inhibition, in combination with inhibition of MEK-
induced differentiation (2 inhibitors, 2i) can together bypass the requirement for the LIF/STAT3 
signalling pathway and moreover, has been proposed to promote a robust ESC self-renewal 
“ground” state (Ying et al., 2008). In mouse EpiSCs and human ESCs, however, activation of the 
WNT signalling is associated with differentiation into mesoderm, when coupled with BMP4 
(Kurek et al., 2015).  
 
 
Figure 1.7 Self-renewal signalling pathways in naïve and primed pluripotent states 
Summary of signalling events that directly (full line) or indirectly (dotted line) are involved in activating 
the expression of self-renewal (green) and blocking expression of differentiation-associated (blue) genes 
in naïve (mouse ESC) and primed (mouse EpiSC) pluripotent states. In ESCs BMP4 (TGF-β), LIF and WNT 
signalling cascades together sustain self-renewal, while MEK/ERK promotes differentiation. In EpiSCs, 
Activin/Nodal and FGF signalling are essential for self-renewal, while induction of BMP4 or WNT pathways 
promotes differentiation.    
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In summary, mouse ESCs and EpiSCs (and human ESCs) require different signals for the 
maintenance of their pluripotency, with the same signalling pathways, remarkably, having 
opposite roles in ESCs versus EpiSCs. However, and despite intrinsic differences, the combinatory 
action of signalling pathways in both naïve and primed pluripotent cell populations is required to 
support the expression of pluripotency genes and prevent that of differentiation genes, hence 
ultimately sustaining the undifferentiated state.    
 
1.5.2 Transcription factors network  
Ultimately, the cell’s pluripotent state reflects the action of multiple signalling cues on the 
downstream gene expression programs. Transcription factors (TF) are the key mediators in this 
process, which will coordinate the activation, repression or even priming of transcription, trough 
recruitment of multi-protein complexes and alteration of the chromatin environments. Gene 
function studies in ESCs have allowed thus far the identification of a critical network of TFs that 
robustly confer their unique pluripotent identity.  
 
1.5.2.1 Core transcription factors  
The triad Oct4-Sox2-Nanog is at the core of the transcriptional regulation in ESCs as revealed 
by their co-binding to the same genome-wide DNA target sites (Kim et al., 2008). Oct4 is a member 
of the Pit-Oct-Unc (POU) family, and is encoded by the Pou5f1 gene. It was one of the first 
transcription factors identified as crucial in early embryo development. It is expressed from the 
8-cell stage and its expression becomes restricted to the pluripotent ICM prior to implantation, 
and remains on in the epiblast after implantation before being confined to the posterior epiblast 
and PGCs (Osorno et al., 2012; Radzisheuskaya et al., 2013; Scholer, 1991). Concordantly, Oct4 is 
highly expressed in embryo-derived ESCs, EpiSCs and EGs, and its expression is reduced when 
cells are induced to lose their pluripotent identity (Nichols et al., 1998). Fine-tuning of Oct4 levels 
is an essential requirement for the pluripotent state in ESCs, as reduction of Oct4 expression is 
sufficient to trigger differentiation into TS-like cells, by lack of Oct4-depentend inhibition of the 
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TE markers Cdx2 (Niwa et al., 2000; Niwa et al., 2005). Conversely, its over-expression induces 
differentiation of ESCs into primitive endoderm and mesoderm fates (Niwa et al., 2000), 
proposing that Oct4 may function in a dynamic context-dependent manner.   
Oct4 regulates the expression of a broad range of genes through direct DNA binding. In 
particular, it has been found to recognise an octamer-sox motif (Oct-Sox) in the DNA, where it 
cooperates with Sox2 in regulating gene activation (Tomioka et al., 2002). Evidence for Oct4 
versatility comes from the identification of novel cell state-dependent protein partners. Upon 
induction of a PrE-like state in ESCs by enforced Sox17 expression, Oct4 is re-distributed into 
regulatory sites of endodermal genes, switching interaction between Sox2 to Sox17 (Aksoy et al., 
2013). Similarly, upon exit of the naïve ESC state into a primed EpiSC-like state, Oct4 binding is 
also re-distributed into Otx2 or Zic motifs, at regulatory regions of genes associated with the post-
implantation epiblast (Buecker et al., 2014; Yang et al., 2014). Notably, some level of Oct4 binding 
is already present at a selection of post-implantation genes in the naïve state such as Fgf5 or 
Brachyury, possibly associated with lineage priming functions.  
In addition to Sox2, genome-wide Oct4 binding sites in ESCs encompass motif sequences for 
other pluripotency factors (Buecker et al., 2014), which integrate the so-called “Oct4-centric 
module”. The definition of such module was based on the chromatin co-occupancy of proteins at 
target chromatin sites, encompassing factors such as Nanog, Sox2, Esrrb, Klf4, Smad1, Stat3, Dax1 
or Tcfp2l1 (Chen et al., 2008; Kim et al., 2008). This analysis further uncovered a second module 
centred on c-Myc (“Myc-centric module”), which involves factors such as n‑Myc, E2f1, Zfx and 
Rex1, and appears to control different sets of genes that are associated with protein metabolism 
and cell cycle (Chen et al., 2008; Hu et al., 2009). Furthermore, Oct4 physically interacts with a set 
of pluripotency factors, consistent with their identified co-binding in the DNA. Since abolishing 
Oct4 strikingly impairs the recruitment of these factors, it has been proposed to play a pioneer 
role in the assembly of multi-protein complexes at the chromatin (van den Berg et al., 2010).  
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Sox2 [SRY (sex determining region Y)-box 2] is a member of the Sox family of transcription 
factors that, like Oct4, is detected in the pluripotent ICM, where it cooperates with Oct4 in TE/ICM 
segregation (Avilion et al., 2003; Masui et al., 2007). However, after implantation the expression 
of Oct4 and Sox2 become oppositely restricted to the posterior (mesoderm, endoderm) and 
anterior (ectoderm) epiblast, respectively. Concordantly, Sox2 is expressed in ESCs, EpiSCs, 
PGCs/EGs, and embryonic and adult neural stem cells (D'Amour and Gage, 2003; Ellis et al., 2004).  
As mentioned above, Oct4 and Sox2 co-regulate pluripotency genes through binding to a 
common Oct–Sox motif at regulatory regions. Similarly to Oct4, upon induction of neuronal fates, 
Sox2 was found to switch partners to activate neuronal genes. Specifically, it has been found to 
co-occupy neuronal-specific regulatory sites with another member of the POU family – Brn2 
(Pou3f2). However, unlike Oct4, Sox2 recognises the same DNA sequence in different cell states, 
suggesting that the re-distribution of binding at target sites is driven by its specific co-partners in 
a context-dependent manner (Lodato et al., 2013) . 
 
Nanog is a homeobox transcription factor that, alongside Oct4 and Sox2, is expressed in the 
pluripotent ICM, but becomes restricted to the epiblast progenitor blastomeres in late blastocysts 
by counteracting Gata6-driven PrE specification (Chazaud et al., 2006). Nanog expression is 
down-regulated before implantation and is re-activated in the posterior primitive-streak until 
early somitogenesis (Osorno et al., 2012). Similarly to Oct4 and Sox2, it is expressed in ESCs, 
EpiSCs and PGCs/EGs, having an essential role in the maintenance of pluripotency as highlighted 
by the loss of ESC self-renewal upon conditional depletion, and the acquisition of LIF-
independence upon over-expression (Chambers et al., 2003; Mitsui et al., 2003). Based on this 
property the gene was named after the legendary Tir na n’Og - the Celtic land of the ever young. 
Nanog inhibits the expression of the PrE markers Gata4 and Gata6, while promoting the 
expression of many pluripotency genes in the Oct4-centric module (Chen et al., 2008; Kim et al., 
2008). Unlike Oct4, the expression levels of Nanog (and Sox2) diminish in the post-implantation 
epiblast and in EpiSCs. Concordantly, forced expression of Nanog in EpiSCs can revert them back 
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to an ESC state, whereas over-expressing in ESCs prevents differentiation (Osorno and Chambers, 
2011).  
Similarly, the expression of a set of naïve pluripotency markers such as Esrrb, Klf4, Klf5, Tbx3 
and Rex1 also become down-regulated in EpiSCs (Festuccia et al., 2012; Osorno and Chambers, 
2011). Given the equal dynamics of Nanog, reduction of this set of pluripotency markers may be 
a consequence of Nanog decrease. In agreement, metastable culture conditions (Serum/LIF) 
stimulate high heterogeneity of Nanog expression, promoted by auto-regulatory loop of Nanog 
(Navarro et al., 2012). Heterogeneous expression of the downstream targets Esrrb, Klf4 and Tbx3 
is also detected in such conditions, suggesting that these fluctuations are directly influenced by 
Nanog expression itself (Osorno and Chambers, 2011). Notably, over-expression of these Nanog’s 
gene targets (Klf4, Tbx3 and Esrrb) is sufficient to confer LIF-independence bypassing the 
requirement for Nanog (Festuccia et al., 2012; Niwa et al., 2009). In particular, LIF-independency 
mediated by enforced Esrrb expression was found to strictly require the recruitment of its 
essential co-activator Ncoa3 in ESCs (Percharde et al., 2012). Additionally, forced expression of 
Esrrb or Klf4 also enables reversion of EpiSCs into an ESC-like state (Festuccia et al., 2012; Guo et 
al., 2009). 
 
LIF-independency studies furthermore highlighted key connections between LIF/STAT3 
signalling and the core transcriptional machinery. Notably, LIF was found to activate a parallel 
circuitry where the JAK-STAT3 branch activates the expression of Klf4, and the Pi3K–AKT 
pathway preferentially induces the expression of Tbx3. Klf4 and Tbx3 stimulate Sox2 and Nanog, 
and contribute to the maintenance of Oct4 (Niwa et al., 2009). Moreover, Esrrb is a key 
downstream target of the canonical WNT signalling pathway and stimulates the expression of 
Oct4, Nanog, Klf4 and Esrrb itself, though recognition of ERRE motifs at these loci (Martello et al., 
2012; Percharde et al., 2012). In turn, the transcription of Esrrb, Tbx3 and Klf4 is positively 
regulated by the core Oct4-Sox2-Nanog transcription factors, which may altogether reinforce the 
stability of the pluripotent state.  In post-implantation, the lower expression of Nanog is instead 
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regulated by the Nodal signalling pathway and directly sustained by Oct4 and Smad2 (Sun et al., 
2014). Altogether, the core network of transcription factors functions in the auto-regulation of 
their expression via an interconnected regulatory loop and by activating expression of genes 
required for the ESC self-renewal, while expressing differentiation-associated genes.  
 
1.5.2.2 Transcription factor clusters at “enhanceosomes” 
Transcription factors (TF) bind proximal DNA elements, usually associated with promoter 
regions in the vicinity of a gene, but also bind to distal regions that can be located up to several 
kb away from the gene itself. These distal elements are typically involved in potentiating gene 
expression and are termed enhancers. Pioneer mapping of TF binding sites through chromatin-
immunoprecipitation techniques, coupled with high-throughput sequencing (ChIP-seq) 
uncovered that multiple TFs tend to bind to the same DNA regions, termed multiple transcription 
factor-binding loci (MTL) (Kim et al., 2008; Chen et al., 2008). Moreover, most of these MTLs 
comprise enhancer regions that are co-occupied by transcriptional co-factors such as p300 and 
Mediator complexes, and furthermore display enhancer activity when cloned into luciferase 
reporters (Chen et al., 2008; Kagey et al., 2010). Thus, MTL regions are often referred as to 
“enhanceosomes” where higher order multi-protein complexes are assembled, being able to 
modify the chromatin environment and hence allowing the recruitment of the basal 
transcriptional machinery.  
 
Enhancer activity implies the coordinated recruitment of co-factors by TFs. These molecules 
do not necessarily have a DNA-binding ability, but are able to further recruit chromatin modifiers. 
In particular, the p300 and Mediator co-activator complexes are large multi-subunit complexes 
that are able to simultaneously interact with several TFs (Malik and Roeder, 2005). Of relevance, 
p300 possesses chromatin modifying activity, being able to acetylate the lysine 27 of histone 3 - 
a modification associated with permissive chromatin environment for TF binding (Tie et al., 
2009). Moreover, the Mediator complex has a key role in mammalian transcription and associates 
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with Cohesin-loading factor Nipbl at Oct4-Sox2-Nanog bound sites. In turn, Nipbl loads cohesin 
ring proteins at enhancer sites contributing to DNA-DNA interactions between enhancer and 
promoters (Kagey et al., 2010). Cohesin is a multi-meric complex that has been firstly identified 
for its role in sister chromatid cohesion, but has later been found to promote DNA double-strand 
break repair and to regulate gene expression in a manner that involves enclosing the DNA within 
its ring-shaped structure (Nasmyth and Haering, 2009). 
The recruitment of given factors at enhancers regions occurs in a cell type specific manner. 
In ESCs, a subset of large enhancers regions are densely occupied by Oct4, Sox2, Nanog, Klf4, Esrrb 
and by Mediator, and potentiate the strong expression of pluripotency and self-renewal-
associated genes. These regions were recently termed “super” enhancers, and  differ from 
“typical” enhancers that are typically smaller and less densely occupied by TFs. Super enhancers 
are sensitive to the reduction levels of subunits of the Mediator complex, similarly to a reduction 
of Oct4, highlighting this TF as a key component of the enhanceosome and cell identity (Kagey et 
al., 2010). Thus, robust assembly of enhancer complexes is a crucial factor in the maintenance of 
a cell’s identity due to their roles in bridging enhancers and promoters, shaping the chromatin 
landscape and allowing the recruitment of the transcriptional machinery for proper expression.  
 
1.5.3 Epigenetic gene regulation  
The genetic information identically contained within each cell is subjected to multiple layers 
of regulation during development to ensure that the appropriate gene expression programs are 
in place at the right time and in a cell type specific manner. Thus, the ability to establish and 
inherit suitable transcriptional states over cell divisions is vital for a cell’s identity. In the nucleus 
of eukaryotic cells, DNA is wrapped around four core histone proteins (H2A, H2B, H3, H4) shaping 
a nucleosome unit. The resulting DNA-protein polymers form the chromatin template. Additional 
histone proteins – the histone protein H1 and its variants, play key roles in the assembly of higher 
order chromatin structures. Chromatin compaction is necessary to accommodate the extended 
DNA molecule into a cell’s nucleus, and moreover to regulate multiple processes such as 
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chromosome segregation, safeguarding the genome integrity, and regulating gene expression and 
DNA replication (Chen and Dent, 2014; Lukas et al., 2011; Rosa and Shaw, 2013). Thus, chromatin 
compaction is dynamically regulated in response to environmental cues and occurs at multiple 
levels including post-translational modifications (PMT) of histone proteins, ATP-dependent 
chromatin remodelling, additional histone variants, DNA modifications and non-coding RNAs 
(Fig.1.8). Modifications in histones and in the DNA, without affecting its sequence, are mostly 
reversible and termed epigenetic modifications (Chen and Dent, 2014).  
 
 
Figure 1.8 Chromatin organization in eukaryotes 
Schematic representation of the levels of genome organisation in eukaryotic cells. DNA is wrapped around 
compact histone complexes containing a pair of each of the four core histones H2A, H2B, H3 and H4. 
Condensation of nucleosomes forms a compact chromatin fibre, which can be dynamically organised into 
functional nuclear territories. Histones can be post-translationally modified (PTM) and DNA can be 
methylated (me). Figure from (Rosa and Shaw, 2013).  
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Histone PMTs include acetylation, methylation and ubiquitination, and are regulated through 
the enzymatic action of histone acetyltransferases (HATs) and deacetylases (HDACs), lysine 
methyltransferases (KMTs) and demethylases (KDMs), and ubiquitylases (E1, E2 and E3 
enzymes) and deubiquitylases (DUBs), respectively. In the other hand, DNA modification 
encompass different forms of cytosine methylation. DNA can be methylated by DNA 
methyltransferases (DNMTs), or demethylated by a passive mechanism, which involves 
inhibition of the “maintenance” DNMTs upon replication, or through an active multi-step 
mechanism that involves oxidation into intermediate states by the TET enzymes (Branco et al., 
2012; Carey et al., 2011; Chen and Dent, 2014). Ultimately, the coordinated action of histone and 
DNA modifiers influences the degree of chromatin compaction, which can be either less compact, 
and thus more accessible – euchromatin, or more compact and inaccessible – heterochromatin. 
In turn, chromatin conformation will further allow recruitment of regulatory factors and enable 
transcription at euchromatin regions, or impede the access of binding factors and disable 
transcription at heterochromatin regions.  
 
1.5.3.1 Chromatin dynamics during early development  
The maternal and paternal genomes exhibit striking asymmetries in their chromatin 
organization in the zygote and early cleavage stage embryos (Burton and Torres-Padilla, 2014). 
Following fertilization, the two parental epigenomes must go through global reprogramming 
events in order to accommodate the gene expression programs necessary for the development of 
the embryo. The paternal chromatin is tightly packed, but upon fertilization is de-condensed 
while undergoing active genome-wide DNA demethylation. In contrast, the maternal genome 
undergoes a passive DNA demethylation process. The only genomic regions that escape 
demethylation are differentially methylated regions encompassing imprinted genes in either the 
paternal or maternal DNA (Burton and Torres-Padilla, 2014; Hemberger et al., 2009). De novo 
DNA methylation starts at the blastocyst stage, coinciding with the first lineage segregation event 
between ICM and TE. Notably, global DNA methylation levels are asymmetric between the two 
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lineages, being higher in the ICM, and this asymmetry persists throughout development (Rossant 
et al., 1986; Santos et al., 2002). Subsequently, a new wave of de novo DNA methylation in the 
epiblast marks the post-implantation stage concomitant with an increase in Dnmt3b expression 
levels, and the occurrence of random X chromosome inactivation (Hirasawa and Sasaki, 2009; 
Reik, 2007).  
Moreover, the prevalence of histone modifications and/or associated histone modifiers has 
been implicated in lineage specification. One of these is the methyltransferase Carm1, which 
methylates H3R2, H3R17 and H3R26 residues; a set of modifications commonly associated with 
gene activation. High levels of Carm1 protein in individual blastomeres of cleavage-stage embryos 
introduce an early bias that preferentially leads to cell allocation within the ICM of newly formed 
blastocysts (Torres-Padilla et al., 2007). Another example is the histone methyltransferase 
Setdb1, which deposits the repressive marks H3K9me2 and H3K9me3 and acts as a co-repressor 
with Oct4 to in vivo silence the expression of TE-associated genes such as Cdx2 in ICM cells.  
Concordantly, depletion of Setb1 in ESCs results into the de-repression of TE-associated genes 
and differentiation into TS-like cell progenitors (Dodge et al., 2004; Yuan et al., 2009). Similarly, 
the nucleosome remodelling and deacetylation (NuRD) complex was involved in ICM/TE 
segregation. Depletion of the component Mbd3 in early embryos is lethal, and in ESCs allows 
conversion into a TS-like state, displaying aberrant expression of the TE markers Elf5 and Eomes 
(Kaji et al., 2006; Latos et al., 2012).   
 
As described earlier in this Chapter, following implantation the epiblast give rises to the three 
germ layers.  As seen in the pre-implantation embryos, several chromatin remodelers have also 
been associated with this process of lineage specification. Particularly, proteins of the Polycomb 
Repressor Complexes (PRC) are known to play an essential role in gastrulation. Depletion of 
members of the PRC2 complex such as Ezh2, Eed or Suz12 results into embryonic lethality shortly 
after implantation (Faust et al., 1995; O'Carroll et al., 2001; Pasini et al., 2004).  Equally, 
components of the PRC1 complex such as Ring1b, Rybp and L3mbtl2 have been found to have a 
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key function at this developmental transition (Pirity et al., 2005; Qin et al., 2012b; Voncken et al., 
2003). Notably, constitutive depletion of PRC1 and PRC2 members in ESCs results in 
inappropriate gene expression of differentiation-associated genes, without impact on the self-
renewal ability of these cells, consistent with a key role for these complexes in the repression of 
lineage-affiliated genes during development (Azuara et al., 2006; Boyer et al., 2006; Pasini et al., 
2004).  
Critically, the expression of pluripotency genes also needs to be silenced during 
development. Persistent expression of Oct4 and Nanog due to a lack of appropriate repression, 
leads to growth retardation and embryonic lethality. One key repressive factor that has been 
involved in the silencing of these genes is the H3K9me2-methyltransferase G9a (Ehmt2) 
(Tachibana et al., 2002). This protein is typically forms a heteromeric complex with the highly 
similar G9a-like protein (GLP; Ehmt1) and silencing each of the two proteins considerably 
reduces the levels of H3K9me1/2 (Collins and Cheng, 2010). ESCs lacking G9a protein expression 
present impaired differentiation due to the inability to silence Oct4. Although H3K9me2 is a 
histone modification typically associated with euchromatin, it is strictly necessary for the further 
formation of heterochromatin by H3K9me3 deposition and de novo Dnmt3b-mediated DNA 
methylation at the Oct4 locus during differentiation (Feldman et al., 2006).  
 
1.5.3.2 ESC-specific chromatin landscaping 
ESCs harbour distinct chromatin features from adult cells. Notably, undifferentiated ESCs are 
characterized by an open and mostly accessible chromatin conformation with disperse chromatin 
fibres spread throughout most of the nuclei and no significant foci of chromatin compaction 
(Fig.1.9)(Ahmed et al., 2010). This is consistent with a widespread enrichment for H3K4 
methylatiom (and concomitant H3K27me3 as discussed below), H3K9 acetylation and DNA 
hypomethylation, reflecting an active genome configuration (Azuara et al., 2006; Meissner et al., 
2008). As differentiation progresses, the chromatin acquires a more compacted configuration 
(Fig.1.9). Staining of repressive heterochromatin marks such as H3K9me3, and the associated 
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protein HP1 reveals a higher density of heterochromatin foci emerging in differentiated cells as 
opposed to ESCs. Thus, in the undifferentiated state, HP1 and linker histones are hyperdynamic, 
as they loosely bind to chromatin (Meshorer et al., 2006). Moreover, the repressive mark 
H3K27me3 also changes from focal distribution in undifferentiated cells into expanded block that 
encompass intergenic regions and silent genes in differentiated cells (Pauler et al., 2009). 
Contrarily, euchromatin marks such as H3K9me2 display local rather than global changes, 
especially at genic regions (Lienert et al., 2011).   
 Concordantly, differences in gene accessibility between undifferentiated and differentiated 
cells are furthermore mirrored by different DNA replication timing at subsets of genes associated 
with development. In ESCs, lineage-affiliates genes display an early S-phase replication timing, 
which reflects an open chromatin environment despite these genes not being expressed. On the 
other hand, in differentiated cells, genes that are affiliated with different (or inappropriate) 
lineages display a late-replication timing, consistent with heterochomatin formation and/or 
stable silencing (Azuara et al., 2006; Hiratani et al., 2004; Hiratani et al., 2010; Hiratani et al., 
2008; Perry et al., 2004). 
ESC-specific chromatin configuration in vitro replicates the correspondent state of their in 
vivo early embryo counterpart, and is directly linked with lineage commitment (Fig.1.9). 
Chromatin in the pluripotent ICM of E3.5 embryos appears highly dispersed, and this 
configuration is established as early as the 8-cell embryo stage. Upon lineage segregation, 
chromatin compaction emerges in the blastomeres restricted to TE and PrE. Thus, higher degree 
of compaction can also be detected in embryo-derived XEN and TS cells as compared to ESCs 
(Ahmed et al., 2010).     
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 Figure 1.9 Genome organization in ESC and Differentiated cells 
Schematic representation of the level of genome compaction as visualized in the nucleus of ESCs and 
differentiated cells. ESCs are characterized by dispersed chromatin fibres, poorly enriched in repressive 
foci of H3K9me3. Differentiated/somatic cells display a higher degree of chromatin compaction with blocks 
of condensed chromatin rich in H3K9me3 and H3K27me3. Adapted from (Chen and Dent, 2014). Bottom 
panel shows electron spectroscopic imaging of E3.5 epiblast (A), lymphocyte (B), and a spleen lymphocyte 
(C), showing the acquisition of chromatin compaction near the nuclear envelope in more differentiated 
cells (arrows). Bottom panel image from (Rapkin et al., 2012).  
 
1.5.3.3 Bivalent chromatin domains  
Accessible chromatin state provides a permissive environment for active transcription a 
seen across a large number of ESC-specific and differentiation-associated genes in ESCs. Thus, 
repressive mechanisms must be put in place in order to maintain lineage-affiliated genes silent, 
yet ready for activation during development. The repression of development genes is imposed 
through the action of the above-mentioned Polycomb Repressive Complexes (PRC), originally 
discovered as gene repressors in Drosophila melanogaster (Schuettengruber et al., 2007). The two 
PRC groups have distinct repressive enzymatic functions at gene promoter regions. PRC2 
contains the enzyme Ezh2, which catalyses tri-methylation of H3K27 (H3K27me3). In turn, the 
Cbx proteins of the PRC1 recognize H3K27me3 and subsequently the enzymes Ring1a and Ring1b 
catalyse the monoubiquitylation of H2AK119 (H2AK119ub1). Conversely, the SET1A/B and MLL 
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family of proteins catalyse the methylation of H3K4 (H3K4me2/3) at promoters of genes, 
typically associated with active transcription (Clouaire et al., 2012; Hu et al., 2013). Notably, both 
active and repressive marks, together with PRC1 and PRC2 complexes, have been found to 
simultaneously occupy a large number of inactive, lineage-associated gene promoters in ESCs, 
thus termed bivalent chromatin structure (Azuara et al., 2006; Bernstein et al., 2006; Boyer et al., 
2006; Lee et al., 2006b).  This distinctive chromatin configuration has also been identified in ICM 
and early epiblast cells of the embryo (Alder et al., 2010; Rugg-Gunn et al., 2010) and has been 
proposed to hold transcription in a poised state, allowing rapid activation (or continued 
repression) of genes upon differentiation stimuli as monitored in ESCs (Azuara et al., 2006; Boyer 
et al., 2006; Pasini et al., 2004). 
 
Accumulating evidence from genome-wide transcriptional and epigenetic profiling has 
shown that during differentiation, the bivalent chromatin structure is resolved to cell-specific 
gene expression programs, but can also be acquired de novo at subsets of genes. Comparing ESCs, 
MEFs, and ESC-derived neuronal progenitor cells (NPC) it was found that most of the bivalently 
marked promoters become either activated by losing the PRC-mediated repressive H3K27me3, 
or repressed by losing the H3K4me3 mark. Yet, 4% (MEFs) and 8% (NPC) retained the bivalent 
marks at the promoters of genes of related lineages (Fig.1.10) (Mikkelsen et al., 2007). In a 
subsequent study comparing ESCs and terminally differentiated neurons, it was independently 
found that, while bivalency was resolved at a large proportion of promoters, it was also regained 
at subsets of previously unmarked regions (Mohn et al., 2008).  
Moreover, during differentiation additional repressive marks such as DNA methylation and 
H3K9 methylation have also been found to be de novo acquired at bivalently marked regions to 
reinforce the silencing of lineage-inappropriate genes (Alder et al., 2010; Senner et al., 2012). 
Active and bivalent domains strongly correlate with CpG islands (Bernstein et al., 2006; Mohn et 
al., 2008), which lack DNA methylation and H3K9me2/3 deposition in ESCs, consistently with 
their mutual exclusion with H3K4me2/3 marks (Lienert et al., 2011; Mikkelsen et al., 2007; Mohn 
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et al., 2008). This is also in concordance with the presence of CpG dense DNA sequences that are 
likely involved in the recruitment at active and bivalent promoters of H3K4 methyltransferases 
SET1A/B and MLL2, respectively (Clouaire et al., 2012; Hu et al., 2013), two activating complexes 
known to specifically recognize unmethylated CpG islands via their DNA-binding domains (Birke 
et al., 2002; Lee et al., 2001). Yet these regions were selectively found to be targeted by Suv39h1-
mediated H3K9 methylation and de novo DNA methylation without losing their activating H3K4 
methylated marks upon ESC conversion into TS-like phenotype. This resulted into the formation 
of trivalent chromatin structure associated with the silencing of lineage-appropriate genes in 
extra-embryonic cells as furthermore confirmed in vivo (Alder et al., 2010).  
 
Another characteristic feature of bivalent promoters is the assembly of a poised 
configuration of RNA Polymerase II (RNAPII) complexes (Brookes and Pombo, 2009; Stock et al., 
2007). Gene expression in somatic cells typically relies on promoter recognition by a pre-
initiation complex (PIC), and enhancer-promoter bridging by the Mediator complex, which, in 
turn, facilitates the recruitment of hypophosphorylated form of RNAPII. Targeted 
phosphorylation at Ser5 of the C-terminal domain (CTD) releases RNAPII from the interaction 
with the Mediator complex, keeping RNAPII arrested at pausing sites (Core and Lis, 2008). 
Phosphorylation on Ser2 of the CTD further promotes the stable assembly of the elongation 
complex, necessary for the progression of transcription (Marshall et al., 1996). Ser2 
phosphorylation further induces elongation through the recruitment of H3K36-
methyltransferases for chromatin remodelling as well as regulating splicing by recruitment of 
polyadenylation factors (Krogan et al., 2003; Proudfoot et al., 2002). Comparatively, bivalent 
promoters in ESCs were found to be selectively occupied by poised Ser5 phosphorylated RNAPII 
with no detectable Ser2 phosphorylated or hypophosphorylated forms at these sites (Brookes 
and Pombo, 2009; Stock et al., 2007). The lack of transcriptional elongation, and hence, Ser2P 
RNAP at PRC-repressed promoters mirrors the low or absent levels of expression of lineage-
affiliated genes. However, a subset of PRC targets, with functions involved in development and 
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metabolism, can be dynamically switch between repressed and active states within an ESC 
population due to either cellular heterogeneity or allelic differences (Brookes et al., 2012) 
 
Figure 1.10 Possible outcomes for bivalent promoters upon differentiation of ESCs 
Schematic representation of the bivalent chromatin structures that characterize ESCs. Promoters of 
lineage-affiliated genes are co-occupied by PRC1, PRC2, MLL2 and enriched in active (H3K4me2/3) and 
inactive (H3K27me3, H2AK119ub1) histone marks, and a poised conformation of RNAPII (closed). Upon 
differentiation, promoters can lose the PRC-mediated repression, RNAPII becomes active (open) and 
transcription progresses. Lineage-inappropriate genes can be silenced by loss of active mark, or by further 
acquisition of repressive marks (H3K9me3, 5mC) without losing the H3K4me2/3 decoration. A small 
subset of genes might retain the bivalent configuration in lineage-committed progenitors and derivatives.  
 
1.5.3.4 Pre-patterning of enhancers  
Enhancers play a key role in driving strong cell-specific gene expression, and are able to 
activate genes located several kilobases (kb) apart. Typically, enhancers are bound by lineage-
specific TFs, which in turn recruit co-activators, chromatin remodellers and proteins involved in 
mediating long-range interactions with the transcriptional machinery (Calo and Wysocka, 2013). 
Nucleosomes flanking TF binding sites at enhancer regions are commonly enriched in H3K4me1 
and H3K27ac, which together with DNAse I hypersensitivity typically mark active enhancers 
SET1A/B
MLL2
MLL2
MLL2
PRC2
TFs
TFs
TFs
PRC2
TFs
PRC1
PRC2
PRC1
PRC2
TFs
PRC1
Dnmt3b
Suv39h1
PRC1
H3K27me3
H3K9me3
H2AK119ub1
H3K4me3
5mC
Bivalent Promoters
Active Inactive Inactive Bivalent
Chapter I - Introduction 
62 
 
(Creyghton et al., 2010; Gross and Garrard, 1988; Zentner et al., 2011). Furthermore, H3K4me1 
has been found to precede nucleosomal depletion and H3K27ac deposition occurring upon 
enhancer activation, thus being associated with pre-marking of development-associated 
enhancers in ESCs (Creyghton et al., 2010; Zentner et al., 2011). Conversely, H3K4me3 is 
predominantly found at promoters, whereas H3K4me2 can be found at both enhancers and 
promoters (Pekowska et al., 2011). Binding of pioneer TFs to inactive enhancers has been 
proposed to trigger chromatin remodelling by nucleosomal repositioning, recruitment of 
additional TFs, co-factors and chromatin modifiers that together are required for gene activation 
(Fig.1.11). Given the association of H3K4me1/2 with poised enhancer regions, this has been 
proposed to facilitate TF binding and nucleosomal mobility, as well as potentially protecting these 
sites from acquisition of DNA methylation (Ooi et al., 2007; Zaret and Carroll, 2011).  However, it 
is not clear whether pre-marking of enhancers with H3K4me1 is strictly required to precede the 
binding of pioneer TFs. Indeed, several TFs including Foxa2, Gata6, Oct4, Sox2 and Klf4 have been 
proposed to directly access and bind DNA motifs within compact chromatin, in order to facilitate 
the recruitment of additional factors, thus having a key role in cell-specific gene activation (Soufi 
et al., 2012; Xu et al., 2011). Furthermore, poised enhancers in human ESCs have been found to 
be already looped to their target promoters, whereas in differentiated cell types, enhancer-
promoter looping events is specifically associated with gene expression (Sanyal et al., 2012). 
H3K27ac marking active enhancers is catalysed by the ubiquitously expressed proteins p300 
and CBP, which can be recruited via distinct TFs in a tissue-specific manner (Bonn et al., 2012; 
Creyghton et al., 2010; Goodman and Smolik, 2000; Zentner et al., 2011). Notably, H3K27ac is 
specifically associated with active, but not with disengaged or poised enhancers, even though 
binding of p300 can be detected before H3K27ac deposition and activation of poised enhancers 
(Rada-Iglesias et al., 2011). In addition, a subset of H3K4me1-marked poised enhancers lacking 
H3K27ac is instead marked by PRC2-mediated H3K27me3 (Rada-Iglesias et al., 2011; Zentner et 
al., 2011).  
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Another feature of poised enhancers is the presence of an intermediate form of cytosine 
methylation termed hydroxymethyl-cytosine (5hmC), mediated by the TET enzymes (Serandour 
et al., 2011; Stroud et al., 2011). Unlike 5mC, 5hmC positively correlates with active gene 
expression and is most abundantly found at both poised and active enhancers rather than at CpG-
dense promoter regions (Yu et al., 2013). This proposes that priming of enhancers might involve 
an active DNA demethylation mechanism mediated by the TET proteins.  
 
Figure 1.11 Configuration of poised and active gene regulatory regions in ESCs 
Schematic representation of chromatin structures that characterize poised and active genes in ESCs. 
Promoters of poised lineage-affiliated genes are bivalently marked by H3K4 and H3K27me2/3 marks, 
repressed by PRC1 and PRC2 and occupied by poised (ser5 phosphorylated) RNAPII complexes (closed), 
whereas enhancers are marked by H3K4me1/2 and harbour 5hmC. Putative pioneer TFs and p300 binding 
might mark poised enhancers prior to activation. Active promoters are free of the repressive action of PRC1 
and PRC2, assemble active RNAPII complexes (open) and are active via long-range interaction of distal 
enhancers enriched in H3K4me1/2, H3K27ac, TF binding and co-activators such as p300 and Mediator.  
 
Altogether, the tight regulation of chromatin decompaction, TF binding, protection from 
silencing epigenetic marks, and long-range DNA crosstalk in ESCs, might altogether facilitate 
rapid and efficient activation of enhancers and promoters of lineage-affiliated genes upon 
differentiation. 
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I.6 Histone demethylases and their role in ESCs 
1.6.1 Families of histone demethylases 
Up until a decade ago, histone methylation was considered to be an irreversible mark. 
However, this idea was challenged by the discovery of the first lysine-specific demethylase 
(LSD1/KDM1), which was found to demethylate both di- and mono-methylated K4 (H3K4me2/1) 
(Shi et al., 2004). Another class of histone demethylase enzymes containing a Jumonji C-terminal 
(JmjC) domain, was later identified and shown to be able to demethylate all three states of lysine-
methylation (Klose et al., 2006a).  These two classes of enzymes demethylate histones via 
different mechanisms. The first utilizes flavin adenine dinucleotide (FAD) as a co-factor for amine 
oxidation, whereas JmjC-domain containing enzymes directly hydrolyse the methyl group 
utilising Fe(II) and αKG as co-factors (Shi et al., 2004; Tsukada et al., 2006).  Several JmjC-domain 
containing proteins have since been identified and grouped into different sub-classes based on 
additional protein domains and substrate specificity, recognising histone substrates that embrace 
methylated lysine 4, 9, 27 and 36 of histone H3 (Table 1).  
 
Family Family member Other Names Histone Substrates 
KDM1 KDM1 LSD1; AOF2; BHC110 H3K4me2/1; H3K9me2/1 
KDM2 
KDM2A JHDM1A; FBXL11 
H3K36me2/1 
KDM2B JHDM1B; FBXL10 
KDM3 
KDM3A JHDM2A; JMJD1A; TSGA 
H3K9me2/1 
KDM3B JHDM2B; JMJD1B 
KDM4 
KDM4A JMJD2A; JHDM3A 
H3K9me3/2; 
H3K36me3/2 
KDM4B JMJD2B; JHDM3B 
KDM4C JMJD2C; GASC1; JHDM3C 
KDM4D JMJD2D; JHDM3C 
KDM5 
KDM5A RBP2; JARID1A 
H3K4me3/2 
KDM5B PLU-1; JARID1B 
KDM5C SMCX; JARID1C 
KDM5D SMCY; JARID1D 
KDM6 
KDM6A UTX 
H3K27me3/2 
KDM6B JMJD3 
 
Table 1. Histone demethylase nomenclature and histone substrates.  
Adapted from (Nottke et al., 2009) 
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Accumulating evidence has shown that the concerted action of lysine methyltransferases 
(KMT) and demethylases (KDM) is crucial in the tight regulation of gene expression in ESCs and 
upon differentiation. As described earlier, promoters of lineage-affiliated genes are enriched in 
MLL2-mediated active (H3K4me3) and PRC2-mediated repressive (H3K27me3) marks, which 
upon differentiation resolve into monovalent chromatin domains for either activation or 
repression. During this process, the H3K27me3 demethylase Utx/Kdm6a was found to associate 
with the KMT complex MLL2, and hence promote activation of bivalent promoters upon 
differentiation together with Jmjd3/Kdm6b (Agger et al., 2007; Cho et al., 2007; Lee et al., 2007). 
Strikingly, the similarity of defective development found in Xenopus and Zebrafish embryos upon 
depletion of either H3K4 or H3K27 methylation suggests that the removal of H3K27me3 is 
functionally coordinated with the addition of H3K4me3 (Lan et al., 2007; Wysocka et al., 2005). 
Moreover, the H3K4me3 KDM Jarid1a/Kdm5a has also been found to extensively overlap and 
physically interact with the PRC2 at the chromatin of ESCs. Depletion of PRC2 impairs Jarid1a 
binding to promoters, suggesting that PRC2 recruits the H3K4me3-demethylase, and that are 
then both lost upon differentiation-induced gene activation (Pasini et al., 2008). Thus, the co-
existence of opposing enzymatic activities occurring at the same complex is likely to be a vital 
mechanism for balancing H3K4 and H3K27 methylation levels, and ensure robust gene regulation 
during development.  
 
Additional roles for, KDMs independent of their demethylase enzymatic activity have been 
most recently associated with PRC-mediated repression. The H3K36-demethylase 
Fbxl10/Kdm2b was, for instance, shown to specifically recognize unmethylated CpG islands 
where it recruits non-canonical PRC1 complexes, a process found to be necessary for the 
deposition of the repressive H2AK119ub1 mark at developmental-associated gene promoters. 
This was, however, not linked with removal of H3K36me3, a mark normally found at gene bodies 
of transcriptionally active genes (Farcas et al., 2012; Wu et al., 2013).  
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1.6.2 The Jmjd2/Kdm4 family of histone demethylases 
The human JMJD2/KDM4 gene family was identified and characterized in 2004 (Katoh and 
Katoh, 2004). Structurally, JMJD2A, 2B and 2C proteins comprise one JmjN (N-terminal), one JmjC 
(C-terminal), two PHD (plant homeobox domain), and two Tudor domains (Fig.1.12). In contrast, 
JMJD2D, E and F are smaller proteins that only contain the two JmjN and JmjC domains. JMJD2A-
D have orthologs in the mouse, whereas JMJD2D is likely to have originated the two additional 
human genes, JMJD2E and JMJD2F, through local retrotransposition (Yang et al., 2000). These 
proteins are highly conserved from yeast to human, suggesting a ubiquitously important role in 
gene regulation (Katoh and Katoh, 2004; Klose et al., 2006a). JMJD2A-C proteins have so far been 
found to demethylate H3K9me2/3, H3K36me2/3 and H1.4K26me3, whereas JMJD2D was 
proposed to demethylate these same histone modifications except H3K36me3 (Chen et al., 2006; 
Klose et al., 2006b; Shin and Janknecht, 2007; Trojer et al., 2009; Whetstine et al., 2006). This 
function does not rely on the PHD or Tudor domains, but requires both the JmjC and JmjN 
domains. Instead, the later domains are required for the retention of JMJD2 proteins in the 
nucleus, as deletion of these domains results into the relocation of JMJD2 to the cytoplasm (Shin 
and Janknecht, 2007).  
 
Figure 1.12 Members of the JMJD2 family in Human/Mouse.  
Members of the JMJD2 family contain two jumonji catalytic domains: JmjN (Jumonji N-terminal; blue) and 
a JmjC (Jumonji C-terminal; yellow) domain. All members of this group apart from Jmjd2d contain 
additional C-terminal domains such as PHD (orange) and Tudor (green) domains, which were proposed to 
be involved in protein targeting (adapted from Klose et al., 2006a). 
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The identified recognition of activating and repressive histone marks suggests wide-ranging 
roles for this family of histone demethylases in gene activation. Thus, JMJD2 proteins have been 
found to act as co-regulators of hormone and hypoxia-mediated gene response, in addition to 
roles in DNA repair and chromosome stability (Berry and Janknecht, 2013; Labbe et al., 2013). 
Moreover, JMJD2 members have been associated to histone demethylase-mediated regulation of 
gene expression in cellular differentiation processes such as adypogenesis, osteogenesis and 
muscle differentiation (Lu et al., 2012; Verrier et al., 2011; Ye et al., 2012). Not surprisingly, 
abnormal expression of JMJD2 members has been extensively linked with deregulated gene 
expression in cancer, making them potential targets for the development of anti-cancer drugs 
(Hamada et al., 2010; Yu et al., 2012). In addition to histone modifications, JMJD2A-C members 
have also been found to demethylate tri-methylated lysine containing peptides from WIZ, CDYL1, 
CSB and G9a proteins at least as tested in vitro (Ponnaluri et al., 2009). Whether these events also 
occur in vivo and furthermore what is the biological significance of non-histone demethylation by 
the JMJD2 family are questions that remain to be investigated. 
 
Although less studied, the Jmjd2 histone demethylases were also proposed to play a role in 
early embryonic mouse development. In silico expression analysis of the mouse Jmjd2 gene family 
revealed that Jmjd2a, Jmjd2b and Jmjd2c might be preferentially expressed in cleavage-stage 
embryos, with Jmjd2c being also highly expressed in undifferentiated ESCs (Katoh and Katoh, 
2007). In the early embryos, Jmjd2c was found to be expressed from the 2-cell stage, reaching its 
peak of expression at the 4-cell stage, subsequently being detected though at lower levels 
throughout pre-implantation development (Wang et al., 2010). Consistently, dsRNA-knockdown 
of Jmjd2c in oocytes and induced parthenogenesis led to early developmental arrest at the 
transition from 8-cell to morula stage in depleted embryos as compared to controls (Wang et al., 
2010). Moreover, this was accompanied by a reduction in the expression levels of Oct4, Nanog 
and other self-renewal genes as seen both at the mRNA and protein level in Jmjd2c-depleted 4-
cell stage embryos (Wang et al., 2010). Specific knockdown of Jmjd2c in mouse ESCs using shRNA 
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vectors similarly suggested an essential role for Jmjd2c in sustaining ESC self-renewal. Jmjd2c was 
found to be a direct target of Oct4 and depletion of this demethylase resulted into a loss of the 
ESC undifferentiated state via deregulation of Nanog expression that strictly correlated with an 
increase in H3K9me3 enrichment levels at its promoter region (Loh et al., 2007).  
 
I.7 Hypothesis and Aims 
As highlighted in this Chapter, tight regulation of the pluripotent state is achieved by 
coordinated regulatory networks integrating cell signaling cues with the action of transcription 
factors and epigenetic remodellers to ultimately execute the appropriate gene expression 
programs that sustain ESC self-renewal, while silencing lineage-affiliated genes. Notably, the 
transcription of differentiation-associated factors is kept in a poised state, allowing for efficient 
activation upon differentiation stimuli. Thus, balancing both activating and repressor signals that 
feed onto the activity of promoters and enhancers of differentiation markers is a crucial 
mechanism in safeguarding gene priming in the ESC state.  
 
Previous work in our lab has identified that ESC-specific and somatic affiliated genes are 
stably silenced by acquisition of additional epigenetic repressor layers in extra-embryonic stem 
cells and in vivo. In particular, Suv39h1-mediated H3K9me3 coupled with de novo DNA 
methylation, is acquired at a subset of bivalent promoters upon ESC conversion into a TS-like 
state, which can be achieved upon doxycycline-dependent Oct4 removal (Fig.1.13) (Alder et al., 
2010). Here, the H3K9 KMT Suv39h1 was identified to be dynamically up-regulated, with the 
H3K9 KDM Jmjd2c being oppositely extinguished upon trophoblast lineage commitment 
(Fig1.13), consistent with Jmjd2c expression being under direct control of Oct4 (Loh et al., 2007).  
The discovery that a set of bivalent promoters is targeted by Suv39h1-mediated 
H3K9me3 and hence harboring a repressed trivalent (H3K27me3/H3K9me3/H3K4me3) 
conformation in TS cells suggested that in ESCs, an active mechanism of H3K9 demethylation 
might be operating to prevent poised promoters from acquiring additional repressive layers. 
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Given the rapid and specific down-regulation of Jmjd2c upon extra-embryonic lineage 
commitment (Alder et al., 2010), and the previously reported requirement for Jmjd2c in 
maintaining an ESC identity (Loh et al., 2007), Jmjd2c was here proposed to play a possible role  
in actively safeguarding bivalent chromatin structure and lineage gene priming both in the ESCs 
and in the early embryo.  
 
Figure 1.13 Gene expression profiles of chromatin regulators upon ES to TS-like conversion 
A. ESCs are derived from the pluripotent ICM, and TS cells from the extra-embryonic TE. Conversion of ESC 
into a TS-like Cdx2-expressing cell population can be achieved by conditional depletion of the expression 
of Oct4 transgene via doxycycline (DOX) treatment in the ZHBTc4 ESC line. B. Expression of chromatin 
modifiers during ESC to TS-like (TSL) conversion, and in embryo-derived TS cells. Blue and red represent 
a decrease in expression of at least 0.5 fold, and an increase of at least 2 fold respectively as compared to 
ESCs. Jmjd2c is specifically down-regulated in this process unlike Jmjd2a or Jmjd2b. Figure B from (Alder et 
al., 2010). 
 
Up until the beginning of this project, little was known about the molecular mechanisms 
by which Jmjd2c function is conferred in pluripotent ESCs. Thus, the overall aim of this project 
was to elucidate the role of the Jmjd2c histone demethylase in undifferentiated ESCs and during 
the early steps of differentiation, taking advantage of newly generated constitutive Jmjd2c-
knockout mouse ESCs as primary tools. Preliminary work in our laboratory had shown that these 
cells could be maintained in an undifferentiated state in culture (German S, MSc Thesis 2010), 
A. B.
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hence providing an notable opportunity for further investigating how Jmjd2c functions in 
pluripotent ESCs. 
In order to assess whether Jmjd2c indeed safeguards the bivalent chromatin structures of 
developmental-associated genes in pluripotent ESCs, specific steps of investigation were 
undertaken. First, careful validation of the established knockout and characterization of the 
phenotype of Jmjd2c-depleted ESCs was conducted, in addition to validating the demethylase 
activity of Jmjd2c in ESCs. Secondly, the impact of Jmjd2c depletion was thoroughly validated in 
differentiation, with particular focus on the early steps of pluripotency exit. Finally, the chromatin 
binding profile of Jmjd2c was explored, and the consequence of Jmjd2c depletion in regulatory 
regions of lineage-affiliated markers was identified.   
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II.1 Materials 
2.1.1 Antibodies 
Primary 
Antibody 
Host 
species 
Catalogue 
Number 
Supplier 
Concentration/Quantity 
Western 
Blot 
IF ChIP Co-IP 
Dab2 rabbit sc13982 SantaCruz - 1:250 - - 
E-Cadherin rat U3254 Sigma - 1:500 - - 
Esrrb mouse H6705 R&D Systems 1:1000 - - - 
FLAG M2 mouse F1804 Sigma 1:1000 1:500 10µg - 
G9a rabbit 3306 Cell Signalling  1:1000 - 0.24µg 5 µg 
G9a mouse PP-A8620A-00 R&D Systems - - - 5 µg 
Gata4 rabbit sc-9053 SantaCruz - 1:250 - - 
Gata6 goat AF1700 R&D Systems - 1:500 - - 
GFP rabbit ab290 Abcam - 1:1000 - - 
GLP mouse PP-B0422-00 R&D Systems 1:1000 - - 5µg 
H3 rabbit ab1791 Abcam 1:50K - - - 
H3K27ac rabbit ab4729 Abcam 1:100K - 5µg - 
H3K27me3 rabbit 07-449 Millipore 1:100K - 5µg - 
H3K36me3 mouse mAb-183-050 Diagenode 1:10K - - - 
H3K4me2 rabbit 07-030 Millipore 1:50K - 5µg - 
H3K9me2 mouse ab1220 Abcam 1:20K - 2µg - 
H3K9me2 mouse mAb-154-050 Diagenode 1:50K - - - 
H3k9me3 rabbit 07-442 Millipore 1:1000 - - - 
H3K9me3 rabbit ab8898 Abcam 1:100K - - - 
H3K9me3 mouse mAb-153-050 Diagenode 1:100K - - - 
Jmjd2b rabbit A301-478A Bethyl Labs 1:2000 - - - 
Jmjd2c rabbit - H. Ng’s lab 1:2000 - - - 
Jmjd2c goat sc-104949 SantaCruz 1:2000 - - - 
Med1 rabbit A300-793A Bethyl Labs 1:1000 - 8µg 5 µg 
Nanog rabbit RC-AB002PF Reprocell 1:2000 - - - 
Oct4 goat sc-8628 SantaCruz 1:1000 - 5µg - 
Oct4 mouse sc-5279 SantaCruz - 1:200 - - 
p300 rabbit sc-585 SantaCruz 1:1000 - 5µg - 
Ring1b mouse 39663 Active Motif - - 10µg - 
Smc1 rabbit A300-055A Bethyl Labs 1:1000 - 8µg - 
Sox7 goat AF2766 R&D Systems - 1:500 - - 
Suz12 rabbit pAb-029-050 Diagenode - - 10µg - 
V5 mouse 46-0705 Invitrogen  1:2000 1:1000 - - 
α-Tubulin mouse T6074 Sigma-Aldrich 1:20K - - - 
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Secondary Antibodies 
Catalogue 
Number 
Supplier 
Concentration 
Western 
Blot 
IF 
Alexa488 Goat Anti-Mouse IgG A11034 ThermoFisher - 1:500 
Alexa488 Goat Anti-Rabbit IgG A11029 ThermoFisher - 1:500 
Alexa488 Donkey Anti-Goat IgG A11055 ThermoFisher - 1:500 
Alexa488 Goat Anti-Rat IgG A11006 ThermoFisher - 1:500 
Alexa633 Goat Anti-Mouse IgG A21052 ThermoFisher - 1:500 
Alexa633 Goat Anti-Rabbit IgG A21071 ThermoFisher - 1:500 
Goat Anti-Mouse IgG-HRP sc-2004 SantaCruz 1:2000 - 
Goat Anti-Rabbit IgG-HRP sc-2005 SantaCruz 1:5000 - 
Donkey Anti-Goat IgG-HRP sc-2020 SantaCruz 1:5000 - 
 
Normal IgG 
Catalogue 
Number 
Supplier 
Amount 
ChIP Co-IP 
Normal Mouse IgG sc-2025 Santa Cruz 2.5µg 5µg 
Normal Rabbit IgG sc-2027 Santa Cruz 2.5µg  5µg 
 
 
2.1.2 Plasmids 
Expression vectors Source 
pPyCAG-IRES-Puro(IP) I.Chambers’s lab 
pPyCAG-IP- Jmjd2c This work 
pPyCAG-IP-Flag(2x)V5 R. Poot’s lab 
pPyCAG-IP-Flag(2x)V5-Jmjd2c This Work 
pPyCAG-IP-GFP J. Nichols’ lab 
pPyCAG-IP-dsRed*MST J Nichols’ lab 
  
Short Hairpin RNA vectors Source 
pLKO.1 shLuciferase H. Ng’s lab 
pLKO.1 shJmjd2c1 H. Ng’s lab 
pLKO.1 shJmjd2c2 H. Ng’s lab 
 
2.1.3 Antibiotics 
Bacterial Selection 
Working 
Concentration 
Catalogue 
Number 
Source 
Ampicillin 100µg/ml 10193433 FisherScientific 
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Eukaryotic Selection 
Working 
Concentration 
Catalogue 
Number 
Source 
Geneticin (G418) 100μg/ml P11-012 PAA 
Hygromicin 25μg/ml P02-015 PAA 
Puromycin 1µg/mL P7255 Sigma-Aldrich 
    
2.1.4 Enzymes 
Enzyme 
Catalogue 
Number 
Source 
RNase Out 10777-019 Lifetechnologies 
Superscript II Reverse Transcriptase 18064014 Lifetechnologies 
Superscript III Reverse Transcriptase 18080044 Lifetechnologies 
KOD HotStart DNA Polymerase 71086-5 Millipore 
BamHI R3136 New England Biolabs 
PacI R0547 New England Biolabs 
SalI R3138 New England Biolabs 
XhoI R0146 New England Biolabs 
Benzonase  70664 Novagen 
Micrococcal nuclease N3755 Sigma 
Proteinase K P2308 Sigma-Aldrich 
Ribonuclease A R6513 Sigma-Aldrich 
SYBR Green  Taq JumpStart Polymerase S4438 Sigma-Aldrich 
SYBR Green  Taq Kicqstart Polymerase KCQS02 Sigma-Aldrich 
 
2.1.5 Kits 
Kit 
Catalogue 
Number 
Source 
Amersham ECL Prime Western Blotting Detection Reagent 25080060 GE Healthcare 
EpiMark 5-hmC and 5-mC Analysis Kit E3317S New England Biolabs 
NEBNext® Multiplex Oligos for Illumina® (Primers Set 1) E7335 New England Biolabs 
NEBNext® Ultra™ DNA Library Prep Kit for Illumina E7370 New England Biolabs 
Quick Ligation Kit M2200S New England Biolabs 
HiSpeed Plasmid Maxi Kit  12663 Qiagen 
RNAeasy mini 74106 Qiagen 
RNase-Free DNase Set (50) 79254 Qiagen 
Leukocyte Alkaline Phosphatase Kit 86R-1KT Sigma-Aldrich 
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2.1.6 Inhibitors 
Protease Inhibitors 
Working  
Dilution 
Catalogue 
Number 
Source 
Phenylmethylsulfonyl fluoride (0.1M) 1:1000 93482 Sigma-Aldrich 
Complete Protease inhibitor tablets (50x) 1:50 11697498001 Roche 
    
Phosphatase Inhibitors 
Working  
Concentration 
Catalogue 
Number 
Source 
Sodium Fluoride (NaF)  5mM 201154 Sigma 
Sodium Orthovanadate (Na3VO4) 2mM S6508 Sigma 
    
Signalling Pathway Inhibitors 
Working  
Concentration 
Catalogue 
Number 
Source 
CHIR99021 - GSK3 inhibitor  3µM 130-103-926  Miltenyi Biotech 
PD0325901 - MEK inhibitor  1µM 04-0006 Stemgent 
LY294002 – Pi3K inhibitor 2-10nM L9908 Sigma-Aldrich 
LDN193189 – BMP receptor inhibitor 250nM SML0559 Sigma-Aldrich 
 
2.1.7 Growth factors media supplements 
Supplement 
Working  
Dilution 
Catalogue 
Number 
Source 
Activin A 20ng/ml - In house 
bFgf / Fgf2 12-20ng/ml 100-18B Peptrotech 
Transferrin 15µg/ml 652202 Roche  
LIF Batch-dependent - In house 
Mono  450µM M6145 Sigma 
Insulin 7µg/ml 1376497 Roche 
polyvinyl alcohol (PVA) 0.1mg/mL P8136 Sigma-Aldrich 
Heparin 1μg/mL H3393 Sigma-Aldrich 
BMP4 10-50 ng/ml  314-BP-010 R&D 
Wnt3a 2ng/ml 315-20 Peprotech  
N2 1x 17502-048 Lifetechnologies 
B27 (-vitamin A) 1x 12587-010 Lifetechnologies 
B27 1x 17504-044 Lifetechnologies 
 
2.1.8 Reagents 
Reagent Source 
Acetone  Fisher Scientific 
Acrylamide/Bis Solution  Biorad 
Agarose  Sigma-Aldrich 
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All Trans Retinoic Acid  Sigma-Aldrich 
Ammonium Persulfate (APS)  Sigma-Aldrich 
Bovine Serum Albumin (BSA) PAA 
Deoxycholic acid (DOC) Sigma-Aldrich 
Deoxynucleotide Triphosphate (dNTPs) 10mM  Lifetechnologies 
DEPC-Treated Water  Ambion 
Dimethyl Sulfoxide (DMSO)  Sigma-Aldrich 
DL-Dithiothreitol (DTT) Sigma-Aldrich 
DL-Dithiothreitol (DTT) for molecular biology Lifetechnologies 
Dyalisis Tubing ThermoScientific 
Dynabeads Protein G-coupled Lifetechnologies 
Ethanol  Fisher Scientific 
Ethidium Bromide  Sigma-Aldrich 
Ethylene Diamine Tetraacetic Acid (EDTA)  Sigma-Aldrich 
Ethylene Glycol Tetraacetic Acid (EGTA) Sigma-Aldrich 
FLAG coated sepharose beads Sigma-Aldrich 
FLAG tripeptide Sigma-Aldrich 
Formaldehyde Solution, 37%  Sigma-Aldrich 
Glycerol  Sigma-Aldrich 
Glycine  Sigma-Aldrich 
Glycogen Blue (GlycoBlue) carrier Ambion  
Sulphuric acid (H2SO4) Sigma-Aldrich 
HEPES  Sigma-Aldrich 
Horse Serum  Sigma-Aldrich 
Isopropanol  Fisher Scientific 
Laemmli Sample Buffer  BioRad 
LB  MP Biomedicals 
Lipofectamine 2000 Transfection Reagent  Lifetechnologies 
Lithium Chloride (LiCl)  Sigma-Aldrich 
Magnesium Sulphate (MgSO2)  Novagen 
Methanol  Fisher Scientific 
MgCl2 Lifetechnologies 
Nonidet P-40 (NP-40)  Sigma-Aldrich 
Normal Goat Serum  Sigma-Aldrich 
Oligonucleotides  Lifetechnologies 
Paraformaldehyde (PFA) Sigma-Aldrich 
Phenol-Chloroform  Sigma-Aldrich 
Phosphate-buffered Saline (PBS) capsules Fisher 
Potassium Chloride (KCL) Sigma-Aldrich 
Protein A-Sepharose  Sigma-Aldrich 
PVDF Membrane  GE Healthcare 
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Random Hexamers  Lifetechnologies 
SDS-PAGE Resolving Buffer  Biorad 
SDS-PAGE Stacking Buffer  BioRad 
Skimmed Milk Powder  Fluka 
Sodium Azide (NaN3) Sigma-Aldrich 
Sodium Chloride (NaCl) VWR 
Sodium Deoxycholate (Na-Doc)  Sigma-Aldrich 
Sodium Dodecyl Sulfate (SDS) Solution 10%  Fluka 
Sodium Hidrogenocarbonate (NaHCO3) Sigma-Aldrich 
Spermidine Sigma-Aldrich 
Spermine tetrahydrochloride Sigma-Aldrich 
Sucrose Sigma-Aldrich 
Tetramethylethylenediamine (TEMED ) Sigma-Aldrich 
Trichloroacetic acid (TCA) Sigma-Aldrich 
Tris Base  Sigma-Aldrich 
Triton X-100  Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
Vectashield with DAPI  Vector Laboratories 
β-Mercaptoethanol  Sigma-Aldrich 
  
 
2.1.9 Solutions 
Alkaline phosphatase staining: 
 
AP fixation solution 
25.5%(v/v) Citrate solution 
66.3%(v/v) Acetone 
 8.2%(v/v) Formaldehyde 37% 
  
AP staining solution 
 1.9%(v/v) Na-Nitrite  
 1.9%(v/v)FRV-alkaline 
94.3%(v/v) dH2O 
 1.9%(v/v) Naphthol Alkaline 
  
Genomic DNA extraction: 
 
 
Lysis Buffer 
200mM NaCl 
100mM Tris-HCL pH 7.4 
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5mM EDTA 
0.2%(w/v) SDS 
0.5mg/ml Proteinase K (added fresh) 
 
Immunofluorescent staining: 
 
PFA 4% 
4% (w/v) Paraformaldehyde in PBS  
2mM NaOH 
  
Blocking Buffer 
 
90%(v/v) PBS 
10%(v/v) serum (same species as the secondary antibody) 
  
Permeabilization Buffer 0.4% TritonX-100  
in Blocking Buffer 
  
Western blot: 
 
 
RIPA Buffer 
(Total Protein Extraction) 
 
50mM Tris pH 8.0 
1mM EDTA 
0.5mM EGTA 
1% (v/v) Triton X-100 
0.1% (w/v) Na-deoxycholate 
140mM NaCl 
Freshly supplemented with protease and phosphatase 
inhibitors. 
  
Hypotonic lysis buffer 
(Histone extraction) 
 
10 mM Tris–Cl pH 8.0 
1 mM KCl 
1.5 mM MgCl2  
1 mM DTT 
Freshly supplemented with protease and phosphatase 
inhibitors. 
  
8% Resolving gel 
375mM Tris HCl pH 8.8 
8% (w/v) Acrylamide/Bis 
0.1% (w/v) SDS 
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0.05% (w/v) Ammonium Persulfate 
0.005% (v/v) TEMED 
  
13% Resolving gel 
375mM Tris HCl pH 8.8 
13% (w/v) Acrylamide/Bis 
0.1% (w/v) SDS 
0.05% (w/v) Ammonium Persulfate 
0.005% (v/v) TEMED 
  
4% Stacking gel 
125mM Tris HCl pH 6.8 
4% (w/v) Acrylamide/Bis 
0.1% (w/v) SDS 
0.05% (w/v) Ammonium Persulfate 
0.01% (v/v) TEMED 
  
SDS Running Buffer 
25mM Tris base 
190mM Glycine 
0.1% (w/v) SDS 
  
Transfer Buffer 
25 mM Tris,  
192 mM glycine 
0.01% (w/v) SDS 
10% (v/v) methanol for proteins >50KDa 
or 20% (v/v) methanol for proteins <50KDa 
  
TBS-T 
130mM NaCl 
20mM Tris pH 7.6 
0.1% (v/v) Tween-20 
  
FLAG pull down: 
 
 
Buffer A 
10 mM Hepes 7.6 
1.5 mM MgCl2 
10 mM KCl 
Freshly supplemented with 0.5 mM DTT and 1x complete 
protease inhibitor tablets  
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Buffer C 
 
20 mM Hepes pH 7.6 
420 mM NaCl 
1.5 mM MgCl2 
 0.2 mM EDTA 
20% (v/v) glycerol 
Freshly supplemented with 0.5 mM DTT and 1x complete 
protease inhibitor tablets 
  
Buffer D 
20 mM Hepes pH 7.6 
100 mM KCl 
1.5 mM MgCl2 
0.2 mM EDTA 
20% (v/v) glycerol 
 Freshly supplemented with 0.5 mM DTT, 1x complete 
protease inhibitor tablets and 0.5µM sodium Meta bisulfite  
  
Buffer C100 
20 mM Hepes pH 7.6 
100 mM KCl 
1.5 mM MgCl2 
0.2 mM EDTA 
20% (v/v) glycerol 
0.02% (v/v) NP-40 
Freshly supplemented with 0.5 mM DTT and 1x complete 
protease inhibitor tablets 
  
Protein co-immunoprecipitation Protocol A: 
 
Hypotonic Buffer 
10 mM Tris-HCl pH 7.6 
1.5 mM MgCl2 
10 mM KCl 
  
Buffer SR 
50 mM HEPES pH 7.0  
0.25 mM EDTA  
10 mM KCl  
70% (w/v) sucrose 
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0.15mM spermine 
0.15mM spermidine 
  
High Salt Buffer 
900 mM NaCl 
20 mM Tris pH 7.65 
25%(v/v) glycerol 
1.5 mM MgCl2 
0.2 mM EDTA 
  
Protein co-immunoprecipitation Protocol B: 
 
Buffer A 
20 mM HEPES pH 7.0  
0.15 mM EDTA  
0.15 mM EGTA  
10 mM KCl 
0.15mM spermine 
0.15mM spermidine 
  
Buffer SR 
50 mM HEPES pH 7.0  
0.25 mM EDTA  
10 mM KCl  
70% (w/v) sucrose 
0.15mM spermine 
0.15mM spermidine 
  
Buffer Sucrose 
20mM Tris pH 7.65 
60 mM NaCl 
15 mM KCl 
0.34 M sucrose 
0.15mM spermine 
0.15mM spermidine 
  
Wash Buffer 
50 mM Tris pH 7.65 
150 mM NaCl                        
0.5%(v/v) Triton X-100             
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TENG 
20mM Tris pH 7.65 
0.1 mM EDTA  
150 mM NaCl 
10%(v/v) glycerol 
0.01% (v/v) NP-40 
  
Protein co-immunoprecipitation Protocol C: 
 
Cell Lysis Buffer 
 
10 mM Tris pH 7.9              
10 mM NaCl 
0.1 mM EDTA pH 8 
0.1 mM EGTA 
  
Nuclei Lysis Buffer 
20 mM Tris pH 7.9 
400 mM NaCl 
1 mM EDTA pH 8 
1 mM EGTA 
  
IP Buffer 
50 mM Tris pH 7.9 
150 mM NaCl 
1 mM EDTA pH 8 
1 mM EGTA 
  
ChIP Protocol A: 
 
 
Lysis Buffer 
25mM HEPES pH 7.9 
1.5 mM MgCl2 
10mM KCl 
0.1%(v/v) NP-40 
  
IP Buffer 
50mM HEPES pH 7.9 
140mM NaCl 
1mM EDTA 
1%(v/v)  Triton X-100 
0.1%(w/v)  Na-Doc 
0.1%(w/v)  SDS 
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Wash Buffer 1 
50mM HEPES pH 7.9 
500mM NaCl 
1mM EDTA 
1%(v/v)  Triton X-100 
0.1%(w/v)  Na-Doc 
0.1%(w/v)  SDS 
  
Wash Buffer 2 
20mM Tris pH 8 
1mM EDTA 
250mM LiCl 
0.5%(v/v) NP-40 
0.5%(w/v) Na-Doc 
  
TE Buffer 
 
10mM Tris pH 8 
1mM EDTA pH 8 
  
Elution Buffer 
 
50 mM Tris pH 8 
1 mM EDTA pH 8 
1% (w/v) SDS 
  
ChIP Protocol B: 
 
 
Lysis Buffer 1 
50 mM HEPES pH 7.5 
140 mM NaCl 
1 mM EDTA  
10% (v/v) glycerol 
0.5% (v/v) NP-40 
0.25% (v/v) Triton X-100 
  
Lysis Buffer 2 
200 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
10 mM Tris pH8 
  
Lysis Buffer 3 50 mM  Tris pH 8 
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10 mM EDTA 
150mM NaCl  
0.1 % (w/v) SDS 
0.95 % (v/v) NP40 
0.1% (w/v) Na-Doc 
  
Wash Buffer 1 
150mM NaCl  
20mM Tris pH 8 
2mM EDTA 
0.1% (w/v) SDS 
1% (v/v) TritonX-100 
  
Wash Buffer 2 
2mM EDTA 
20mM Tris pH8 
500mM NaCl  
0.1% (w/v) SDS 
1% (v/v) TritonX-100 
  
Wash Buffer 3 
0.25M LiCl 
1% (v/v) NP-40 
1 % (w/v) NaDoc 
1mM EDTA 
10mM Tris pH8 
  
TE Buffer 
 
50mM Tris-HCL  pH8 
1mM EDTA pH8 
50mM NaCl  
  
Elution Buffer 
50mM Tris-HCL  pH8 
1mM EDTA pH8 
1% (w/v) SDS 
  
 
ChIP Protocol C: 
 
 
Lysis Buffer 100mM NaCl 
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50mM Tris-Cl pH8.1 
5mM EDTA pH8.0 
0.02% (v/v) NaN3 
0.5% (w/v) SDS 
  
IP Buffer 1V Lysis Buffer + 0.5V Dilution Buffer 
  
Dilution Buffer 
100mM Tris-HCl pH8.6 
100mM NaCl 
5mM EDTA pH8.0 
0.2% (w/v) NaN3 
5% (v/v) Triton X-100 
  
Wash Buffer 1 
150mM NaCl 
20mM Tris-HCl pH8.1 
5mM EDTA pH8.0 
5.2% (w/v) Sucrose 
0.02% (w/v) NaN3 
1% (v/v) Triton X-100 
0.2% (w/v) SDS 
  
Wash Buffer 2 
0.5% (w/v) DOC 
1mM EDTA 
250mM LiCl 
10mM Tris-HCl pH8.0 
0.02% (w/v) NaN3 
0.5% (v/v) NP-40  
  
Wash Buffer 3 
0.1% (w/v) DOC 
1mM EDTA 
50mM HEPES pH7.5 
500mM NaCl 
1% (v/v) Triton X-100 
0.02% (w/v) NaN3 
  
TE Buffer 10mM Tris-HCl pH 8 
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1mM EDTA 
  
Elution Buffer 1% (w/v) SDS  
0.1M NaHCO3 
  
All buffers were freshly supplemented with protease and phosphatase inhibitors. 
 
2.1.10 Media 
Bacterial media and agar  
LB Agar 
1% (w/v) Bactotryptone   
0.5% (w/v) Yeast Extract  
0.5% (w/v) NaCl  
0.1% (w/v) Glucose  
1.5% (w/v) Bactoagar 
 
LB Broth 
1% (w/v) Bactotryptone  
0.5% (w/v) Yeast Extract  
0.5% (w/v) NaCl  
0.1% (w/v) Glucose 
 
Low-Salt 2X LB Broth 
2% (w/v) LB-Broth-Lennox 
1% (w/v) Peptone 
0.5% (w/v) Yeast Extract 
 
SOC Media (Invitrogen) 
2% (w/v) Bactotryptone   
0.5% (w/v) Yeast 
10mM NaCl   
2.5mM KCl  
10mM MgCl2  
10mM MgSO4  
20mM Glucose 
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Mammalian tissue culture media 
 
Embryonic stem cell media: 
 
 
JM8 Media 
 
Knock-out DMEM supplemented with: 
10% (v/v) Batch tested FBS 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
25U/mL Penicillin 
25µg/mL Streptomycin 
Optimized dilution of LIF  
 
E14 Media 
 
GMEM- BHK21  supplemented with: 
10% (v/v) Batch tested FBS 
0.1mM 2-Mercaptoethanol 
0.24% (w/v) Sodium Bicarbonate 
1mM Sodium Pyruvate 
0.1mM Non-essential Amino Acids 
2mM L-Glutamine 
25U/mL Penicillin 
25µg/mL Streptomycin 
Optimized dilution of LIF  
 
2i/LIF Media 
 
1:1 mixture of Neurobasal and DMEM-F12 media 
supplemented with: 
0.5% (v/v) N-2 supplement  
1% (v/v) B-27 supplement 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
Optimized dilution of LIF 
Freshly supplemented with 3µM CHIR99021 and 1µM 
PD0325901. 
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Neuronal differentiation media: 
 
NDM Rich Media 
1:1 mixture of Neurobasal and DMEM-F12 media 
supplemented with: 
1% (v/v) N-2 supplement  
2% (v/v) B-27 supplement 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
 
Epiblast stem cell media: 
 
 
N2B27 Media 
1:1 mixture of Neurobasal and DMEM-F12 media 
supplemented with: 
0.5% (v/v) N-2 supplement  
1% (v/v) B-27 minus supplement vitamin A 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
Freshly supplemented with 20ng/ml Activin A and 12ng/ml 
bFGF 
 
Rich Media 
1:1 mixture of Neurobasal and DMEM-F12 media 
supplemented with: 
1% (v/v) N-2 supplement  
2% (v/v) B-27 minus supplement vitamin A 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
50U/mL Penicillin 
50µg/mL Streptomycin 
Freshly supplemented with 20ng/ml Activin A and 12ng/ml 
bFGF 
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CDM-PVA Media 
1:1 mixture of IMDM and Ham’s F12 medium supplemented 
with:  
1mg/ml Poly(vinyl alcohol) 
1% (v/v) Chemically Defined Lipid Concentrate 
15µg/ml transferrin  
450µM  Monothioglycerol  
7µg/ml Insulin 
Freshly supplemented with 20ng/ml Activin A and 12ng/ml 
bFGF 
 
CDM-BSA Media 
1:1 mixture of IMDM and Ham’s F12 medium supplemented 
with:  
5mg/ml BSA 
1% (v/v) Chemically Defined Lipid Concentrate 
15µg/ml transferrin  
450µM  Monothioglycerol  
7µg/ml Insulin 
Freshly supplemented with 20ng/ml Activin A and 12ng/ml 
bFGF 
 
Coating Media 
DMEM supplemented with: 
10% (v/v) FBS 
25U/mL Penicillin 
25µg/mL Streptomycin 
 
Mesoderm differentiation media: 
 
FlyB 
CDM-PVA Media freshly supplemented with: 
20ng/µl bFgf 
10nM LY294002 
10ng/ml BMP4  
 
FB40 
CDM-PVA Media freshly supplemented with: 
20ng/µl bFgf 
50ng/ml BMP4  
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FlyWLDN 
CDM-PVA Media freshly supplemented with: 
20ng/ul bFgf 
2nM LY294002 
2ng/ml Wnt3a  
250nM LDN 
 
XEN cell media: 
 
 
Standard Media 
RPMI supplemented with: 
15% (v/v) FBS 
0.1mM 2-Mercaptoethanol 
1mM Sodium Pyruvate 
2mM L-Glutamine 
25U/ml Penicillin 
25µg/ml Streptomycin 
 
Derivation  media 
 
Advanced RPMI supplemented with: 
15% (v/v) Biosera FBS 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
25U/ml Penicillin 
25µg/mL Streptomycin 
Freshly supplemented with 10ng/mL Activin A, 0.01μM 
atRA, 24 ng/mL bFGF, 1 μg/mL Heparin 
 
MEF/COS-7 media: 
 
 
 
DMEM supplemented with: 
10% (v/v) FBS 
0.1mM 2-Mercaptoethanol 
2mM L-Glutamine 
25U/mL Penicillin 
25µg/mL Streptomycin 
 
All reagents used in mammalian cell culture media, unless previously stated, were purchased from 
Lifetechnologies (Gibco). 
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2.1.11 Strains and cell lines 
Bacterial 
strains 
Genotype Information 
TAM1 
 
mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74 
recA1 ara∆139 (ara-leu)7697. galU galK rpsL endA1 
nupG 
Chemically 
competent 
Echerichia Coli. 
 
Mammalian 
Cell lines 
Parental 
Line 
Genetic 
Background 
Information 
E14 E14Tg2A 129/Ola 
Feeder-independent Hprt-deficient mouse ES cell line 
derived from Lesch-Nyhan embryos (Morita et al. 
2000). 
WT JM8.N4 C57BL/6N 
Feeder-independent wildtype mouse ES cell line 
derived from the subclone N4 of the JM8 parental line 
(Skarnes et al. 2011) 
E2-/- JM8.N4 C57BL/6N 
Feeder-independent Jmjd2c homozygous knock-out 
mouse ES cell clone derived from the WT JM8.N4 
(Skarnes et al. 2011) 
E3-/- JM8.N4 C57BL/6N 
Feeder-independent Jmjd2c homozygous knock-out 
mouse ES cell clone derived from the WT JM8.N4 
(Skarnes et al. 2011) 
XEN IM8A1 PO 
Feeder-independent extra-embryonic (XEN) stem cells 
hemizygous for the ROSA26 β-geo transgene (Kunath 
et al. 2005) 
MEF - CF-1 
Primary culture of mouse embryonic fibroblasts 
derived from CF-1 mice. 
COS-7 COS-7 CV-1 
Derived from monkey kidney tissue cell line CV-1 by 
transformation with an origin defective mutant of 
SV40 which codes for wild type T antigen (Gluzman, 
1981) 
HeLa - Human 
 Immortalized cell line derived from cervical cancer 
(Schercher et al., 1953)  
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II.2 Methods 
2.2.1 Cell culture 
Unless stated, all cell lines used in this work were previously derived from mouse embryos 
and were maintained in culture at 37°C and 5% CO2 in their respective media as described in I.1. 
In general, all stem cell lines were not used beyond 45 passages. Cells and media were 
manipulated in a laminar flow cabinet under aseptic conditions, except for isolation of cell 
colonies. All cell lines used in experiments were routinely tested negative for the presence of 
Mycoplasma infections.  
 
2.2.1.1 Embryonic stem cell culture 
The wild-type (WT) JM8.N4 and the two Jmjd2c-knockout (Jmjd2c-KO) embryonic stem cell 
clones (E2, E3) derived from the same parental line were routinely cultured in feeder-free 
conditions, in plates pre-coated with 0.1% gelatine and in FBS-containing medium (JM8 media). 
Geneticin (100μg/ml) and Hygromycin B (25μg/ml) were routinely added to the culture medium 
in the Jmjd2c-KO cell lines for selection. Drug selection was removed prior to any differentiation 
experiments or lysate collection. The E14Tg2A (E14) embryonic cell line was also routinely 
cultured in feeder-free conditions, in plates pre-coated with 0.1% gelatin and in FBS-containing 
medium (E14 media). Genetically modified cell lines derived from any of these ESC lines were 
maintained in culture in the same conditions as the parental cell line, with the presence of 
Puromycin (1µg/mL) for selection.  
Where mentioned, ESC cultures were adapted to serum-free conditions and cultured in 
2i/LIF media. Cells were seeded in their respective FBS-containing medium in plates pre-coated 
with 0.2% gelatin and medium was changed to 2i/LIF medium after 24 hours of seeding. Cells 
were expanded in these conditions for at least 7 days prior to any experiment or lysate collection. 
For passaging, ESCs were dissociated into single cells with Trypsin for 3 minutes at 37°C, 
after being washed with DPBS. Trypsin was inactivated by dilution and cells suspensions were 
collected and centrifuged for 5 minutes at 1000rpm (FBS-containing media) or 1200rpm (2i/LIF 
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media). Cells were seeded in a 1:5 – 1:10 ratio every other day or every 3 days. The media was 
replenished every day.  
 
2.2.1.2 Epiblast cell culture 
The parental epiblast cell line EpiSCOct4GIP was routinely cultured in Epiblast N2B27 media 
with Puromycin (1µg/mL), whereas a second parental epiblast cell line was routinely cultured in 
Epiblast CDM-BSA media. Both cell lines were cultured in plates pre-coated with 0.1% gelatin and 
Epiblast Coating Media. For passaging, cells were washed and incubated with DPBS for 2 minutes 
at 37°C. The detached clumps of cells were collected and centrifuged for 5 minutes at 1000rpm. 
Clumps were gently dissociated to into smaller clumps by pipetting and seeded in a 1:5 – 1:10 
ratio every 3 days. The media was replenished every other day. 
 
2.2.1.3 XEN cell culture and differentiation 
The IM8A1 extra-embryonic (XEN) cell line was routinely cultured in XEN media in the 
absence of coating. For passaging, cells were dissociated through the same process as embryonic 
stem cells and seeded in a 1:20 ratio every 3 days. Media was replenished every other day.   
For visceral endoderm differentiation, XEN cells were seeded in a 1:50 ratio and cultured in 
the presence of BMP4 (10ng/ml) for 4 days.  
 
2.2.1.4 Derivation of mouse embryonic fibroblast  
Primary mouse embryonic fibroblasts (MEFs) were derived from E13.5 embryos. Once the 
embryos were removed from the uteri of pregnant mice, the head and internal organs were 
removed, and the remaining tissue incubated with trypsin for 10 minutes at 37°C. The tissue was 
then dissociated by passing through 18G needles 5 times then incubated for a further 5 min at 
37°C. Trypsin was inactivated by dilution with MEF media and cells were centrifuged at 1000rpm 
for 5 minutes. Cell pellets were resuspended in MEF media (10ml per embryo) and plated in 
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100mm dishes (1 plate per embryo).  Adherent fibroblasts were cultured until confluent and 
frozen until further use.  
For mitotic inactivation, MEFs were expanded up to 3 passages and dissociated with Trypsin 
when 80% confluent. Cell suspensions were exposed to 40Gγ of γ-radiation. Irradiated MEFs 
(iMEFs) were used as feeders in specific experiments. 
 
2.2.1.5 Cryopreservation 
All cell lines were routinely frozen in their respective media supplemented with 10% DMSO 
and 50% FBS (only for cells growing in FBS-containing media) and stored in cryogenic tubes 
which were transferred into a Mr Frosty Freezing Container and kept at -80°C for up to a month 
before moved indefinitely into N2 liquid. All cell lines were thaw by placing the cryogenic tube in 
a 37°C water bath for 2 minutes, and subsequent dilution of the cell suspension by 10 times with 
plain media. Cells were centrifuged for 5 minutes at 950rpm and seeded in their respective 
conditions. Media was replenished the next morning to eliminate dead cells. 
 
2.2.1.6 Production of Leukaemia Inhibitory Factor  
The Leukaemia Inhibitory Factor (LIF), a key component of mouse ES cell media, was 
prepared in-house. The monkey kidney cell line COS-7 was used as a host for the production of 
this component. COS-7 cells were cultured in COS-7 media for one passage, after which cells were 
expanded in 20x10cm plates in 10ml of E14 media in the absence of LIF. When cells reached 70% 
confluency 24µg of LIF-expressing vector were delivered per plate following the procedures 
described in 2.3.3. After 24h the media of each plate was collected and replenished with fresh 
10ml of E14 media (minus LIF) per plate. After 24h the media was again collected and the 2 
batches mixed together, filtered, aliquoted and stored at -20°C. The optimal dilution of each batch 
produced was determined by titration and comparison with the previous batch and a 
commercially available batch of LIF. Cells plated at low density were cultured in the presence of 
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the three batches of LIF and their undifferentiated state evaluated following Alkaline Phosphatase 
Staining (Section 2.2.2.2). 
 
2.2.2 Phenotypic characterization of embryonic stem cells 
2.2.2.1 Growth curve 
To access the growth rate of ESC lines, 500,000 cells (per well) were plated in FBS-containing 
medium supplemented with LIF, in the absence of drug selection (Jmjd2c-KO ESCs), in a 6-well 
pre-coated with 0.1%gelatin. After 48h the cells were dissociated to single cell level with Trypsin 
and the total number of cells counted using a haemocytometer. Subsequently, the initial number 
of cells (500.000) was re-plated in a new well. The same procedure was repeated over 8 passages 
and the media replenished in between.  The total number of cells at each passage was determined 
by multiplying by the previous passage.  
  
2.2.2.2 Self-renewal assay 
To access the self-renewal ability of an ESC population, 1000 cells (per well) were seeded in 
6-well plates, in duplicate. The medium (plus LIF and minus LIF; without drug selection) was 
changed every day and after five days the colonies were assessed for alkaline phosphatase activity 
following the manufacturer’s instruction. Briefly, the cells were washed with DPBS and fixed for 
30 seconds with 600µl of AP fixation solution, washed with distilled water (dH2O) for 45 sec and 
stained with 600µl of AP staining solution for up to 20 min in the dark. Finally, stained cells were 
washed with dH2O and allowed to dry at room temperature. Colony morphology was scored as 
differentiated (<20% stained), mixed (>20%-90% stained), undifferentiated (>90% stained).  
 
Chapter II – Materials and Methods 
96 
 
2.2.3 Differentiation of embryonic stem cells 
2.2.3.1 Embryoid body formation 
JM8 and E14 ES cells growing routinely in FBS-containing media were dissociated with 
Trypsin and 100,000 cells (per well) were thoroughly re-suspended in 4 ml (per well) of JM8/E14 
media with 5% FBS and no LIF and transferred into a 6-well ultra-low attachment plate (Corning, 
USA). Half of the media was replenished every day. EB aggregates were collected at the indicated 
time points for RNA extraction.   
For hanging drop EB (HD-EB) assay, approximately 500 cells were used to form single drops 
of 30µl which were deposited in an inverted lid of a 10cm plate. Nearly 30 drops were added in 
each lid, and 3 to 4 plates were used per time point of RNA collection. The bottom of the plate was 
filled with about 10ml of DPBS to maintain humidity levels within the plate. Lids were swiftly 
turned and placed on the plates, allowing the individual cells to aggregate at the bottom of the 
drops.  
 
2.2.3.2 Retinoic acid treatment 
For all trans retinoic-acid (atRA) induced differentiation, JM8 ESCs growing routinely in JM8 
media were dissociated and 80,000 cells (per well) seeded in 12-well plates in routine conditions 
for 24h. Media was then changed into JM8 media with 5% FBS with 1µM of atRA and no LIF to 
promote differentiation, and replenished every day for up to 4 days. Cells were collected at the 
indicated time point for RNA extraction. For staining, 20,000 cells (per well) were plated in 8-well 
chamber wells, and treated for 4 days under the same conditions mentioned above.  
 
2.2.3.3 XEN cell conversion  
JM8 ESCs growing routinely in FBS-containing were dissociated with Trypsin and 
resuspended in XEN media. Around 30,000 cells (per well) were plated in a 6-well plate pre-
coated with 0.1% gelatin. After 24h the media was replaced with XEN derivation media 
(containing atRA/Activin A/bFGF/Heparin). 
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The derivation media was replenished again, allowing a total of 48h of derivation, after which 
the differentiated cells were dissociated with Trypsin and re-plated again in derivation media 
into a 6-well plate previously coated with iMEFs. The next day, the medium was changed into 
standard XEN media supplemented with bFGF (24ng/mL) and Heparin (1μg/mL). Approximately 
10 days after the beginning of the experiment, converted XEN (cXEN) colonies were picked under 
the microscope by scraping the boundaries of the colonies with an 18G needle. Detached colonies 
were collected and dissociated by pipetting several times with a P1000. Colonies were seeded in 
XEN media supplemented with bFGF and Heparin in a 24-well plate pre-coated with iMEFs. From 
here on, the cXEN populations were split when confluent into 6-well plates pre-coated with 0.1% 
gelatin until all the cell population resembled XEN cells. RNA was extracted from 3 different 
passages of established cXEN cell lines.  
 
2.2.3.4 Epiblast cell conversion  
ESCs growing routinely in serum-free conditions (2i/LIF) for at least 7 days dissociated with 
Trypsin and 50,000 cells (per well) were plated in 6-well plates previously coated with 
Fibronectin (10ug/ml) for at least 1 hour, in 2i/LIF media. After 24h the following procedures 
were taken: 
-  For short Epiblast-like (EpiLC) conversion, the media was changed to Epiblast N2B27 
Media supplemented with 1%KOSR (Buecker et al, 2014). RNA, protein and chromatin were 
extracted after 24h and/or 48h.  
- For transient EpiLC conversion, the media was changed to Epiblast Rich Media 
supplemented with Activin A (20ng/ml) and bFGF (12ng/ml) and replenished every day. 
RNA was extracted every day up to day 3.  
- For stable EpiSC conversion, the cells were cultured in Epiblast Rich Media for 7 to 10 
days days, after which cells were detached by incubation on DPBS for 5 minutes at 37°C and 
gentle scraping with a tip. Cell clumps were plated in a 1:3 ratio in Fibronectin-coated wells 
with Epiblast Rich Media for up to 5 passages. From here on, cells were passaged by 
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incubation on DPBS for 2 minutes at 37°C and gentle tapping on the plate to specifically 
detach EpiS-like colonies. Converted EpiSC (cEpiSC) cultures were routinely seeded in 
Epiblast N2B27 Media in a 1:5 – 1:10 ratios in 6-well plates previously coated with Epiblast 
Coating Media. After at least 12 passages in these conditions cells were used for subsequent 
experiments. RNA, protein and chromatin were extracted from at least 3 different passages 
in stable conditions.  
  
2.2.3.5 Neuronal differentiation  
ES cells growing routinely in serum-free conditions (2i/LIF) for at least 7 days dissociated 
with Trypsin and 50.000 cells (per well) were plated in 6-well plates previously coated with 0.2% 
gelatin, in 2i/LIF media. After 24h the media was changed to Neuronal Rich Media, which was 
replenished every day up to day 5. At day 5, differentiated cells were fixed in the plate and stained 
as described in Section 2.2.7.1.  
 
2.2.3.6 Mesoderm differentiation  
Converted EpiSCs routinely cultured in Epiblast N2B27 media, and the parental EpiSC line 
routinely cultured in Epiblast CDM-BSA media were dissociated by incubation on DPBS, and 
seeded in their respective media at a 1:6 ratio in a 6-well plate previously coated with Epiblast 
Coating media. After 24h the media was changed into FlyB media. After 36h in FlyB conditions, 
the media was changed into either FB40 or FlyWLDN, for lateral plate mesoderm and paraxial 
mesoderm differentiation, respectively. The media was replenished every day up to 4 days in both 
conditions, after which the cells were harvested for FACS analysis (section 2.2.7.2), or fixed and 
stained (section 2.2.7.1). RNA was extracted at the indicated time points.  
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2.2.4 Cloning and DNA delivery 
2.2.4.1 Generation of plasmids 
For the generation of the vectors pPyCAG-IP-Jmjd2c and pPyCAG-IP-FLAG(x2)V5-Jmjd2c, the 
Jmjd2c full-length transcript was amplified from the cDNA of WT ESCs with primers containing 
restriction sequences recognised by the enzymes containing a restriction site in each of the 
vectors used (Primer sequences in Appendix B). In particular, restriction sites for XhoI and PacI 
were inserted in the 5’ and 3’ sites of Jmjd2c by PCR, and used to ligate this insert into the pPyCAG-
IP vector. Similarly, the restriction sites for BamHI and SalI were inserted in the 5’ and 3’ sites of 
Jmjd2c by PCR, and used to ligate this insert into the pPyCAG-IP-FLAG(x2)V5 vector. For 
amplification of Jmjd2c with the indicated restriction sites, a PCR reaction was prepared with the 
following components: 1X KOD buffer, 1mM MgSO2, 0.2mM dNTP mix, 0.3μM each primer, 1U 
KOD Hotstart Polymerase and approximately 5ng template cDNA.  The following cycling 
conditions were used: 95°C for  2 minutes (denaturation), 35 cycles of 95°C for 20 seconds 
(denaturation) and  58°C  for  25 seconds (annealing), and finally 70°C  for  60 seconds 
(extension); followed by a final elongation step of 70°C  for  10 minutes. A sample of the amplified 
product were separated in a 1% (w/v) agarose gel containing 0.01 g/mL Ethidium Bromide by 
electrophoresis 1X TBE buffer, over 1h at 100V.  
Insert and vector DNA were digested with the respective restriction endonucleases. 
Reactions were performed in a total volume of 50μL containing no more than 10% (v/v) of 
enzyme, and 1x of the recommended NEB buffer (10x), with addition of 1x BSA. Digestions were 
performed at 37°C for 2-3 hours followed by an inactivation step of 65°C, for 20 min. Digested 
PCR products were purified using the QIAquick PCR Purification Kit. Digested products were 
separated by electrophoresis, excised from the gel and purified with QIAquick PCR Gel Extraction 
Kit.  
Inserts were ligated into the corresponding vectors with the NEB Quick Ligation Kit. 50ng 
linearized vector DNA was incubated with 1uL Quick T4 DNA Ligase, 1X Quick Ligation Buffer and 
a 3-fold molar excess of insert DNA, and in a total volume of 20μL. Reactions were performed for 
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5 minutes at room temperature then incubated on ice for 5 minutes more. Prior to plasmid 
amplification, vectors were purified with the QIAquick PCR Purification kit. 
 
2.2.4.2 Plasmid amplification  
The following procedure was used for amplification of any of the plasmids used in this work. 
Per reaction, 50μL of chemically competent TAM1 cells were thawed on ice briefly. Between 1 to 
5μL of DNA ligation, plasmid, or shRNA vector, were pipetted into each vial and mixed gently, 
then incubated on ice for 30 minutes. DNA was inserted by heat-shock, upon incubation of 
bacteria at 42°C for 30 seconds. Transformed bacteria were incubated again on ice for 2 minutes, 
after which 250μL of SOC media were added per vial, and incubated for 1 hour at 37°C with 
rotation. Bacteria were spread onto pre-warmed LB-agar plates containing 50μg/mL Ampicillin 
and plates were incubated overnight at 37°C. Newly formed single colonies were picked and 
further expanded in liquid cultures in 2X-low salt LB-broth (shRNA pLKO.1 plasmids) or LB-broth 
(all other plasmids) containing 100μg/mL Ampicillin, overnight at 37°C with agitation. 
Transformed bacteria cultures were pelleted by centrifugation at 4,500rpm for 15 min, and DNA 
was collected and purified using the HiSpeed Plasmid Maxi Kit, and eluted in 500-1000μL sterile 
TE buffer and stored at 4°C.  
 
2.2.4.3 Transfection of embryonic stem cells 
All transfected ESC lines were routinely cultured in FBS-containing media. When necessary, 
cell density was optimized for each cell line, type of transfection and surface area. The 
DNA/Lipofectamine2000 ratio was kept constant but absolute quantities adjusted according to 
the surface area.  
Transient transfections were used to validate newly generated expression vectors and to 
validate the efficiency of shRNA vectors, whereas stable transfections were used to generate new 
cell lines and perform long-term knockdown experiments.  
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- For transient transfections: 100.000 to 200.000cells/cm2 were seeded in the routinely 
used media depleted of antibiotics (penicillin/streptomycin). Between 4 to 6 hours after 
plating, the transfection mix was prepared as follows. In general, per well of a 6-well plate, 1µg 
of plasmid DNA was diluted in 200µl of OPTIMEM and 3µl of Lipofectamine2000 in 200µl 
OPTIMEM. The 2 solutions were mixed together in a ratio of 1:1 and incubated at room 
temperature for 20 minutes. Transfection mix was added to each well drop-wise, and 
homogenised by gentle movement of the plate. The next day, the media was changed into 
routine ESC media (with antibiotics), and cells lysates collected 48h post-transfection for RNA 
or protein extraction. 
- For stable transfection: 50.000 to 100.000cells/cm2 were seeded and transfected as 
described above. Additionally, 24h post-transfection 1µg/ml Puromycin was added for 
selection and these culture conditions maintained for 4 days (for knockdown experiments) or 
indefinitely (for stable cells lines). In the latter, individual cell clones were isolated from the 
pool of transfected cells 5 to 10 days post-transfection, by scraping and aspirating each clone 
with a pipette. Individual clones were transferred into 96-well plates and expanded for 
validation and further use.  
 
2.2.5 Quantitative reverse transcriptase PCR 
2.2.5.1 RNA extraction  
RNA extraction was performed using RNeasy Mini kit following the manufacturer’s 
instructions. For RNA extraction of adherent cultures, 350ul of RLT buffer supplemented with 1% 
(v/v) 2-Mercaptoethanol, were added to each well of cells washed with DPBS and the lysates 
collected and frozen at -80°C until extraction. For RNA extraction of suspension cultures (EBs), 
cells were collected and pelleted by centrifugation, before the same procedure above was applied.  
In brief, compete lysis was achieved by pipetting and vortexing the cell suspension in RLT. 
The lysates were mixed with 1 volume of 70%(v/v) ethanol and transferred into a MinElute spin 
column. Columns were centrifuged at 10.000rpm for 1 minute and flow-through discarded. 
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Columns were washed with 350µl of Buffer BW1 and contaminant DNA was removed by 
incubation with 10µl DNAse I diluted in 70µl of buffer RDD, at room temperature for 20 minutes. 
After a second wash with 350µl of Buffer BW1, columns were washed twice with 500µl Buffer 
RPE. RNA was eluted from the columns with 30µl RNase-free water. Concentration was measured 
in a NanoDrop 2000 spectrophotometer and RNA samples stored at -80°C.  
 
2.2.5.2 cDNA synthesis 
Between 0.5 and 1µg of total RNA were reverse transcribed using Superscript First‐Strand 
Synthesis kit.  RNA was mixed with 1µl  of  10 mM  dNTP  mix  and  1 µl  of  oligo  (dT)12‐18 and  
diluted  in  RNase-free water  to  a final  volume of  13  µl and incubated  at  65°C for  5  minutes.   
Subsequently,  2 µl  of  0.1 M DTT,  4µl  of  5X  first  strand  buffer,  and 1 µl  of RnaseOUT were  
added  and the mixture at  42°C. After 1 minute 1µl of 200U/µl Superscript II was added to each 
reaction and incubated at 42°C for 1hour and at 70°C for 15 min. Each newly synthesised cDNA 
sample was diluted 20 times with RNase‐free and stored a -20°C. 
 
2.2.5.3 Quantitative real‐time PCR analysis   
Quantitative real‐time polymerase chain reactions (qPCR) were carried out in either a total 
volume of 20µl with 50% (v/v) Jumpstart Sybr‐Green PCR Mastermix and 1% ROX, or in a total 
volume of 10µl with 50% (v/v) KicQstart Sybr‐Green PCR Mastermix (incuding ROX). To each 
reaction 300nM of primers and 5% (v/v) of cDNA/DNA were added. A control reaction without 
cDNA/DNA was included to check for the formation of primer-dimers, and all reactions were 
performed in duplicate in the same plate. Cycling conditions were as follows: 95°C for 15 minutes 
(denaturation), 40 cycles of 94°C for 15seconds (denaturation) and  60°C  for  30seconds 
(annealing), and finally 72°C  for  30 seconds (extension).  
The quantification of the abundance of target sequences was determined by using the ΔCT 
and ΔΔCT method (Livak and Schmittgen, 2001; Pfaffl, 2001) in which the CT represents the 
number of cycles in the reaction necessary to achieve a defined level of fluorescence in the 
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exponential phase of amplification. For gene expression analysis, this was either normalized to 
the CT average of 2 housekeeping genes (S17 and L19) and represented as mRNA levels, or 
normalized to both the housekeeping genes and a control sample and represented as fold 
enrichment over control. 
For detection of protein binding by chromatin immunoprecipitation, the CT of the target 
region was normalized to 1% of input DNA and to a background (typically intergenic) region and 
represented as fold enrichment over background. 
 
2.2.5.4. Primer design and validation 
Primers for RT-qPCR were design with the following criteria: amplicon  size  of  100‐
200bp,  primer GC  content  of  45‐55%,  primer melting  temperature  57‐63°C , low 3’ stability 
(no more than 2 C’2 and/or G’s in the last 5bp of the primer) and primer  size  of 18‐25bp. 
Moreover, for expression analysis primers were designed in different exons. Target sequences 
were obtained in the Ensembl and the UCSB genome browsers and the primers were aligned to 
the genome using the BLAT function of the NCBI. 
For each pair of primers designed, the efficiency in qRT-PCR was tested in 2-fold dilutions of 
DNA/cDNA (Pfaffl, 2001). Primers were considered efficient, and therefore suitable for the ΔΔCT 
method, when yielding a good linear fit (R2<0.98) in Ct vs. logarithm of the dilution factor plot 
and the efficiency calculated was between 1.8 and 2.2 (Efficiency=10(1/slope)).  
 
2.2.6 Analysis of DNA methylation  
2.2.6.1 Genomic DNA extraction 
Genomic DNA was extracted from adherent cells expanded in 10cm dishes. Cells were 
dissociated with Trypsin and washed with DPBS. Cell pellets were resuspended in 0.5-1ml DNA 
Lysis Buffer with 0.5mg/ml Proteinase K and incubate for 16h at 55°C. An equal volume of Phenol-
chloroform was added to the sample, followed by vortexing and centrifugation for 5 minutes at 
14000rpm. The organic (top) layer was collected and mixed with 50% volume of isopropanol. 
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Samples were incubated at -20°C for at least 2 hours, after which were centrifuged at 4°C for 
20minutes at 14000rpm. DNA pellets were washed with 70% (v/v) ethanol and centrifuged again 
for 10 minutes. Pellets were allowed to dry at room temperature until all ethanol had evaporated 
and finally resuspended in 0.5 – 1ml of TE buffer with 20ug/ml RNAse A. Samples were stored at 
-20°C until further use. 
 
2.2.6.2 Restriction analysis 
The levels of DNA methylation and hydroxymethylation at target sequences were evaluated 
with the EpiMark 5-hmC and 5-mC Analysis Kit, following the manufacturer’s instructions.  First, 
5hmC sites were glycosylated (5ghmC) by adding 15U of T4-β-glucosyltransferase, 80µM UDP-
Glucose and 1%(v/v) NEBuffer 4 to 3µg of genomic DNA. The reactions were incubated at 37°C 
for 16h. One third of the sample was further incubated with 100U of MspI, one third with 50U of 
HpaII and another third with the equivalent volume of H2O. The 3 reactions were incubated at 
37°C for 6 hours, followed by the addition of 20µg of Proteinase K and incubation at 40°C for 30 
minutes. The Proteinase K was finally inactivated at 95°C for 10 minutes and samples diluted 1:3 
in nuclease-free H2O for qPCR analysis. Primers for this assay were designed around target 
sequences containing one (or more) CCGG, which is recognized by both restriction enzymes. 
However, digestion by HpaII is blocked by any modification (5mC, 5hmC or 5-ghmC), whereas 
MspI is only blocked by 5ghmC. Therefore, HpaII is only able to digest unmethylated DNA, 
whereas MspI is only able to digest 5mC DNA. Amplification of HpaII-resistant products is 
proportional to the levels of 5mC plus 5ghmC DNA, whereas amplification of MspI-resistant 
products is proportional to the levels of 5ghmC (and thus 5hmC) DNA alone. Thus, the levels of 
total DNA were determined by the amplification levels in the un-digested fraction, the 5hmC 
levels corresponded to the levels quantified in MspI-resistant 5mC DNA, and the 5mC levels were 
determined by subtracting the level quantified in HpaII-resistant (5mC + 5ghmC) fraction by the 
levels of MspI-resistant (5hmC) DNA. All reactions were normalized to a control region (without 
a restriction site) and represented as percentage relative to total DNA (100%). 
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2.2.7 Protein analysis  
2.2.7.1 Immunofluorescent staining 
Cells were cultured on 0.2% gelatin-coated glass coverslips or plastic 8-well chambers. When 
at the desired confluency, cells were washed in PBS and fixed in 4% paraformaldehyde (PFA) for 
10 minutes. Fixed cells were permeabilised with 0.4% Triton X-100 in blocking buffer (Section 
2.1.9), for 30 minutes at room temperature. After washing with PBS, the coverslips were 
incubated in blocking buffer for 30 minutes. Finally, samples were incubated with primary 
antibody diluted in blocking buffer overnight at 4°C in a humid chamber. Coverslips were washed 
in PBS and incubated with the fluorophore-conjugated secondary antibodies diluted in blocking 
buffer for 1 hour at room temperature. Coverslips were washed in PBS and mounted in 
Vectashield with 1µg/ml DAPI. Samples were visualised using a SP5 Leica laser-scanning confocal 
microscope or an inverted fluorescent/brightfield microscope with an attached Nikon camera. 
 
2.2.7.2 Flow cytometry analysis  
Cells were harvested using cell dissociation buffer (Gibco) and 10.000 cells were blocked in 
PBS containing 2%(v/v) FBS, stained for Flk-1 with 5µg/mL of  anti-Flk-1-Biotin (avas12 a1 clone, 
eBioscience), followed by 0.4 µg/mL APC-conjugated streptavidin (Biolegend) or Pdgfrα with 
2µg/mL anti-Pdgfrα-PE (clone APA5, eBioscience) and analysed on an Accuri C6 Flow cytometer. 
 
2.2.7.3 Protein western blot 
Whole cell extracts were obtained by lysing the cells cultured in 6-well plates with cold RIPA 
buffer supplemented with protease and phosphatase inhibitors. Lysates were incubated for 20 
minutes on a rotating wheel at 4°C, centrifuged at 14,000rpm for 20 minutes and the supernatant 
collected. The protein extracts were quantified by Bradford assay and stored at -20°C.  
The appropriate amount of protein lysates (5-30μg for whole extracts) was diluted 3:1 with 
Laemmli sample buffer (4x) with 5%(v/v) β-mercaptoethanol and incubated at 95˚C for 5 
minutes. Lysates were resolved on an 8% SDS polyacrylamide gel electrophoresis (SDS-PAGE) gel 
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and subsequently transferred into a methanol-activated Polyvinylidene fluoride (PDVF) 
membrane using wet-transfer method at 90V for 1 hour at 4˚C. Blots were blocked with 5% 
skimmed milk in Tris-Buffered Saline with 0.5% Tween20 (TBS-T) for 1 hour at room 
temperature. After washing with TBS-T, the appropriate amount of primary antibody was diluted 
in 5% skimmed milk in TBS-T and incubated overnight t 4˚C. Membranes were washed with TBS-
T and then incubated with the appropriate HRP-conjugated secondary antibody diluted in 5% 
skimmed milk in TBS-T for 1 hour at room temperature. After washing with TBS-T, detection of 
the proteins was achieved by treating the blots with enhanced chemiluminescence (ECL) western 
blotting detection reagents and exposing in the ImagQuant LAS4000. 
 
2.2.7.4 Histone western blot 
Histones were acid extracted from adherent cells (Shechter et al., 2007), which were 
expanded in 10cm dishes. Cells were dissociated with Trypsin and centrifuged at 1200rpm for 4 
minutes. After washing with DPBS, cell pellets were resuspended in 1ml of hypotonic lysis buffer 
and incubated on ice for 30 minutes. Lysates were centrifuged for 10,000rpm for 10 minutes at 
4°C. The intact nuclei were pelleted by spinning in cooled tabletop centrifuge: 10,000rpm, 10 
minutes at 4 °C. Pelleted nuclei were resuspended in 400 μl 0.4N H2SO4 and incubated on a wheel 
overnight. Nuclear debris were removed by centrifuging samples for 10 minutes at 14.000rpm. 
Histones were precipitated with 33%(v/v) TCA for 30 minutes on ice, followed by a 
centrifugation step at 14,000rpm for 10 minutes at 4°C. Pellets were washed with ice-cold 
acetone, and centrifuged again. After air drying, the pellets were resuspended in 100μl dH2O, 
quantified by Bradford assay and stored at -20°C.  
1 or 2μg of histones were diluted 3:1 with Laemmli sample buffer (4x) with 5%(v/v) β-
mercaptoethanol and incubated at 95˚C for 5 minutes. Histone lysates were resolved on a 13% 
SDS-PAGE gel and subsequently transferred into a methanol-activated PVDF using a semi-dry 
method at 20V for 1 hour at room temperature. The remaining steps were as described above 
(Section 2.2.7.3). Relative quantification of band intensity was performed using ImageJ software. 
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2.2.8 Protein-Protein interaction analysis  
2.2.8.1 FLAG pull down and mass spectrometry 
Cells were expanded into 25x 15cm plates, which were washed with PBS twice and scraped 
in ice-cold PBS supplemented with protease inhibitors. Cell suspensions were centrifuged at 
1100rpm for 5minutes at 4˚C. Cell pellets were resuspended in 5 volumes of Buffer A and 
incubated on ice for 10 minutes. Lysates were centrifuged at 3000rpm for 10minutes and pellets 
resuspended in 2 volumes of Buffer A. Suspensions were subject to mechanical lysis with loose 
pestle in a dounce homogeneizer. After a centrifugation step at 3000rpm for 10 minutes, nuclear 
extracts were ressuspended in 1.5 pellet volume of Buffer C and subject to mechanical lysis with 
a tight pestle in a dounce homogeneizer, and further incubated at 4˚C for 30 minutes. Insoluble 
fractions were removed by centrifugation. Nuclear (soluble) fraction was dialyzed twice against 
1L of Buffer D in a 7kDa dialysis bag (Thermoscientific). FLAG protein and bound complexes were 
purified by incubation with 60µl anti-FLAG M2 beads and 0.15U/µl Benzonase. Beads were 
washed 5 times in Buffer C100 and complexes eluted with 0.2 mg/ml FLAG tripeptide four times. 
Elution of the FLAG-tagged protein was validated by western blot. Positive fractions were pooled 
together and the proteins precipitated for 30 minutes on ice with 0.25%(v/v) of TCA and 
0.1%(w/v) DOC. Protein pellets were washed with ice-cold acetone and allowed to dry at room 
temperature. Finally samples were dissolved in 50µl sample buffer and incubated at 95 ˚C for 10 
minutes. Samples were run on a SDS-PAGE gel up to 2/3 of the size and the gel and stained with 
Colloidial Coomassie kit for 2 hours.  
Mass spectrometric analysis was performed as van der Berg et al., 2010. Briefly, gel lanes 
were cut with an automatic gel slicer and reduced. Peptides were separated on a capillary system 
coupled to a mass spectrometer. A Mascot search algorithm was used for identification of 
peptides against the NCBI database and emPAI scores were attributed to each identified peptide. 
The Mascot score cut-off for a positive protein here used was 40, given the high variability 
between experiments. Moreover, only peptides with a score 3-fold higher in the test sample 
versus the control sample were retained as significant. The list of proteins obtained in the three 
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experiments was overlapped, and a new list was generated containing only proteins identified in 
2 out 3, or 3 out of 3, experiments. For the purpose of this work, cellular location of the identified 
proteins was manually annotated and only nuclear proteins were considered as biologically 
significant.   
 
2.2.8.2 Protein co-immunoprecipitation 
Co-IP of nuclear extracts from HeLa cells was performed with Co-IP protocol A (Section 
2.1.9), as described in Fritsch et al., 2010. Briefly, HeLa-S3 cell lines expressing a HA-FLAG-G9a 
were generated, together with control cell line expressing an empty vector. Cells were expanded, 
washed in DPBS, scraped and pelleted. Pellets were resuspended in the hypotonic buffer and 
disrupted with 20 strokes of a tight-fitting Dounce homogenizer. Subsequently, a sucrose, 
spermidine and spermine-containing buffer (Buffer SR) was added to limit nuclei leak. The 
cytosolic fraction was separated from nuclei (pellet) after centrifugation for 7 minutes at 
9000rpm, at 4°C. The nuclear soluble fraction was obtained upon incubation of the pellet in a high 
salt buffer for 30 minutes at 4°C followed by centrifugation at 10,000 rpm. The pellet 
corresponded to chromatin fraction and the supernatant to the nuclear soluble fraction. The 
chromatin fraction was resuspended and digested with micrococcal nuclease (Mnase). Nuclear 
soluble and chromatin fractions were then centrifuged at 3,200 rpm for 1 h at 4 °C. G9a-bound 
complexes were purified by IP with anti-FLAG antibody bound beads overnight on a rotating 
wheel at 4°C. Complexes were eluted with a FLAG peptide and further purified on anti-HA 
antibody-conjugated agarose beads, and subsequently eluted with the HA peptide. Double-
immunopurified complexes were resolved on 4-12% SDS-PAGE bis Tris acrylamide gradient gel 
and immunoblotted with the indicated antibodies.  
Co-IPs in nuclear extracts of ESCcontrol and ESCFV-Jmjd2c-WT were performed with the Co-IP 
Protocol B (Section 2.1.9). Cells were expanded, washed and scraped with ice-cold PBS 
supplemented with protease inhibitors. Cells were centrifuged at 1300rpm for 5minutes, at 4°C 
and pellets were snap-frozen in dry ice until extraction. For protein extraction, the pellets were 3 
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times the volume (V) of the pellet in Buffer A.  NP-40 was added to a final concentration of 1% 
(v/v) and lysates homogenised by inversion. 8V/9 of Buffer SR were added and lysates again 
homogenised by inversion. The nuclei were pelleted at 2000x g for 5 minutes at 4°C and 
resuspended in 1V of Sucrose Buffer. High Salt Buffer was added to the nuclei pellet drop by drop 
and incubated on ice for 30 minutes. 1V/3 of Sucrose Buffer was added, together with 1mM Cacl2 
and 0.00025U/µl of Mnase. The reaction was incubated at 37°C for 10 minutes, and stopped by 
the addition of   4mM EDTA. Nuclei suspensions were briefly sonicated in a bioruptor (Diagenode) 
and lysates were centrifuged at 86.600 RCF for 30 minutes at 4°C. The protein concentration of 
the nuclear extract (supernatant) was quantified by BCA assay. The required amount was pre-
cleared with 10 µl protein G-coupled sepharose beads, previously washed twice with Washing 
Buffer, for 2h at 4°C on rotating wheel. The supernatant was recovered after spinning and 500 to 
1000µg of nuclear extract were used per IP.  After diluting in a total volume of 500µl with TEGN 
buffer, 2.5 to 5µg of the antibody of interest or 5µg of the corresponding normal IgG as negative 
control, were added and IP’s were incubated overnight on a rotating wheel at 4°C. Lipids and 
debris were removed from the IPs after centrifugation and 7.5µl of protein G beads previously 
blocked with 0.3% (w/v) BSA and 0.6µg/µl of ssDNA, were added and further incubated for 2 
hours. IPs were washed 5 times with Wash Buffer. The protein complexes were eluted from the 
beads by incubation at 95°C for 10 minutes in 7µl of Wash Buffer and 7µl of Laemmli Buffer with 
5%(v/v) β-mercaptoethanol. Proteins were detected following western blot (Section 2.2.7.3). 
Co-IP in nuclear extracts of ESCcontrol shown in Fig.5.7C was performed with Co-IP Protocol C 
(2.1.9).  Cells were washed and scraped with DPBS and protease inhibitors, and pelleted 
at1300rpm for 5 minutes at 4°C. Cell pellets were resuspend in Cell Lysis Buffer and incubate on 
ice for 10 to 25 minutes. Cells were further lysed with a dounce homogneizer with a loose pestle, 
10% (v/v) NP-40 were added to a final concentration of 0.5% and cells  vortexed for 5 seconds, 
and incubate on ice 3 minutes. Nulei were pelleted at 4000rpm for 5 minutes at 4°C and 
resuspend in Nuclei Lysis Buffer and incubated for 10 minutes on ice. Pellets were further 
homogenised with a tight pestle in a douncer homogeneiser. Samples were sonicated in a 
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Diagenode bioruptor for 10 minutes with a cycle of 30 seconds ON/30 seconds OFF for 10min at 
high intensity. Nuclear extracts were centrifuge at 14,000rpm for 20 minutes at 4°C and the 
supernatant kept. The appropriate amount was precleared with 10 µl of magnetic Dynabeads for 
2h at 4°C on rotating wheel. About 1mg of protein was used per IP and diluted in IP Buffer with 
the indicated antibodies. IPs were performed overnight on rotating wheel at 4°C. About 20 µl of 
Dynabeads were used to capture the IP complexes, which were subsequently washed in IP Buffer 
and separated by Western Blot after being eluted from the beads by incubation at 95°C for 10 
minutes in IP Buffer and Laemmli Buffer with 5% (v/v) β-mercaptoethanol.  
 
2.2.9 Protein-DNA interaction analysis 
2.2.9.1 Chromatin immunoprecipitation 
In general, all chromatin immunoprecipitation (ChIP) experiments followed the procedure 
described below with minor changes between as outlined at the end of this section. Solutions used 
in each protocol (A, B or C) are described in Section 2.1.9. Cells were expanded in 1 to 3 175cm2 
flasks and cross-linked in either 2mM DSG in fixation mix for 45 minutes followed by 1% 
formaldehyde for 10 minutes at 37°C (double fixed), or uniquely in the later conditions (single 
fixed). The reaction was then quenched with 125mM glycine, and the cells washed in PBS and 
scraped from the plates. Cell lysis was performed with the indicated lysis buffers for each 
protocol. This procedure was accompanied by douce homogeneizer with a loose pestle when cell 
lysis appeared incomplete. The nuclei were pelleted by centrifugation at 1200rpm and 
resuspended in the respective IP buffers (Section 2.1.9) and sonicated in a Diagenode bioruptor. 
Sonication cycles were optimized for each cell line and protocol to produce fragments with sizes 
between 200 and 500bp. Following a rapid de-crosslinking at 65°C, the fragment size of sonicated 
DNA was confirmed by separating a small sample in a 1%(w/v) agarose gel containing 0.01 g/mL 
Ethidium Bromide by electrophoresis in 1X TBE buffer, over 1h30 at 90V. DNA was measured by 
spectrophotometry and/or protein measured by BCA assay. The amounts of DNA or protein 
indicated below was pre-cleared with sepharose beads or magnetic Dynabeads for 2h at 4°C on 
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rotating wheel. IPs were also performed on rotating wheel overnight at 4°C with the indicated 
amount of primary antibodies. When indicated, normal IgG of the same species as the primary 
antibody was used as negative control. The antibody-protein complexes were further incubated 
with the indicated amount of beads for 3h. The unbound chromatin was removed by sequential 
washes with the indicated wash buffers for each protocol, followed by a final wash with TE buffer. 
For magnetic Dynabeads, protein-DNA complexes were isolated by incubation on a magnetic rack 
for 1 minute, whereas for sepharose beads these were separated by centrifugation at 1300 rpm 
for 3 minutes.  Chromatin was eluted from the beads with addition of 250μl of elution buffer 
supplemented with 0.04µg/µl RNase A at in a shaker at 65°C overnight. Samples were 
subsequently diluted 1:2 in TE Buffer and treated with 0.2µg/µl Proteinase K at 55°C for 2 hours. 
DNA was purified by addition of equal volume of phenol/chloroform extraction. DNA was then 
precipitated overnight at -20°C with 20-30μg GlycoBlue carrier, 1/10 volumes of of NaAc 3M and 
2 volumes of 100% ethanol. Pellets were centrifuged, washed in 70%(v/v) ethanol and finally 
resuspended in TE buffer and used for qPCR (Section 2.2.5.3) with primers listed in Appendix B, 
or for generation of libraries for sequencing.  
 
Target 
protein 
ChIP 
Protocol 
Fixation 
DNA 
amount 
Protein 
amount 
Antibody 
amount 
Volume 
of 
Beads 
Beads 
coating 
Type of 
Beads 
 
Suz12 
Ring1b 
IgG 
A Single 
600μg 
600μg 
600μg 
- 
10μg 
10μg 
10μg 
100μl 
100μl 
100μl 
Protein 
A 
Sepharose 
 
H3K9me2 
 
B Double 20μg - 2μg 20μl 
Protein 
G 
Magnetic 
Oct4 
H3K27ac 
p300 
FLAG 
Med1 
 
C 
 
Single - 
400μg 
500μg 
500μg 
500μg 
800μg 
5μg 
5μg 
5μg 
5μg 
8μg 
20μl 
40μl 
40μl 
40μl 
40μl 
Protein 
G 
Magnetic 
 
G9a 
Smc1a 
 
C 
 
Double 
 
- 
 
250μg 
800μg 
 
5μg 
8μg 
 
40μl 
40μl 
 
Protein 
G 
 
Magnetic 
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2.2.9.2 Generation of libraries for sequencing  
Libraries were prepared from ChIP DNA using the NEBNext® Ultra™ DNA Library Prep Kit 
and Multiplex Oligos. Briefly, 5ng of eluted DNA were incubated with 3 µl End Prep Enzyme Mix 
and 6.5 µl of End Repair Reaction Buffer, in a 65 µl reaction volume. Reactions were incubated at 
20°C for 30 minutes, and to 65°C for 30 minutes, for dA tailing and repair of the 3’ end. 
Subsequently, a sequence adaptor was ligated by incubation with 15 µl Blunt/TA Ligase Master 
Mix, 1 µl of Ligation Enhancer and 2.5 µl of the NEBNext Adaptor (1.5µM) in a total reaction 
volume of 83.5 µl. Following a 15 minute incubation at 20°C for 15 minutes, 3 µl of USER Enzyme 
were added. Ligation reactions were incubate at 37°C for 15 minutes. 
For selection of inserts containing 200bp size, 3.5 µl DEPC-treated dH2O were added to the 
ligation reaction for a 100 µl total volume, followed by 55 µl of AMPure XP Beads. Following a 10 
minute incubation at room temperature, the unwanted large fragments bound to the Beads were 
removed by separation in a magnetic stand. Separated DNA was further incubated with 25 µl of 
AMPure XP Beads to the supernatant, for another 10 minutes at room temperature. Bound DNA 
was kept after magnetic separation and washed 3 times with 85% (v/v) ethanol. DNA was eluted 
with 25 µl of 10 mM Tris-HCl pH8, from which 20 µl were taken for further amplification by PCR 
with 1x NEBNext High Fidelity Master Mix (2X), 2.5 µl of each individual Index Primers and 2.5 µl 
of the Universal PCR Primer in a total volume of 50 µl. Combination of index primer in each lane 
are outlines below. PCR cycling were as follows:  98°C for 30 seconds,  15 cycles of 98°C for 10 
seconds, 65°C  for  30 seconds and 72°C  for  30 seconds, and finally  an extension step of 72°C  for  
5 minutes. PCR products were separated by incubation with 40 µl of AMPure XP Beads for 10 
minutes at room temperature and washed twice with 85% (v/v) ethanol. DNA was eluted with 
33 µl 10 mM Tris-HCl and size distribution was analysed in an Agilent Bioanalyzer and sequenced 
in an Illumina platform. A sample was taken for validation of a known target region by qPCR. 
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Condition Sample Rep Index  Lane Barcode 
2i  input  rep1 4 A TGACCA 
2i IP rep1 5 A ACAGTG 
2i IP rep3 6 A GCCAAT 
FBS  input  rep1 7 A CAGATC 
FBS IP rep1 12 A CTTGTA 
EpiLC  input  rep1 4 B TGACCA 
EpiLC IP rep1 5 B ACAGTG 
EpiLC IP rep2+3 6 B GCCAAT 
FBS  input  rep3 7 B CAGATC 
FBS IP rep3 12 B CTTGTA 
 
2.2.9.3 Bioinformatic analysis of ChIP-seq datasets 
Quality of the generated ChIP-seq reads was assessed using the FASTQC program (Babraham 
Bioinformatics). Reads were aligned to the UCSC mouse mm9 reference genomes using Bowtie2 
(Langmead and Salzberg, 2012), and only reads with one match were retained. Aligned reads 
(BAM) were converted into SAM files, and further transformed into a BED format to subsequently 
generate bigwig files for visualization in the IGV browser (Robinson et al., 2011). Bigwig files of 
each pair or replicates were correlated with a wigcorrelate, which showed high correlation in all 
comparisons. Thus, individual BAM files for each replicate were merged with the second replicate 
and used in peak calling. List of enriched peaks were obtained using MACS2 with an FDR <0.0001 
by calling peaks relative to the respective input control samples (background). Gene annotation 
and motif enrichment analysis were performed using HOMER (Heinz et al., 2010). Peak overlaps 
were identified with the R package ChiPpeakAnno (Zhu et al., 2010). Density plots and heatmaps 
were generated with deepTools (Ramirez et al., 2014). Snapshots were taken from the IGV  
(Robinson et al., 2011) and UCSC browsers (Kent et al., 2002). 
The accession numbers of the published ChIP-seq datasets used in the generation of 
heatmaps, peak overlaps and snapshots are listed below. As indicted, treated files were obtained 
from the ESC ChIP-seq compendium (Martello et al., 2012), from the Gene Expression Omnibus 
(GEO) repository or the Cistome pipeline (Qin et al., 2012a; Sun et al., 2013). When files were 
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unavailable, bigwig or BED files were generated using the pipeline here described earlier, with 
the specified parameters indicates in each report.  
Project Reference Factor Source of files 
GSE11724 (Marson et al., 2008) Oct4 Compendium 
GSE22562 (Kagey et al., 2010) Med1 Compendium 
GSE22562 (Kagey et al., 2010) Smc1a Compendium 
GSE24165 (Creyghton et al., 2010) p300 Compendium 
GSE27827 (Lienert et al., 2010) H3K4me2 GEO 
GSE57092 (Bulut-Karslioglu et al., 2014) Suv39h1 GEO 
GSE48519 (Hon et al., 2014) H3K4me1  GEO 
GSE48519 (Hon et al., 2014) H3K27ac  GEO 
GSE48519 (Hon et al., 2014) H3K4me3 GEO 
GSE48519 (Hon et al., 2014) H3K9me3 GEO 
GSE43229 (Das et al., 2014) H3K9me2  generated 
GSE46536 (Mozzetta et al., 2012) G9a generated 
GSE56138 (Buecker et al., 2014) Oct4 - 2i Cistrome 
GSE56138 (Buecker et al., 2014) H3K27ac - 2i Cistrome 
GSE56138 (Buecker et al., 2014) H3K4me1 - 2i Cistrome 
GSE56138 (Buecker et al., 2014) Oct4 - EpiLC Cistrome 
GSE56138 (Buecker et al., 2014) H3K27ac – EpiLC Cistrome 
GSE56138 (Buecker et al., 2014) H3K4me1 – EpiLC Cistrome 
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III.1 Introduction 
Jmjd2c has been identified as a member of the Jmjd2 family of histone demethylases 
specifically targeting the histone marks H3K9me2/3 and H3K36me3 (Katoh and Katoh, 2004; 
Klose et al., 2006b; Whetstine et al., 2006). In silico expression analysis of Jmjd2 gene family 
members in early mouse embryogenesis revealed that Jmjd2a, Jmjd2b and Jmjd2c may be 
preferentially expressed in cleavage-stage embryos, with Jmjd2c being also highly expressed in 
undifferentiated ESCs (Katoh and Katoh, 2007; Wang et al., 2010). Jmjd2c was furthermore 
proposed to play a key role in maintaining ESC identity. Specific knock-down of Jmjd2c using 
shRNA vectors resulted in the rapid down-regulation of Nanog expression, and this effect was 
strictly correlated with an increase in H3K9me3 enrichment levels at Nanog gene promoter 
region (Loh et al., 2007). Double-stranded RNA-knockdown of Jmjd2c in oocytes and induction of 
parthogenesis resulted in early developmental arrest during the transition from 8-cell to morula 
stages (Wang et al., 2010). Additionally, this was accompanied by a reduction in the expression 
levels of Oct4 and Nanog in 4-cell stage embryos, corroborating with Jmjd2c-dependent 
regulation of pluripotency-associated gene expression in ESCs (Wang et al., 2010). Altogether, 
these observations pointed to a critical role for Jmjd2c in the early developing embryo and in 
pluripotent stem cells; a role that remained to be fully explored at the start of this project.  
 
In this chapter, the impact of Jmjd2c depletion on ESC self-renewal and differentiation 
potential was explored in-depth taking advantaged of newly generated Jmjd2c-knockout ESCs, 
which were obtained from a large-scale knockout (KO) consortia (Bradley et al., 2012; Skarnes et 
al., 2011). Here, the approaches used to generate these cells are described, as well as the steps 
taken towards the validation of their KO status. A detailed characterization of the phenotype and 
functional abilities of Jmjd2c-depleted ESCs was conducted using well-established methodologies. 
In particular, Jmjd2c-depleted ESC pluripotency –i.e their ability to differentiate into the three 
germ layers, was investigated upon formation of embryoid bodies using both Jmjd2c-KO and 
Jmjd2c-knockdown ESC clones. 
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III.2 Results 
3.2.1 Generation of Jmjd2c-knockout ESC lines  
ESCs lines carrying a single Jmjd2c targeted allele and their wild-type (WT) counterparts, 
both from C57BL/6 mouse genetic background, were obtained from the EUCOMM/IKMC 
repository pipeline through collaboration with Dr Cynthia Fisher and Dr William Skarnes 
(Wellcome Trust Sanger Institute, Cambridge) (Bradley et al., 2012; Skarnes et al., 2011). The KO 
first allele (tm1a) was generated by gene trapping through the insertion of a cassette encoding 
lacZ/β-galactosidase and a neomycin resistance gene, upstream of a “critical exon” common to all 
predicted Jmjd2c transcripts (Fig.3.1A). The generation of homozygous knockout cell lines was 
then carried out by Dr Cynthia Fisher (Wellcome Trust Sanger Institute, Cambridge) through 
homologous recombination of a gene-trap cassette into the second allele (tm2), encoding the 
hygromycin resistance gene and GFP (Fig.3.1.A). Both cassettes are promoterless, hence relying 
on the active transcription of Jmjd2c, and contain an En2 splice acceptor (SA) signal and the SV40 
polyadenylation (pA) sequences to ensure transcription is spliced into the cassette and is stopped 
at the inserted sites (Fig.3.1A).  
Validation of the knockout was performed by Dr Cynthia Fisher (Wellcome Trust Sanger 
Institute, Cambridge) at the DNA level using a Long-Range PCR approach with specific primer 
pairs (Fig.3.1A; Table B-I – Appendix  B), hence showing correct insertion of the trapping 
cassettes in both alleles. A 5kb and a 6.3kb fragment corresponding to the first and second 
mutated alleles, respectively, were successfully amplified using genomic DNA extracted from the 
homozygous Jmjd2c-KO ESC (ESCJmjd2c-KO) clones E2 and E3, as opposed to WT ESCs (ESCWT) 
(Fig.3.1B). Additionally, the expression of GFP from the second allele was confirmed in E2 and E3 
mutant clones by immunofluorescence (ESCKO-E2, ESCKO-E3; Fig.3.1C). GFP expression, alongside 
with drug resistance to neomycin and hygromycin in culture, further indicated correct 
transcription of the inserted cassettes in homozygous KO clones.  
The depletion of Jmjd2c was validated both at the mRNA and protein level in the two 
independent Jmjd2c-KO ESC lines. For this, specific primer pairs were designed spanning exons 
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located upstream (exons 5 and 7; Fig3.1D) and downstream (exons 14 and 15, exons 18 and 20; 
Fig.3.1.D) of the “critical exon” and hence the trapping cassettes. Jmjd2c mRNA levels detected 
when using upstream primer pairs were unchanged in mutant cells relative to WT ESCs. In 
contrast, transcript levels spanning exons located downstream of the critical exon were 
significantly reduced by about 90% (Fig.3.1D). The residual expression of full-length transcript 
could arise due to alternative splicing around the inserted cassettes, but this however did not 
result in translation of a full-length Jmjd2c protein, as described below.   
To examine whether the targeted trapping resulted in the abolishment of full-length Jmjd2c 
protein, western blot analysis was performed on total protein lysates extracted from WT and 
Jmjd2c-KO ESC clones E2 and E3 using a previously described (Loh et al., 2007) anti-Jmjd2c 
antibody (kindly provided by Professor Huck-Hui Ng, Genome Institute Singapore). As expected, 
high levels of Jmjd2c protein were detected in the WT ESC line, whereas expression of full-length 
Jmjd2c was completely abolished in Jmjd2c-KO ESC lines (Fig.3.1E), hence confirming that these 
cells are indeed constitutively depleted for Jmjd2c. Moreover, Jmjd2c depletion did not affect 
Jmjd2b, as Jmjd2b protein expression remained unchanged between the same WT and KO ESC 
lines (Fig.3.1E). The insertion of gene trapping cassettes is predicted to result in the expression 
of putative truncated proteins, however since the trapping cassettes are inserted upstream from 
the PHD and Tudor domains, this is not expected to be located in the nucleus (Pedersen et al., 
2014; Shin and Janknecht, 2007). Altogether, these results validate the successful generation of 
homozygous Jmjd2c-knockout ESC clones.  
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Figure 3.1 Validation of Jmjd2c-knockout in ESCs  
A. Schematic representation of the double knockout strategy. The first and second mutated alleles carry a 
cassette containing the neomycin-βgalactosidase and hygromycin-GFP resistance/expression genes, to 
allow for efficient selection and identification. In the first allele, the FRT sites were inserted to allow for 
optional reversion of homozygous to heterozygous by removal of the cassette with FLP recombinase. The 
loxP sites were inserted in the vicinity of the critical exon 9 to allow for the optional creation of a conditional 
null allele with Cre recombinase. The splice acceptor (SA) site in the cassettes promotes incorporation of 
the insert into the RNA transcript after RNA splicing, whereas the polyA (pA) signal site ensures that RNA 
polymerase transcription is stopped. Arrows indicate the location of the primers used for genotyping and 
the expected PCR band sizes is indicated for each primer pair. B. Genotyping of both alleles was achieved 
by Long Range PCR on the JM8 wild-type (ESCWT) cells, and homozygous Jmjd2c-knockout (ESCJmjd2c-KO) 
mutant clones (E2, E3). Performed in collaboration with Dr Cynthia Fisher. C. Immunofluorescent labelling 
of GFP in ESCWT and ESCJmjd2c-KO clones (KO-E2, KO-E3). DAPI staining was used to visualise nuclei. Scale, 
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100 µm. D. Transcript levels of Jmjd2c were quantified using primers located upstream (exon5-7) and 
downstream (exon14-5, exon18-20) of the critical exon. Levels were normalized to 2 housekeeping genes 
(S17 and L19), and expressed relative to ESCWT. Error bars represent SEM of 3 biological replicates. P<0.05 
(*), Mann-Whitney U test. E. Western Blot for Jmjd2c and Jmjd2b and on whole cell extracts from ESCWT and 
ESCJmjd2c-KO clones as indicated. α-Tubulin was used as a loading control. 
 
3.2.2 Jmjd2c-KO ESC clones remain undifferentiated in culture 
The resulting Jmjd2c-KO  ESC lines were able to be routinely maintained in culture in the 
presence of  leukemia inhibitory factor (LIF) and serum, suggesting that the constitutive depletion 
of this protein was not detrimental to the maintenance of an undifferentiated ESC state, unlike 
previously reported upon transient knockdown (Loh et al., 2007). Although the targeted trapping 
approaches used for the generation of this knockout relies solely on having an active Jmjd2c 
promoter, Jmjd2c-KO ESCs were maintained under selection with G418/geneticin and 
hygromycin, to prevent any cross-contamination with their WT counterparts, cultured in parallel. 
This selection was however removed prior to any functional experiment to avoid influencing their 
cell growth rate, and hence the outcome of the experiments. 
To fully evaluate the undifferentiated state of Jmjd2c-KO ESCs, the growth rate was initially 
assessed by scoring the number of cells cumulating in routine culture conditions over eight 
consecutive passages, and found to be similar between WT and KO ESC populations (Fig.3.2A).    
Next, Alkaline Phosphatase (AP) activity was used as an indicator of undifferentiated state in 
colony forming efficiency assays. For this, Jmjd2c-KO and WT cells were plated at low density, 
cultured in the presence or in the absence of LIF for 5 days, and then scored as undifferentiated, 
mixed or differentiated colonies based on the observed AP staining intensity and colony 
morphology (Fig.3.2B). In the presence of LIF, the three cell lines (WT, E2 and E3) studied 
demonstrated similar self-renewing abilities regardless of Jmjd2c expression (Fig.3.2B). In all 
cases, over 60% of colonies were scored as undifferentiated (Undiff), showing a typical round and 
compact morphology and strong AP staining, whereas nearly 30% and 10% of colonies were 
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scored as mixed and differentiated respectively, with bright AP-positive centres surrounded by a 
ring of flattened, differentiated cells (Mixed) or displaying a sparse morphology and little or no 
AP staining (Diff) (Fig.3.2B). As expected, in the absence of LIF, 80-90% of colonies stained 
negative for AP, indicative of spontaneous differentiation (Fig.3.2B). Noteworthy, increased 
percentages of AP-positive colonies (Undiff and Mixed) were observed in Jmjd2c-KO ESC clones 
(10-20%) as compared to their WT counterparts (5-10%), suggesting that a higher proportion of 
Jmjd2c-depleted colonies could retained an undifferentiated state in the absence of LIF.  
Finally, the expression of pluripotency-associated markers was investigated through three 
approaches: immunofluorescent staining, western blotting and quantitative expression analysis 
(RT-qPCR).  Nanog is typically expressed in a heterogeneous manner in ESCs grown under routine 
(LIF, serum) culture conditions as used in our laboratory (Chambers et al., 2007). Indeed we 
detected a strong and heterogeneous expression pattern for Nanog by immunofluorescence 
staining in both WT and Jmjd2c-KO ESC lines (Fig.3.2C). Moreover, strong Oct4 signal was also 
detected in all of the three cell lines (WT, E2 and E3) analysed, though Oct4 expression appeared 
more heterogeneous in Jmjd2c-KO ESC relative to WT ESCs (Fig.3.2C). The levels of Nanog, Oct4 
and Esrrb protein were also assessed by western blot in WT and KO ESC clones (Fig.3.2D), 
showing variable expression patterns across these cell lines. Here, Nanog levels were reduced in 
KO clone E2, whereas the levels of Esrrb were conversely increased in the same clone. Oct4 
appeared slightly reduced in the KO clone E3 as compared to WT ESCs (Fig.3.2D).  
Moreover, the transcript levels of the pluripotency-associated markers Nanog, Oct4, Sox2, 
Klf4, Esrrb, and Tbx3 were also quantified in the RNA from WT and Jmjd2c-KO ESCs, showing an 
overall reduction of about 20-50% of expression of all markers as seen  in both KO clones E2 and 
E3 (Fig.3.2D). Altogether, the analysis of pluripotency markers in Jmjd2c-KO ESC by three 
different approached revealed a high degree of heterogeneity, reiterating a role for Jmjd2c in the 
stability of ESC-specific gene expression.  
 
 
Chapter III – Results 
122 
 
 
Figure 3.2 Jmjd2c-knockout ESCs retain normal self-renewal ability  
A. Growth curve of WT (ESCWT) and Jmjd2c-KO (ESCJmjd2c-KO) clones E2 (KO-E2) and E3 (KO-E3) in self-
renewing conditions over 8 passages (16 days). Plot represents an average of the cell number scored in 3 
independent experiments. Error bars indicate ±SEM. B. Percentage of colony types scored in cells growing 
with (+) or without (-) LIF for 5 days. Colonies were counted and scored as undifferentiated (Undiff), mixed 
or differentiated (Diff) according to the intensity of alkaline phosphatase (AP) staining. Plots represent 
percentage of colonies counted in two biological replicates plated in duplicate. Error bars indicate ±SEM. C. 
Immunofluorescent labelling of Nanog and Oct4 in ESCWT and ESCJmjd2c-KO clones. DAPI staining was used to 
visualise nuclei. Scale, 100 µm.  D. Western blot for Nanog, Oct4 and Esrrb in whole cell lysates from ESCWT 
and ESCJmjd2c-KO clones as indicated. α-Tubulin was used as a loading control. E. Transcript levels of 
pluripotency-associated markers Nanog, Oct4, Sox2, Klf4, Esrrb and Tbx3 in ESCWT and ESCJmjd2c-KO clones. 
Data were normalized to 2 housekeeping genes (S17 and L19), and expressed relative to ESCWT. Error bars 
represent ±SEM of 3 biological replicates.  P<0.05 (*), Mann-Whitney U test.  
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Altogether, these results suggest that that constitutively Jmjd2c-depleted ESCs retain normal 
self-renewal abilities despite lessened and more heterogeneous expression levels of 
pluripotency-associated genes.  
 
Another key feature of ESC identity is their unique epigenetic signature at the promoters of 
differentiation-associated genes, which is characterized by the simultaneous presence of 
permissive (H3K4me2/3) and repressive (H3K27me3) histone modifications (Fig.3.3A) (Azuara 
et al., 2006; Bernstein et al., 2006). These so-called bivalent chromatin domains are thought to 
prime genes for future activation (or repression) upon differentiation. Their premature 
expression is prevented by the action of the Polycomb Repressive Complexes 1 and 2, which 
maintain these genes repressed by tri-methylating H3K27 (PRC2) and mono-ubiquitinating 
H2AK119 (PRC1; Fig.3.3A).  
To evaluate whether the depletion of Jmjd2c had an impact on PRC’s action or recruitment, 
as reported for the histone demethylase Kdm2b (Farcas et al., 2012; Wu et al., 2013), and hence 
on the maintenance of a transcriptional repressive state at differentiation-associated genes, the 
transcript levels of a selected panel of genes was evaluated by RT-qPCR (Fig.3.3B). This panel 
included markers associated with the trophoectoderm (Cdx2, Hand1), mesoderm (Brachyury/T, 
Mixl1), endoderm (Gata6, Foxa2) and neuroectoderm (Math1, Pax3) lineages, and none of them 
were found to be de-repressed in Jmjd2c-KO clones compared to WT ESCs (Fig.3.3B). Moreover, 
the enrichment levels for members of PRC2 (Suz12) and PRC1 (Ring1B) complexes was evaluated 
using Chromatin Immunoprecipitation (ChIP) and qPCR, at the bivalent promoters of 
differentiation-associated genes: Cdx2, Hand1, Flk-1, Mixl1, Gata4, Sox7, Pax3 and Math1 alongside 
a control active gene (Actin) and a non PRC-bound gene region (Gata1).  Likewise, a similar 
pattern of enrichment was detected in WT cells, and the two Jmjd2c-KO clones E2 and E3, 
indicating that PRC recruitment and action was not affected by Jmjd2c depletion in ESCs 
(Fig.3.3C). 
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Figure 3.3 PRC-mediated repression of bivalent genes is preserved in Jmjd2c-knockout ESCs 
A. Schematic representation of bivalent chromatin structure harboring H3K4me3 (active), H3K27me3 
(inactive) and H2AK119Ub histone marks, deposited by Mll2, PRC2 and PRC1, respectively, and a poised 
conformation of RNA Polymerase II (RNAP) complexes. B. Transcript levels of a selection of genes 
associated with each of the indicated lineages in WT (ESCWT) and KO (ESCJmjd2c-KO) clones E2 (KO-E2) and 
E3 (KO-E3), cultured under self-renewing conditions. Data was normalised to 2 housekeeping genes (S17 
and L19) and expressed relative to ESCWT. Error bars represent ±SEM of 3 biological replicates. C. Binding 
of PRC2 and PRC1 components, Suz12 (green) and Ring1b (purple), at the promoters of differentiation-
associated genes were assessed by ChIP and quantitative PCR of the immunoprecipitated DNA fragments 
in ESCWT and ESCJmjd2c-KO clones. Background levels (IgG binding) are shown as white bars. Negative controls 
(not occupied by PRC1 and PRC2) included Actin and Gata1. Enrichment is expressed relative to input. 
Error bars represent ±SD of two independent ChIP assays. The experiment in C. was performed by Sergio 
German and Anne Helness. 
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In summary, these data demonstrate that Jmjd2c-KO ESC lines retain an undifferentiated 
state in culture despite unstable expression of pluripotency-associated genes. The epigenetic 
signature of Jmjd2c-KO ESC lines appeared unaffected, and differentiation-associated genes 
remained repressed and bound by PRC1 and PRC2 complexes as seen in WT ESCs.  
 
3.2.3. Depletion of Jmjd2c in ESCs correlates with an increase in bulk H3K9 
methylation levels  
Jmjd2c has been previously identified as an H3K9me2/me3 and H3K36me3 histone 
demethylase in various cell types (Katoh and Katoh, 2004; Klose et al., 2006b; Whetstine et al., 
2006). Transient knockdown of Jmjd2c in ESCs was, however, shown to result in an increase of 
H3K9me3 levels alone, with no effect on H3K9me2 and H3K36me3 (Loh et al., 2007). Hence, the 
effect of constitutive Jmjd2c depletion in the bulk levels of these histone modifications was re-
visited using acid-extracted histone lysates from WT and Jmjd2c-KO ESC clones. Here, an initial 
titration of the amount of histone lysates used was conducted for H3K9me2 and H3K9me3 
together with H3K4me2 as control (Fig.A-I – Appendix A). With 2ug of histone lysates, an increase 
in the bulk levels of H3K9me2 was consistently identified in Jmjd2c-KO as compared to WT ESCs, 
whereas only a milder effect and no effect were observed when analysing H3K9me3 and 
H3K36me3 levels, respectively (Fig3.4A; Fig.A-I – Appendix A), which was validated with 
different antibody sources (Fig.A-I – Appendix A).  Moreover, no changes were detected in the 
bulk levels of control (H3K4me2 and H3K27me3) histone modifications whose deposition is not 
linked with Jmjd2c activity in ESCs (Fig.3.4A). To ensure that the identified increase in the levels 
of H3K9me2 and H3K9me3 strictly correlated with the absence of Jmjd2c in the KO ESCs, the 
mRNA expression levels of other H3K9-demethylases (Jmjd2a, Jmjd2b, Jmjd1a and Lsd1; Fig.3.4B) 
and H3K9-methytransferases (G9a, GLP, Suv39h1, Suv39h2 and Eset; Fig.3.4C) were quantified 
and found to be similar to WT levels for most genes, despite slight variations in clone E3.   
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Figure 3.4 Depletion of Jmjd2c results in increased bulk levels of di- and tri-methylation of H3K9 
A. Western blots showing the bulk levels of H3K9me2, H3K9me3, H3K36me3,  H3K4me2, H3K27me3 and 
total H3 in acid-extracted histone lysates from WT (ESCWT) and KO (ESCJmjd2c-KO) clones E2 (KO-E2) and E3 
(KO-E3) ESCs. Results were produced in at least 3 biological replicates and differences validated with 
alternative antibody sources. Band quantification is shown below relative to WT. B. Transcript levels of a 
selection of H3K9-demethylases (left panel) and H3K9-methyltransferases (right panel) in ESCWT and 
ESCJmjd2c-KO clones growing in self-renewing conditions. Data was normalised to 2 housekeeping genes (S17 
and L19) and expressed relative to ESCWT. Error bars represent ±SEM of 3 biological replicates. P<0.05 (*), 
Mann-Whitney U test.   
 
To further demonstrate the link between Jmjd2c and H3K9-demethylation in ESCs, a rescue 
ESC line was generated by stably transfecting a vector carrying wildtype Jmjd2c cDNA into Jmjd2c-
KO clone E3 (ESCKO-rescue; Fig.3.5). As a control, an empty vector was transfected in a parallel 
culture of the same clone (ESCKO-control). Validation of the rescued phenotype was carried out at 
the protein level by western blot (Fig.3.5A). Additionally, the protein expression levels of the 
pluripotency markers Nanog, Oct4 and Esrrb was also assessed and found to be higher for Nanog 
and, to some extent, for Esrrb in the rescued KO clone E3 (Fig.3.5A). A significant up-regulation 
of Nanog was also confirmed at the transcript levels, whereas the levels of Oct4, Klf4 and Esrrb 
remained comparatively unchanged (Fig.3.5B). This observation corroborates with a key role for 
Jmjd2c in regulating Nanog gene expression in ESCs (Loh et al., 2007). Nanog and Oct4 protein 
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expression was also evaluated by immunofluorescence. Rescuing the expression of Jmjd2c did 
not impact on the mosaic expression pattern of Nanog (Fig.3.5C), but appeared to restore a more 
homogeneous Oct4 expression pattern as compared to control KO ESCs (Fig.3.5C) and WT ESCs 
(Fig3.2C).  
 
Figure 3.5 Rescue of Jmjd2c expression in knockout ESCs 
A. Western blot for Jmjd2c, Nanog, Oct4 and Esrrb in ESCJmjd2c-KO clone E3 transfected with full-length 
Jmjd2c cDNA (Rescue) or with an empty vector (Control). α-Tubulin was used as a loading control. B. 
Transcript levels of pluripotency markers Nanog, Oct4, Klf4, and Esrrb in rescued (ESCKO-Rescue) and control 
(ESCKO-Control) clones. Data were normalized to 2 housekeeping genes (S17 and L19), and expressed relative 
to control. Error bars represent ±SEM of 3 biological replicates. C. Immunofluorescent labelling of Nanog 
and Oct4, in rescue and control KO ESCs. DAPI staining was used to visualise nuclei. Scale, 30µm. D. Western 
blots showing the bulk levels of H3K9me2, H3K9me3 and total H3 in acid-extracted histone lysates from 
ESCWT and ESCJmjd2c-KO clone E3, and E3 rescue and control KO ESCs. E. Western blots for G9a and GLP in 
Jmjd2c Rescue and Control ESCs. α-Tubulin was used as a loading control. The rescue and control ESC lines 
and results in figure C were produced by Lauren Weavers.  
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Finally, the impact of re-introducing Jmjd2c on the levels of H3K9me2/3 was investigated on 
histone lysates from rescued and control KO ESCs, showing restoration to WT levels in the 
rescued cells (Fig.3.5D). Importantly, this occurred without any obvious alteration in the protein 
levels of the known H3K9me2-methytransferases G9a and GLP in ESCs (Fig.3.5E).   
 
Overall, these experiments demonstrate that constitutive depletion of Jmjd2c in ESCs results 
in a noticeable increase of H3K9me2 with a milder effect on H3K9me3 levels, hence inferring a 
specific role for Jmdj2c as an H3K9me2, in addition to H3K9me3 demethylase in ESCs, as 
previously reported upon transient knockdown of Jmjd2c (Loh et al., 2007).  
 
3.2.4. Jmjd2c is required for efficient somatic ESC differentiation 
Pluripotent ESCs can be induced to differentiate into the three germ layers, when cultured 
under permissive conditions. To address whether depleting Jmjd2c in ESCs impacts on ESC 
differentiation, WT and Jmjd2c-KO clone E3 ESCs were induced to form embryoid bodies (EB). 
This involves culturing ESCs in suspension in the absence of LIF and in reduced serum level over 
9 days, during which cell aggregates will form allowing the spontaneous emergence of cells 
derived from the three embryonic germ layers.  EB morphology was recorded on a daily basis 
(Fig.3.6A), and samples were collected over different time-points for subsequent mRNA 
expression analysis (Fig.3.6B).  In particular, the kinetics of induction of early lineage-specific 
markers for epiblast (Fgf5) and mesoderm (Brachyury and Mixl1), and late markers for endoderm 
(Foxa2, Gata6, Gata4) and neuroectoderm (Mash1, Pax3 and Pax6) was investigated. Additionally, 
the expression of the pluripotency-associated factors Nanog and Oct4, and Jmjd2c itself, were also 
profiled during EB formation.   
Under these conditions WT ESCs formed large compact cell aggregates (Fig.3.6A; upper 
panel), whereas Jmjd2c-KO ESCs formed smaller aggregates, indicative of compromised 
differentiation and/or increased cell death (Fig.3.6A; lower panel).  
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Figure 3.6 Embryoid body (EB) formation is impaired in Jmjd2c-knockout ESCs 
A. ESCs were cultured in suspension and induced to differentiate upon EBs formation in the absence of LIF 
and reduced serum level. Representative phase-contrast images of day 9 EBs are shown. Bars, 100µm. B. 
Transcript levels for pluripotency-associated (Nanog, Oct4), Jmjd2c, epiblast (Fgf5), mesoderm (Brachyury, 
Mixl1), endoderm (Foxa2, Gata6, Gata4), and neuroectoderm (Mash1, Pax3, Pax6) markers in WT and 
Jmjd2c-KO clone E3 derived EBs collected at day 0, 3, 5, 6 and 9 of differentiation. Values were multiplied 
by 100 and plotted as the average of 4 experiments, normalized to housekeeping genes (S17, L19). Error 
bars represent ±SEM of at least 3 experiments. Data represented as day 6 is an average of day 5 (n=2) and 
day 6 (n=2).  P<0.05 (*), Mann-Whitney U test performed at peak time points in WT for each differentiation 
marker. 
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time-points in Jmjc2c-KO EBs only (Fig.3.6B). Interestingly, Jmjd2c mRNA levels remained high in 
early WT EBs together with Oct4, then progressively declined to near background levels as found 
in Jmjc2c-KO cells (Fig.3.6B), suggesting that Jmjd2c activity may be required during the early 
steps of ESC differentiation. The expression of the early epiblast-specific marker Fgf5 transiently 
peaked at day 3 during WT EBs formation and decreased back to basal levels at day 9 (Fig.3.6A). 
In Jmjd2c-KO EBs Fgf5 induction was about 3-fold lower at day 3 relative to WT EBs, and its 
expression was also retained at day 9 as seen for both Oct4 and Nanog (Fig.3.6B). Similarly, the 
expression of the early mesoderm-specific markers Brachyury and Mixl1 peaked at day 6 in WT 
EBs, being reduced by about 10 and 5-fold, respectively, in Jmjd2c-KO EBs (Fig.3.6B). The 
expression of the late endoderm- and neuroectoderm-specific markers only peaked at day 9 in 
WT EBs, and was found to be again severely impaired or reduced in Jmjd2c-KO EBs (Fig.3B).  
 
These striking impairment of the induction of differentiation markers in Jmjd2c-KO EBs 
suggests that Jmjd2c might be essential for the proper execution of multi-lineage pathways, with 
a possible blockage during the early steps of ESC differentiation. 
 
To further explore this and confirm the requirement of Jmjd2c for proper ESC differentiation, 
an alternative differentiation assay was used: monolayer differentiation of ESCs into neuronal 
precursors. In this assay, ESCs are cultured at low density in serum-free N2B27 media in the 
absence of LIF, for a period of 5 days, during which typical neuronal rosette-like structures 
emerge (Ying et al., 2003b). Initial optimization of this assay revealed that there was a high level 
of cellular stress when swapping the media conditions from serum-based ESC media to serum-
free N2B27 media. In order to overcome this effect and ensure that both cell populations were 
differentiated in optimal conditions, the WT and Jmjd2c-KO clone E3 ESC cultures were adapted 
into serum-free media by being cultured in the so-called 2i conditions: N2B27 supplemented with 
LIF, the Mek inhibitor PD0325901 and the Gsk3 inhibitor CHIR99021 (Ying et al., 2008). These 
ESCs culture conditions have been reported to promote the acquisition of a more naïve or ground-
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state of pluripotency, with lower or absent gene priming for differentiation, and acquisition of 
dome-shaped colonies (Fig.3.7A), as opposed to the metastable state cells exhibited in serum 
cultures. Morphology changes were monitored for induction of neuronal precursors over the 
course of differentiation (Fig.3.7B) and the expression of the neuronal-specific marker Nestin was 
assessed at day 5 by immunofluorescence staining (Fig.3.7C). During this process, a transient 
epiblast(EpiS)-like population has been proposed to emerge at days 2/3, which has been 
identified by the expression of the epiblast marker Fgf5 (Abranches et al., 2009). Here, both cell 
populations adopted an EpiS-like morphology by day 2 (Fig.3.7B), with no striking morphological 
differences between them. By day 5 neuronal progenitor colonies emerged in WT cultures 
revealed by the appearance of neural tube-like and rosette-like structures (Fig.3.7B; Fig.A-II – 
Appendix A).  
 
Figure 3.7 Inefficient generation of neuronal progenitors in Jmjd2c-depleted ESCs 
 A. WT (ESCWT) and KO (ESCJmjd2c-KO) clone E3 were cultured in serum-free 2i/LIF conditions prior to 
differentiation. B. ESCs were seeded at low density and cultured in neuronal differentiation media for 5 
days. Phase-contrast images showing the morphology at day 2 and day 5 in these conditions are shown. C. 
Phase-contrast and fluorescent signals for the staining of the neuronal marker Nestin in day 5 neuronal 
precursors Bars, 100µm.  
 
In comparison, a lower incidence of Jmjd2c-KO neural-like colony formation was observed at 
this late time point (Fig.3.7B; Fig.A-II – Appendix A) the nature of which was further confirmed 
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by immunofluorescence using the early neuronal marker Nestin (Fig.3.7C).Notably, the few 
colonies present at this late stage of differentiation were harbouring a neural-like phenotype and 
showed positive Nestin signals indicating that differentiation towards neuronal progenitors was 
possible, although strikingly less efficient. 
 
Altogether, these two experimental approaches uncovered a key role for Jmjd2c in the proper 
execution of ESC differentiation. Moreover, the persistence of Fgf5 expression upon EB formation, 
and the possible blockage of differentiation after an EpiS-like step under neuronal conditions in 
Jmjd2c-KO ESCs, suggest that Jmjd2c function might be essential at the onset of ESC 
differentiation, possibly during the transition to an early Fgf5-expressing epiblast-like stage.  
 
3.2.5 Stable knockdown of Jmjd2c mimics Jmjd2c-knockout phenotype 
Transient depletion of Jmjd2c was previously shown to be detrimental for the maintenance 
of ESC integrity (Loh et al., 2007). However, under constitutive depletion of Jmjd2c using gene-
trap and homologous recombination approaches, ESCs were able to sustain a self-renewing and 
undifferentiated state, as demonstrated in this Chapter.  To re-assess the effect of knocking down 
Jmjd2c expression using shRNA vectors, the possibility to stably generate undifferentiated Jmjd2c 
knockdown (KD) ESC clones was carefully investigated upon colony picking and prolonged drug 
selection. ESCs from a different mouse background (129) than Jmjd2c-KO (B6) cells were chosen 
to be independently transfected with two previously validated Jmjd2c shRNA vectors (shRNA1 
and shRNA2) and a control shRNA against Luciferase (shLuc), kindly provided by Professor Huck 
Ng (Genome Institute of Singapore; Loh et al., 2007). The knockdown efficiency of these vectors 
was firstly tested upon transient transfection followed by 4 days of puromycin selection. As 
previously reported, this ensued a notable incidence of spontaneous differentiation as indicated 
by the presence of AP-negative colonies in pools of transfected cells with either shRNA1 or 
shRNA2 vector in contrast to control cultures (Fig.3.8A).  Concordantly, the expression of Jmjd2c 
upon transient knockdown was significantly reduced by about 50% with both vectors (Fig.3.8.B).  
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Nevertheless, AP-positive and puromycin-resistant colonies could still be identified following 
Jmjd2c knockdown, which suggested that stable ESC cell lines could be established. To achieve 
this, ESCs were transfected with either shRNA1 or shRNA-Luc vectors, and after four days of 
puromycin selection individual ESC clones were manually picked and seeded in order to be 
further expanded under puromycin selection. Three ESC clones were selected for 
characterization, and the knockdown efficiency in these clones validated by western blot 
(Fig.3.8C) and mRNA quantification (F.3.8D). Here, a knockdown efficiency of about 80% was 
achieved, with no dramatic impact on the expression of other Jmjd2 family members (Fig.3.8D). 
Moreover, the expression of pluripotency-associated markers Nanog, Oct4, Sox2, Klf4, Esrrb and 
Tbx3 was assessed in three Jmjd2c KD clones and found to be heterogeneous or unstable 
(Fig.3.8D). Concordantly with the effect observed in constitutive Jmjd2c-KO, shJmjd2c-clone1 
presented down-regulation of all pluripotency factors, clone2 showed down-regulation of Esrrb 
and Tbx3, whereas clone3 did not show any difference (Fig.3.8D). Notably, the mild decrease in 
expression of pluripotency markers in KD clones 1 and 2 mirrored the mild down-regulation 
detected in the expression of Jmjd2b (Fig.3.8D). This is concordant with a recently described role 
for Jmjd2b in the regulation of these markers (Das et al., 2014), further discussed in Chapter VII. 
Importantly, all Jmjd2c KD and control clones exhibited similar self-renewal abilities in the 
presence of LIF, with around 80% of colonies showing a strong-AP staining and undifferentiated 
morphology, reiterating that Jmjd2c is dispensable for ESC self-renewal (Fig.3.8E).  
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Figure 3.8 Generation of stable Jmjd2c-knockdown ESC lines  
A. E14 ESCs cells were transfected with either of two different Jmjd2c shRNA vectors (shRNA1 and 2) or a 
control vector for Luciferase (shRNA-Luc). Alkaline phosphatase (AP) staining was preformed 4 days after 
puromycin selection. Bars, 100µm. B. Jmjd2c mRNA levels upon transfection with Jmjd2c shRNA1, 2 or 
shRNA-Luc, 4 days after puromycin selection. Expression levels were normalised to housekeeping genes 
(L19 and S17) and represented as the average of 3 experiments ±SEM, normalised to the control vector. 
P<0.05 (*), Mann-Whitney U test. C. Western blot for Jmjd2c in 3 stable clones picked from ESCs transfected 
with Jmjd2c shRNA1 and a control shRNA-Luc cell line. D. Transcript levels of Jmjd2 family members and 
pluripotency factors in 3 stable clones picked  from Jmjd2c shRNA1-transfected ESCs. Levels were 
normalised to housekeeping genes (L19 and S17) and expressed relative to control (shRNA-Luc) as average 
±SEM of 3 biological replicates. P<0.05 (*), Mann-Whitney U test. E. Percentage of colonies scored as 
undifferentiated (Undiff), mixed or differentiated (Diff) according to the intensity of AP staining of 3 stable 
shRNA1-Jmjd2c transfected ESC clones, and a control shRNA-Luc ESC clone. Cells were grown with (+) or 
without (-) LIF for 5 days. Plots represent percentage of colonies counted in 3 biological replicates. Error 
bars represent ±SEM. The results in figures A and B were produced by Lauren Weavers, whereas the results 
in figures D and E were produced by Donja Karimlou.      
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Constitutive knockout of Jmjd2c resulted in impaired differentiation upon EB formation 
(Section 3.2.4), presumably at the onset of ESC differentiation, as suggested by maintenance of 
Oct4 and Fgf5 low expression levels at the later stages of EB induction. Here, the differentiation 
abilities of stable Jmjd2c-KD ESCs upon EB formation was subsequently investigated, with a focus 
on early epiblast and primitive streak markers. Upon EB formation, no striking morphological 
differences were observed between the control shLuc and shJmjd2-clone1 (Fig.3.9A). Progressive 
down-regulation of the pluripotency factors Nanog and Oct4 was measured in both shRNA-Luc 
and shRNA1-Jmjd2c EBs, and a decrease in the expression of Jmjd2c was consistently identified in 
shRNA-Luc EBs (Fig.3.9B).  
 
Figure 3.9 Embryoid body (EB) formation is compromised in stable Jmjd2c-knockdown ESCs 
 A. Jmjd2c-knockdown clone 1 and the control shRNA-Luc ESCs were cultured in suspension and induced 
to differentiate upon EBs formation in the absence of LIF and reduced serum levels. Representative phase-
contrast images of day 9 EBs are shown. Bars, 100µm. B. Transcript levels for pluripotency-associated 
(Nanog, Oct4), Jmjd2c, and early differentiation markers for epiblast (Fgf5), mesoderm (Brachyury, Mixl1) 
lineages in shRNA1-Jmjd2c clone 1 and shRNA Luc EBs collected at day 0, 3, 6 and 9 of differentiation. Levels 
were multiplied by 100 and plotted as the average of at least 4 experiments, normalized to housekeeping 
genes (S17 and L19), ±SEM. The results in this figure were produced by Donja Karimlou.  
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Moreover, the expression of the epiblast marker Fgf5 peaked at day 3 in both EB cultures 
(Fig.3.9B). Strikingly, however, the induction of mesodermal markers Brachyury and Mixl1 was 
greatly diminished in shRNA1-Jmjd2c EBs (Fig.3.9B), as seen in Jmjd2c-KO EBs (Fig.3.6B). 
Similarly to Jmjd2c-KO EBs (Fig.3.6B), the expression of Oct4 and Fgf5 was also retained higher 
levels at day 9 (Fig.3.9.B). Altogether, these results recapitulate the impaired differentiation 
ability observed in constitutive Jmjd2c-KO ESCs and reinforce the specific requirement for Jmjd2c 
at the onset of differentiation. 
 
III.3 Summary and Conclusions 
In summary, Jmjd2c-knockout ESC model was successfully generated via gene-trap and 
homologous recombination approaches. These Jmjd2c-depleted ESCs retain an undifferentiated 
state in culture with similar growth rate than their WT counterparts, and no obvious de-
repression of differentiation-associated genes known to be occupied by PRC complexes. Despite 
retaining normal self-renewal ability, the transcriptional activity of pluripotency-associated 
factors in Jmjd2c-KO ESCs was found to be attenuated with factors such as Nanog and Esrrb being 
variably down-regulated in independent KO clones and cultures. Moreover, abolishing Jmjd2c 
expression resulted in an increase in the bulk levels of H3K9me2 and a milder increase in the 
levels of H3K9me3, highlighting Jmjd2c as a key H3K9me2 and H3K9me3 demethylase in ESCs, 
unlike previously reported. This effect in H3K9-methylation levels, together with the down-
regulation of Nanog and Esrrb, could be rescued by re-introducing Jmjd2c in KO ESCs.  
Importantly, the differentiation abilities of Jmjd2c-KO were here further examined and found 
to be consistently impaired upon embryoid body formation and upon lineage-specific induction 
by neuronal differentiation, indicating an important role for Jmjd2c in the proper execution of 
multi-lineage pathways. Interestingly, the partial retention of Oct4, Nanog and Fgf5 expression 
upon EB formation in the absence of Jmjd2c points to a possible blockage at an early epiblast-like 
stage of ESC differentiation. Finally, the normal self-renewal capacity and reduced differentiation 
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potential, the identified key features of Jmjd2c-KO ESCs phenotype, could be mimicked using an 
alternative ESC model of stable Jmjd2c depletion via RNA interference.    
The maintenance of an undifferentiated identity in Jmjd2c-depleted ESCs contrasted with 
previous reports showing that acute differentiation occurred upon transient knockdown of 
Jmjd2c with shRNA vectors. Here, the generation of stably depleted cell populations upon 
prolonged culture might have allowed for the selection of clones in which functional 
compensation by other demethylases is put in place, hence safeguarding robust expression of 
ESC-specific genes. Nevertheless, in both strategies (knockout and knockdown) an impaired 
ability to differentiate into somatic cell types was detected, uncovering a specific requirement for 
Jmjd2c in this process which cannot be functionally compensated in an in vitro system. 
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Chapter IV – Results: Identification of a pivotal role for 
Jmjd2c at the onset of differentiation 
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IV.1 Introduction 
 The experiments described in Chapter III demonstrate that, in the absence of Jmjd2c, ESCs 
grow normally, and furthermore sustain an undifferentiated state in prolonged culture. However, 
the ability of Jmjd2c-KO ESCs to differentiate towards epiblast-derived germ layers was severely 
compromised, as assessed upon embryoid body formation. Upon blastocyst injection, ICM-
derived mouse ESCs contribute mostly to the epiblast of chimeric embryos and, although at a 
lesser frequency, can also colonize the yolk sac of the primitive endoderm (PrE) (Beddington and 
Robertson, 1989). Under self-renewing conditions, a subset of ESCs expresses PrE factors such as 
Gata4, Gata6, Sox17 and Hex at variable levels (Canham et al., 2010; Niakan et al., 2010), indicative 
of priming for this extra-embryonic lineage. Moreover, ESCs can be converted into PrE-like cells 
upon LIF withdrawal, atRA treatment (Artus et al., 2010; Capo-Chichi et al., 2005) and forced 
expression of the PrE-specific transcription factors Gata4 or Gata6 (Fujikura et al., 2002; 
Shimosato et al., 2007; Wamaitha et al., 2015).  In this chapter, to further explore the 
differentiation abilities of Jmjd2c-depleted ESCs, their capacity of generating extra-embryonic 
PrE-like cells was tested using different approaches. To additionally identify the specific stage at 
which embryonic (epiblast) differentiation is impeded in Jmjd2c-KO ESCs, these cells were stably 
converted into EpiSCs, and their phenotypic and functional properties further characterized.  
 
IV.2 Results 
4.2.1 Jmjd2c-KO ESCs swiftly adopt a primitive endoderm-like phenotype upon 
retinoic acid treatment 
 In order to test the ability of Jmjd2c-KO ESCs to differentiate towards a PrE-like state, cells 
were transiently treated with all-trans retinoic acid (atRA), previously shown to induce the 
expression of PrE markers (Capo-Chichi et al., 2005). For this, ESCs routinely cultured in 
serum/LIF conditions were cultured in monolayer over 4 days using reduced serum level and 
1µM atRA, in the absence of LIF. The expression levels of Nanog, Jmjd2c, epiblast and PrE markers 
were quantified in RNA samples collected every 24h. As expected, Nanog expression was down-
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regulated upon atRA treatment (Fig.4.1A), although substantial Nanog transcript levels were 
sustained 3-4 days post-treatment in WT, but not in Jmjd2c-KO cultures, possibly due to a small 
proportion of ESC retaining an undifferentiated state (Fig.4.1A). Conversely, the expression of PrE 
markers Gata6, Gata4 and Dab2 gradually increased upon atRA treatment, yet the kinetics and 
induction levels of these genes were strikingly higher in Jmjd2c-KO relative to WT cells (Fig.4.1A). 
Interestingly, and in contrast to the gradual decreased of Jmjd2c transcript observed upon EB 
differentiation, Jmjd2c expression was swiftly reduced in treated WT ESC cultures (Fig.4.1A). As 
a control, the expression of the epiblast-specific marker Fgf5 was also assessed, which remained 
low in both cell populations (Fig.4.1A), reiterating that atRA-induced cells preferentially adopt an 
extra-embryonic identity. This observation was furthermore evidenced by dramatic changes in 
cell morphology with a loss of typical ESC colonies in culture and the emergence of large 
epithelial-like cells in both populations (Fig.4.1B).  Additionally, WT and Jmjd2c-KO ESCs were 
fixed and stained for Oct4, Gata6 along with the cell membrane protein phalloidin prior to and 
after 4 days of atRA treatment (Fig.4.1C). This confirmed a complete loss of the pluripotency Oct4 
protein in both treated cell populations, as opposed to untreated (Fig.4.1C). A positive staining 
for the PrE-associated Gata6 marker was then detected in most (if not all) cells upon atRA 
treatment (Fig.4.1C). Phalloidin staining here clearly highlighted cell morphology changes 
between self-renewing and atRA-treated cultures (Fig.4.1C).   
 
 These observations indicate that Jmjd2c is not required for atRA-induced PrE 
differentiation, and furthermore that Jmjd2c-depleted ESCs might have a higher propensity to 
differentiate towards the extra-embryonic lineages, as compared to WT ESCs. 
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Figure 4.1 All-trans retinoic acid-induced differentiation to primitive endoderm (PrE)-like is 
enhanced in Jmjd2c-knockout ESCs 
A. Transcript levels of Nanog, Jmjd2c, Fgf5 (epiblast), and Gata6, Gata4 and Dab2 (PrE) markers upon 
treatment with 1µM all-trans retinoic acid (atRA) and LIF withdrawal in WT(ESCWT) and KO (ESCJmjd2c-KO) 
clone E3 cultures for 4 days. Data were multiplied by 100, normalized to housekeeping genes (S17 and L19) 
and represented as average of 3 experiments ±SEM.P<0.05 (*), Mann-Whitney U test at final time point. B.  
Phase-contrast images of ESCWT and ESCJmjd2c-KO clone E3 growing in serum/LIF conditions (LIF) and after 
4 days of atRA treatment (atRA). Bars, 100µm. C. Immunofluorescence staining for Oct4 (green), Gata6 
(yellow) and Phalloidin (red) in ESCWT and ESCJmjd2c-KO clone E3 growing in serum/LIF conditions (+LIF) 
and after 4 days of atRA treatment (atRA).  DAPI staining was used to visualize nuclei. Bars, 100µm.   
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4.2.2 Jmjd2c is dispensable for ESC conversion into extra-embryonic endoderm stem 
cells 
To further demonstrate the ability of Jmjd2c-depleted cells to stably adopt a PrE-like 
phenotype, a newly developed protocol for the establishment of self-renewing extra-embryonic 
endoderm stem (XEN) cells from ESCs was used (Niakan et al., 2013) During this process, ESCs  
were initially treated with low dose of atRA and Activin for 2 days (Fig.4.2A), after which cells 
were passaged onto irradiated MEFs (iMEFs), allowing the emergence of highly refractile and 
compact colonies in both cultures over the following 7 days (highlighted in Fig.4.2B). These 
colonies were carefully picked and re-plated onto iMEFs for an additional 2-day period, after 
which cells were expanded on gelatinised plates using standard XEN cell medium supplemented 
with serum and a combination of growth factors (Fgf2 and Heparin) (Niakan et al., 2013). Both 
WT and Jmjd2c-KO converted XEN (cXEN) cell populations acquired and faithfully retained a 
typical XEN-like morphology with a mixture of round refractile and flat epithelial-like cells over 
serial passages (Fig.4.2C). These cXEN cell populations, alongside embryo-derived XEN cells used 
as control, were stained for the XEN markers Dab2 and Gata4, showing strong positive signals in 
both WT and Jmjd2c-KO converted cultures (Fig.4.2C). Furthermore, expression levels of Nanog, 
Jmjd2c and several typical XEN cell markers (Gata6, Gata4, Sox17, Lama1, Sparc and Sox7), 
previously found to be induced upon XEN cell conversion (Cho et al., 2012), was quantified by RT-
qPCR in ESCs and cXEN populations and compared to embryo-derived XEN cells (Fig.4.2D). As 
expected, Nanog transcript was undetectable in converted XEN cell lines and embryo-derived 
XEN cells (Fig.4.2D). The expression of Jmjd2c was reduced to background levels in WT cXEN as 
also seen in embryo-derived XEN cells, further suggesting that Jmjd2c is dispensable in this extra-
embryonic lineage (Fig.4.2D). Lastly, the expression of all XEN cell markers analysed was 
successfully induced, and stably expressed in both cXEN cell populations to similar levels 
expressed by the IM8A-XEN cell line, with the exception of Gata4, which consistently harboured 
lower levels in WT and Jmjd2c-KO cXEN cells (Fig.4.2D). 
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Figure 4.2 Conversion of Jmjd2c-knockout ESCs into extra-embryonic endoderm (XEN) stem cells  
A. Timeline of ESC-to-cXEN derivation protocol (adapted from Cho et al., 2012). After day 12 established 
cell lines were routinely cultured on gelatinised plates and passaged about 15 times before staining and 
expression analysis. B. Representative phase-contrast images upon conversion of WT (ESCWT) and KO 
(ESCJmjd2c-KO) clone E3 into XEN cells (cXENWT and cXENKO, respectively) at the indicated time points. 
Emerging cXEN colonies are depicted with a white dotted line. C. Phase-contrast and fluorescent signals 
detected for the staining of Dab2 and Gata4 in stable ESC-derived cXENWT and cXENKO and an embryo-
derived XEN cell line. Bars, 100µm. D. Transcript levels of Nanog, Jmjd2c and XEN-associated markers 
(Gata6, Gata4, Sox17, Lama1, Sparc and Sox7) in WT and Jmjd2c-KO ESCs, cXEN, and embryo-derived XEN 
cells. Data were normalized to housekeeping genes (S17 and L19) and represented as average of 3 biological 
replicates ±SEM. P<0.05 (*), Mann-Whitney U test versus ESCWT (Nanog, Jmjd2c) or versus XENIM8A (all the 
other markers). 
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 Collectively, these experiments establish that Jmjd2c-KO ESCs, alike their WT counterparts, 
can efficiently differentiate towards the primitive endoderm lineage in vitro, where Jmjd2c is 
functionally expendable and expressed at greatly reduced levels relative to ESCs.   
 
4.2.3 Jmjd2c-depleted ESCs adopt an immature epiblast stem cell identity upon 
activin and fibroblast growth factor induction 
 Experiments presented in Chapter III demonstrate that differentiation of Jmjd2c-KO ESCs 
is impaired upon EB formation and neuronal induction (Section 3.2.4). Moreover, Jmjd2c-KO ESCs 
were capable of transiting through an epiblast (EpiS)-like state upon neuronal induction, as seen 
in WT cultures, but failed to efficiently differentiate into neural-like progenitors (Fig.3.7B). 
Noticeably, Jmjd2c-depleted cells induced Fgf5 upon EB induction. Yet this early epiblast marker 
remained inappropriately expressed, to some extent, in late EB differentiation time-points (Fig. 
3.6B). Altogether, these observations point to a possible differentiation blockage at an EpiS-like 
state in the absence of Jmjd2c.  
To explore this hypothesis, the ability of Jmjd2c-KO ESCs to adopt an EpiS-like phenotype 
was tested by culturing ESCs in serum-free media supplemented with activin and basic fibroblast 
growth factor (bFgf/Fgf2) (Guo et al., 2009). Transient ESC-to-EpiS-like conversion was initially 
optimized in WT ESCs by testing different plating conditions and coating as depicted in Fig.A-III 
(Appendix A). Similarly to neuronal progenitor induction (Section 3.2.4), this optimization 
revealed a high incidence of cell death when swapping media from serum-based to serum-free 
N2B27 conditions, with consequently fewer colonies surviving and/or exhibiting a clear EpiS-like 
morphology after 4 days of conversion (Fig.A-III – Appendix A).  Moreover, stronger induction of 
Fgf5 was detected when ESCs were initially grown in 2i/LIF compared to serum/LIF prior to 
conversion (Fig.A-III – Appendix A).  Therefore, both WT and Jmjd2c-KO ESCs were first adapted 
to serum-free 2i/LIF for at least 7 days, and furthermore, plated on fibronectin-coated plates in 
these same conditions prior to EpiSC induction in the presence of activin and bFgf. The emergence 
of EpiS-like colonies occurred within a week under these conditions, after which cells were 
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serially propagated over 10 passages to generate stably converted EpiSC (cEpiSC) populations. 
Both WT and Jmjd2c-KO ESCs were equally capable of acquiring an EpiS-like cell morphology that 
closely resembled that of embryo-derived EpiSCs grown in the same conditions, and this 
morphology was retained in long-term culture (Fig.4.3A). Expression of Oct4 was also confirmed 
in both cEpiSC cultures by immunofluorescence staining, and compared to embryo-derived EpiSC 
cell line carrying an Oct4 eGFP-Ires-Puro (GiP) transgene (Ying et al., 2002), stably maintained 
under puromycin selection (Fig.4.3B). Oct4 expression was also quantified and confirmed at the 
transcript level, together with Nanog, the epiblast markers Fgf5, Otx2 and Dnmt3b in early time 
points of EpiSC induction and in converted cells, as well as the expression of differentiation 
markers Brachyury/T and Foxa2 and, Jmjd2c itself (Fig.4.3C). The expression of Oct4 transcript 
was maintained at high levels in both cEpiSC cultures, although at a lower level in Jmjd2c-KO 
cEpiSC (Fig.4.3C). As expected, Nanog was down-regulated by day 2 and maintained low in stable 
cultures (Fig.4.3C). The Epiblast markers Fgf5 and Otx2 were greatly induced in the first 3 days 
of conversion, alongside with Dnmt3b (Fig.4.3C), previously linked with the known wave of DNA 
methylation that occurs between these 2 stages (Veillard et al., 2014). 
Although conversion of Jmjd2c-null ESCs appeared successful, closer examination revealed 
clear phenotypic differences between WT and Jmjd2c-KO cEpiSCs. In culture, Jmjd2c-KO cEpiSCs 
colonies displayed a flat and round morphology, with well-defined borders, as opposed to the WT 
cEpiSC colonies which displayed some degree of metastability as revealed by spontaneous 
differentiation at the edge of the colonies.  Notably, the initial burst of expression of early epiblast 
markers Fgf5, Otx2 and Dnmt3b in WT ESCs occurred after two days of EpiSC induction, but this 
appeared consistently delayed in Jmjd2c-KO cultures, where expression peaked at day 3 rather 
than day 2 (Fig.4.3C). Moreover, in stable cultures the expression of these markers were stably 
maintained at lower levels, with the exception of Fgf5, which was maintained highly expressed in 
WT but not in Jmjd2c-KO cEpiSC (Fig.4.3C). Consistent with the observed morphological 
differences for WT and Jmjd2c-KO cEpiSC colonies, the mesoderm marker Brachyury/T and 
endoderm marker Foxa2 acquired a low degree of expression in stable WT, but not KO, cEpiSC 
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cultures, concordant with the acquisition of some degree of gene priming (Fig.4.3C). Furthermore, 
the expression of Jmjd2c remained high throughout ES-to-EpiS-like conversion of WT ESCs, 
decreasing by half in stable cEpiSC cultures (Fig.4.3C).  
 
Figure 4.3 Conversion of Jmjd2c-knockout ESCs into epiblast stem cells (EpiSC) cells  
A. Phase-contrast images of stable EpiSC cell lines derived from WT (cEpiSCWT) and KO (ESCKO) clone E3 
ESCs, and embryo-derived EpiSCOct4-GiP. B. Fluorescent signals detected for the staining of Oct4 in stable 
cEpiSCWT and cEpiSCKO and embryo-derived EpiSCOct4-GiP in which GFP expression is coupled with Oct4. 
DAPI staining was used to visualize nuclei. Bars, 100µm. C. Transcript levels of ESC (Nanog), Epiblast (Oct4, 
Fgf5, Otx2, and Dnmt3b), differentiation markers (Brachyury and Foxa2), and Jmjd2c during conversion of 
ESCWT and ESCJmjd2-KO into cEpiSCs (day 0 to 3) and in stably converted cEpiSCs (day >30). Data were 
multiplied by 100, normalized to housekeeping genes (S17 and L19) and represented as average of at least 
3 biological replicates ±SEM. P<0.05 (*), Mann-Whitney U test in stable cEpiSC.  
 
 Together, these results indicate that Jmjd2c-KO ESCs could successfully be converted into 
stable EpiSCs that, however, expressed lower levels of Fgf5 and no expression of differentiation 
markers, most likely indicative of an immature EpiSC phenotype.  
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4.2.4 Skewed cell fate differentiation towards extra-embryonic visceral endoderm-
like identity in Jmjd2c-KO cEpiSCs.   
 Generating stably converted EpiSCs (cEpiSCs) lines from both WT and Jmjd2c-KO ESCs 
formally establish that, in the absence of Jmjd2c, ESCs can transit to an EpiSC-like state in vitro. 
These cell lines were also crucial to further pinpoint the stage at which epiblast differentiation is 
blocked in Jmjd2c-depleted cells. In collaboration with Jennifer Harman and Dr. Helle Jørgensen 
(Cambridge University), the behavior of Jmjd2c-KO cEpiSCs was here studied upon induction of 
the mesoderm lineage. Firstly, cEpiSCs were cultured in chemically defined media (CDM)(Brons 
et al., 2007) supplemented with bFgf/Fgf2, BMP4 and the PI3K inhibitor LY294002 (FlyB 
conditions) for 36h to induce differentiation into mesoderm progenitors (MP) that typically 
express the primitive streak and early mesodermal marker Brachyury (Fig.4.4A). Secondly, FlyB-
treated cEpiSCs were subsequently differentiated into distinct mesoderm subtypes: lateral plate 
mesoderm (LPM) cells with Fgf2 and BMP4 (FB40 conditions) and, paraxial mesoderm (PM) with 
Fgf2, Wnt3a, and inhibitors for both PI3K and BMP (LY294002 and LDN193189; FlyWLDN 
conditions) (Fig.4.4A). The efficiency of differentiation was scored by monitoring the emergence 
of Flk-1 (LPM) and Pdgfrα (PM) expressing (+) cells as detected by FACS analysis, alongside with 
embryo-derived EpiSCs differentiated under the same conditions (Fig.4.4B). In these control 
(EpiSC) cultures,  differentiation towards LPM was generally more efficient than PM with over 55 
% of Flk-1+ cells emerging under FB40 conditions, and about 28% Pdgfrα+ cells under FlyWLDN 
conditions (Fig.4.4B). Similar efficiency was obtained when differentiating WT cEpiSC, with about 
46% Flk-1+ and 37% Pdgfrα+ emerging in FB40 and FlyWLDN, respectively (Fig.4.4B). 
Remarkably, the efficiency of differentiation was greatly reduced in Jmjd2c-KO cEpiSC, with 
approximately 14% and 6% cells staining positive for Flk-1 and Pdgfrα, respectively (Fig.4.5B). 
Moreover, the morphology adopted by WT and Jmjd2c-KO differentiated cEpiSCs was also 
strikingly different (Fig.4.4C). After 4 days of differentiation, WT cEpiSCs appeared as small 
elongated cells (Fig.4.4C), similarly to differentiated embryo-derived EpiSCs (Fig.A-IV – Appendix 
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A). On the contrary, differentiated Jmjd2c-KO cEpiSC formed a monolayer of adhesive and 
polarized epithelial-like cells regardless of culture conditions (Fig.4.4C).  
 
Figure 4.4 Induction of mesoderm is impaired in Jmjd2c-knockout cEpiSCs   
A. Time line of Mesoderm induction. EpiSC are initially cultured in FlyB conditions to induce the emergence 
of early mesoderm progenitors (MP). Subsequently, cells are cultured for 3 days in either FB40 conditions 
to induce lateral plate mesoderm (LPM) differentiation, or in FlyWLDN to induce paraxial mesoderm (PM) 
differentiation. B. Average percentage (±SEM) of Flk-1 and Pdgfrα-positive cells detected by FACS analysis 
in embryo-derived EpiSC and WT (cEpiSCWT) and KO (ESCJmjd2c-KO) cEpiSCs differentiated in FB40 (PM) and 
FlyWLDN (LPM) conditions, respectively. C. Representative phase-contrast images of day 4 differentiated 
WT and Jmjd2c-KO cEpiSCs populations, in FB40 (PM) or FlyWLDN (LPM) conditions. Bars, 100µm. D. 
Transcript levels of Fgf5, Brachyury/T, Nanog, Oct4 in cEpiSC (day 0) differentiated with FlyB for 1 and 1.5 
days, and FB40 at day 4. Transcript levels of Flk-1, and Isl1 and Pdgfra and Meox1, in cEpiSC prior and after 
4 day LPM and PM differentiation, respectively. Data were normalized to housekeeping genes (Hmbs, Ywak 
and Gapdh) and represented as average of at least 3 independent experiments ±SEM. P<0.05 (*), Mann-
Whitney U test. Results in this figure were produced by Jennifer Harman.  
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of LPM and PM differentiation pathways (Fig. 4.4D). Here, Fgf5 and Nanog were promptly down-
regulated upon early mesoderm progenitor induction in both cell populations (Fig.4.4D). 
However, while the expression of Brachyury peaked 36h after FlyB treatment in WT cEpiSCs, this 
failed to be induced in Jmjd2c-KO cEpiSCs (Fig.4.4D). Conversely, the expression of Oct4 was 
down-regulated at the onset of differentiation in WT cEpiSCs, but was maintained at 
heterogeneous levels during FlyB treatment in Jmjd2c-KO cEpiSCs, indicating that these cells 
might not have acquired an early mesodermal progenitor phenotype (Fig.4.5D). Consequently, 
the induction of LPM markers (Flk-1 and Isl1), and PM markers (Pdgfra and Meox1) was 
dramatically reduced upon FB40 and FlyWLDN treatment respectively in Jmjd2c-KO cEpiSCs 
relative to WT cEpiSCs and embryo-derived EpiSCs, as assessed by RT-qPCR (Fig.4.4D). These 
results demonstrate that mesodermal induction in cEpiSCs is inhibited at an early stage (MP) in 
the absence of Jmjd2c.  
Notably, the epithelial-like cell morphology acquired by Jmjd2c-KO cEpiSCs upon 
mesodermal induction closely resembled that of either definitive endoderm (mesendoderm 
derivatives) or visceral endoderm (extra-embryonic derivatives) (Yasunaga et al., 2005). To 
clarify the identity of cells similarly emerging under FB40 and FlyWLDN treatments of Jmjd2c-KO 
cEpiSCs, the expression of visceral and parietal endoderm markers (Lrp2 and Sparc) and 
definitive endoderm (Foxa2 and Cxcr4) was further quantified at the end time-points of 
differentiation (Fig.4.5A). Remarkably, the expression of both Lrp2 and Sparc was greatly induced 
in differentiated Jmjd2c-KO cEpiSC (Fig.4.5A). In contrast, Foxa2 expression was poorly induced 
in differentiated WT cEpiSCs, as expected, and not induced in Jmjd2c-KO cEpiSC. The expression 
of the definitive endoderm marker Cxcr4 was also poorly induced, although at similar levels in 
both cell populations (Fig4.5A), suggesting that Jmjd2c-KO cEpiSCs preferentially adopt an extra-
embryonic endoderm-like phenotype. In line with this, differentiated Jmjd2c-KO cEpiScs also 
stained positive for the adherent junction marker E-Cadherin, clearly outlining the retained 
polarized epithelium-like cell morphology (Fig. 4.5B), as seen upon BMP4 treatment of XEN cells, 
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which was previously reported to induce visceral endoderm differentiation in extra-embryonic 
stem cells (Artus et al., 2012) 
 
Figure 4.5 Characterization of skewed differentiation towards extra-embryonic endoderm-like 
phenotype of Jmjd2c-knockout cEpiSC 
A. Transcript levels of visceral and parietal endoderm (Lrp2, Sparc) and endoderm (Foxa2, Cxcr4) in WT 
(cEpiSCWT) and KO (cEpiSCJmjd2c-KO) cEpiSC before (day0, Epi) and after differentiation in FB40 conditions 
(LPM) and FlyWLDN condition (PM) at day 4. Data were normalized to housekeeping genes (Hmbs, Ywak, 
Gpdh) and represented as average of at least 3 independent experiments ±SEM. P<0.05 (*), Mann-Whitey 
U test. B. Phase-contrast images and fluorescent signals detected for the staining of E-cadherin in cEpiSCWT 
, cEpiSCJmjd2c-KO and embryo-derived EpiSC at day 4 of lateral plate mesoderm (LPM) and paraxial mesoderm 
(PM ) differentiation, and in BMP4-treated and non-treated embryo-derived XEN cells. Bars, 100µm.  
 
 Taken together, these experiments demonstrate that, in the absence of Jmjd2c, epiblast 
stem cell fate determination is skewed towards an extra-embryonic endoderm-like identity as 
tested in permissive conditions for mesodermal differentiation.  
 
0
20
40
60
0 4 4
Sparc1
0
10
20
30
40
0 4 4
Lrp2
0
10
20
0 4 4
Cxcr4
0.0
2.0
4.0
6.0
8.0
0 4 4
Foxa2
Epi LPM  PM
Time/days
A. cEpiSC
WT cEpiSCJmjd2c-KO
R
e
la
ti
ve
 m
R
N
A
 le
ve
ls
cEpiSCWT
cEpiSCKO
LP
M
P
M
EpiSC
XEN
LP
M
P
M
LP
M
P
M
+B
M
P
4
-B
M
P
4
E-cadherin E-cadherin
E-cadherin E-cadherin
B.
*
Epi LPM  PM
Epi LPM  PM Epi LPM  PM
*
Chapter IV – Results 
151 
 
4.2.5 Exploring the impact of Jmjd2c depletion in early cell fate commitment 
Experiments described above unveiled that Jmjd2c is not required for the generation and 
maintenance of extra-embryonic endoderm and epiblast stem cells. Moreover, Jmjd2c-depleted 
cells exhibit a higher propensity to differentiate towards extra-embryonic endoderm lineages, as 
notably suggested by the rapid induction of PrE markers upon atRA treatment of Jmjd2c-KO ESCs 
(Fig.4.1), and by skewed differentiation into extra-embryonic endoderm-like cells upon cEpiSC 
mesoderm induction (Fig.4.5). To further test whether Jmjd2c might impact on the balance 
between PrE and epiblast lineage segregation, WT and Jmjd2c-KO ESCs were induced to 
differentiate upon hanging-drop embryoid body (HD-EB) formation. Unlike classic embryoid 
body assays, static suspension of EBs formed by low number of cells here facilitates the 
synchronised emergence of PrE- and epiblast-like populations in a 'salt-and-pepper' manner, 
which are subsequently segregated into an organized outer (PrE-like) layer and an inner 
(epiblast-like) population (Fig.4.6A), hence mimicking the early PrE/epiblast segregation events 
seen in the developing blastocyst (Lavial et al., 2012; Rula et al., 2007). A comprehensive 
optimization was initially preformed for drop volume, cell number, and timing of differentiation. 
About 500 ESCs were used per drop to induce the formation small aggregates in the presence of 
reduced serum level and in the absence of LIF, over 5 days. Expression of epiblast (Oct4, Fgf5) 
and PrE (Gata4, Gata6) markers was quantified over the course of the experiment by RT-qPCR 
(Fig.4.6B). Additionally, day 5 HD-EBs were fixed and stained for Oct4 and Gata4, in order to 
delineate the formation of the two inner (epiblast-like) and outer (PrE-like) EB layers, 
respectively (Fig.4.6C). Despite careful optimization this approach proved to be technically 
challenging and only two independent experiments out of 10 performed provided a sufficient 
amount of material for transcript quantification (Fig.4.6B). Here, overall down-regulation of Oct4 
was observed in WT HD-EBs, in contrast to Jmjd2c-KO HD-EBs that retained partial Oct4 
expression at day 5 of differentiation, as previously found in late Jmjd2c-KO EBs (Section 3.2.4). 
Fgf5 expression was induced from day 3 onwards and the early PrE marker Gata6 highly up-
regulated by day 5 in both cell populations. (Fig.4.6B). Interestingly, the expression of the late PrE 
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maker Gata4 was also prominently induced but in Jmjd2c-KO HD-EBs only (Fig.4.6B). Gata4 is a 
known Gata6 target gene, indicative of PrE maturation rather than specification (Frankenberg et 
al., 2011), hence suggesting that PrE maturation might be favoured or accelerated in HD-EBs in 
the absence of Jmjd2c. However, in the few successful Gata4 staining experiments performed on 
whole HD-EBs, no striking prevalence for the formation of an outer layer could be identified in 
Jmjd2c-KO HD-EBs (Fig.4.6C).  
 
Figure 4.6 Induction of hanging-drop embryoid bodies (HD-EBs) is insufficient to uncover a bias in 
cell fate commitment in Jmjd2c-knockout ESCs 
A. Schematic representation of hanging-drop embryoid body (HD-EB) assay, mimicking the early 
segregation events in the blastocyst. Formation of cell aggregates from low number of cells in suspension 
promotes the synchronised emergence of primitive-endoderm (PrE)- and epiblast(Epi)-like populations in 
a 'salt-and-pepper' manner, which are subsequently segregated into and organized outer (green) an inner 
(red) layer, respectively. B. Transcript levels of epiblast (Oct4, Fgf5) and PrE markers (Gata6, Gata4), during 
induction of HD-EBs from WT (ESCWT) and KO (ESCJmjd2c-KO) ESCs. Data were normalized to housekeeping 
genes (S17, L19) and represented as average of 2 independent experiments ±SD. C. Immunofluorescence 
labelling of Oct4 and Gata6, for identification of Epi-like and PrE-like (arrows) layers respectively in HD-
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EBs induced from WT and Jmjd2c-KO ESCs at day 6. Bars, 100µm. Results in B and the HD-EBs used to 
generate the results in C were produced by Donja Karimlou. 
The unforeseen variability between experiments suggested that this approach might not be 
fully reliable to uncover a bias towards the extra-embryonic PrE in Jmjd2c-KO ESCs. Moreover, 
the quality of immunofluorescent staining could have been greatly improved by alternative 
approaches such as staining of sectioned agarose-embedded EBs (Lavial et al., 2012).     
 
 As a different approach to test whether Jmjd2c-KO ESCs might preferentially be allocated 
into the outer PrE-like layer as opposed to the inner epiblast-like layer, labelled WT and Jmjd2c-
KO ESCs were mixed in a 50:50 ratio, and induced to form chimeric HD-EBs (Lavial et al., 2012). 
For this, WT ESCs were first labelled with a red fluorescence protein by transfection with a 
piggyBac vector carrying a CAG promoter driven dsRed transgene (CAG-dsRed*MST). Moreover, 
to ensure that the level of GFP produced by the genetrap cassette in Jmjd2c-KO ESCs would not 
be a limitation, and to guarantee that both ESC lines would be subjected to the same 
manipulations, KO ESCs were also transfected with a piggyBac vector carrying a CAG promoter 
driven GFP (CAG-GFP). These vectors were kindly provided by Dr Jennifer Nichols (Cambridge 
University). Thus, both cell populations were cultured for at least 4 passages under puromycin 
selection before induction of HD-EBs, and the levels of fluorescence produced by these vectors 
was confirmed under ESC culture conditions (Fig.4.7A). An equal ratio of WT (red) and KO (GFP) 
ESCs was mixed and 500 cells were used per drop in this assay (Fig.4.7A). The distribution of GFP 
and Red fluorescence was determined by confocal microscopy up to 7 days after HD-EB formation 
(Fig.4.7B). Both Green and Red signals appeared however, evenly distributed throughout the 
analysed aggregates, showing no striking evidence for preferential assignment of Jmjd2c-KO ESCs 
to the PrE layer (Fig.4.7B).  
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Figure 4.7 Generation of chimeric hanging-drop embryoid bodies  
A. Schematic representation of generation chimeric hanging-drop embryoid body (HD-EB) with equal 
number of labelled WT (dsRed) and Jmjd2c-KO (GFP) ESCs. B. Immunofluorescence signals for WT (red) 
and Jmjd2c-KO (green) ESCs upon HD-EB formation at day 5, 6, and 7, showing no preferential location of 
labelled cells in the outer (PrE) and inner (epiblast) parts of chimeric HD-EBs. Bar, 100µm.  
 
IV.3 Summary and Conclusions 
Collectively, experiments described in Chapters III and IV uncover that Jmjd2c-KO ESCs fail 
to execute multi-lineage, epiblast-derived differentiation upon EB formation. Instead, these cells 
were found to preferentially adopt an extra-embryonic endoderm-like phenotype during the 
early steps of germ layer differentiation as further unveiled upon mesodermal induction of 
converted Jmjd2c-KO EpiSCs. This corroborates with a prominent and rapid induction of a PrE-
like phenotype upon atRA treatment of Jmjd2c-depleted ESCs. Moreover, these cells also proved 
capable to stably convert into self-renewing XEN cell-like populations. However, no evidence 
could be obtained to suggest that Jmjd2c might directly impact in PrE and epiblast lineage 
segregation in the early embryo, as investigated here in vitro upon hanging-drop EB formation.  
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Moreover, the persistent expression of the Epiblast marker Fgf5 upon EB induction, and the 
EpiS-like phenotype adopted upon neuronal progenitor induction, uncovered in Chapter III, 
suggested that Jmjd2c-KO differentiation was blocked at an epiblast-like stage. To validate this 
assumption, the ability of Jmjd2c-KO ESCs to be converted into EpiSCs was tested. Interestingly, 
converted EpiSCs were established, acquiring however an immature phenotype in the absence of 
Jmjd2c. Testing the differentiation capacity of this “immature” cell population upon mesoderm 
induction uncovered a differentiation bias towards an extra-embryonic endoderm like 
phenotype.  
Altogether, these experiments established that Jmjd2c is strictly required for proper somatic 
differentiation after an epiblast-like stage, but dispensable for the emergence of an extra-
embryonic phenotype.  The molecular basis for the impaired differentiation and the lack of 
transcriptional lineage priming in mutant cEpiSCs will be further deciphered in the following 
Chapter V and VI.   
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V.1 Introduction 
 Results described in Chapters III and IV uncovered a key requirement for Jmjd2c at the 
onset of pluripotent stem cell differentiation into epiblast-derived lineages, as opposed to extra-
embryonic endoderm. Impaired differentiation was evident from the inability of Jmjd2c-depleted 
cells to fully activate the required gene expression programs upon somatic lineage induction. 
Moreover, Jmjd2c-KO ESCs exhibited lessened and variable expression levels of pluripotency-
associated factors, although this did not impact on their self-renewal ability. Additionally, an 
increase in global levels of H3K9 di- and tri- methylation was observed in the absence of Jmjd2c 
in ESCs, a set of histone modifications which, together with de novo DNA methylation, have been 
specifically linked with silencing of inappropriate gene expression in ESCs and in extra-
embryonic lineages (Alder et al., 2010; Senner et al., 2012; Yuan et al., 2009). Altogether, these 
observations led to the hypothesis that Jmjd2c might play a key role in gene transcriptional 
regulation at the exit of pluripotency and/or during epiblast lineage priming, possibly through its 
H3K9-demethylase activity. In particular, it is here proposed that Jmjd2c, could prevent the 
acquisition of repressive epigenetic marks at the promoter regions of pluripotency and poised 
differentiation-associated genes in pluripotent stem cells.  
 
 During the course of this project, two reports employing chromatin immunoprecipitation 
(ChIP) coupled with high-throughput DNA sequencing (ChIP-seq) identified the genome-wide 
DNA-binding sites for Jmjd2c in ESCs, hence revealing that Jmjd2c is predominantly located at 
CpG-dense regions encompassing H3K4me3-rich TSS of both active and silent (bivalent) genes in 
these cells (Das et al., 2014; Pedersen et al., 2014). These findings corroborate with the proposed 
molecular basis for Jmjd2c-KO pluripotent stem cell differentiation defect. It is worth noting, 
however, that the two studies employed different ESC model systems and culture conditions – i.e. 
2i/LIF (Pedersen et al., 2014) and serum/LIF (Das et al., 2014) known to distinctively support a 
naïve and primed ESC state, respectively (Ying et al., 2008). Although these reports commonly 
focused on the prevalent location of Jmjd2c at TSS gene regions, careful interrogation of the 
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deposited ChIP-seq data revealed striking differences in Jmjd2c distribution, with a higher 
number of non-TSS Jmjd2c DNA-binding sites being found in ESC “priming” (serum/LIF) (Das et 
al., 2014) as compared to 2i/LIF conditions (Pedersen et al., 2014). Nonetheless, the fact that 
different experimental approaches (Biotin-tagging versus endogenous IP) were used does not 
exclude that these differences might be due to different ChIP efficiencies rather than a direct effect 
of culture conditions and, hence, distinct ESC states on Jmjd2c genomic distribution.      
 
 Hence, to further explore this and test whether Jmjd2c DNA-binding sites are indeed re-
distributed at the onset of differentiation, ChIP-seq analysis was performed in ESCs expressing 
tagged-Jmjd2c molecule under naïve (2i/LIF) and priming (serum/LIF) culture conditions as well 
as upon induction of an early epiblast-like state as previously described (Buecker et al., 2014). 
Candidate binding sites were then validated by ChiP-qPCR in ESCs that express wild-type or 
mutant tagged-Jmjd2c protein lacking the two Tudor domains required for Jmjd2c recognition 
and recruitment at H3K4 methylated sites (Pedersen et al., 2014). Moreover, in this Chapter, 
different approaches were employed to identify putative protein partners acting in complex with 
Jmjd2c in the control of gene transcription in ESCs.    
 
V.2 Results 
5.2.1 Generation of FLAG-tagged Jmjd2c expressing ESC lines 
 To map the genome-wide DNA-binding sites of Jmjd2c, tagged Jmjd2c expressing ESC lines 
were established due to the lack of commercially available ChIP grade antibodies. Three ESC lines 
were generated by stable transfection with a FLAG-FLAG-V5 tagged full-length Jmjd2c cDNA (FV-
Jmjd2c-WT; Fig5.1A) in serum/LIF conditions. Empty FLAG-FLAG-V5 vector was kindly provided 
by Dr Raymond Poot (Erasmus MC, Rotterdam). Moreover, a stop codon was introduced at exon 
18 to create a deletion of the two downstream Jmjdc2’s Tudor domains (FV-Jmjd2c-ΔT; Fig5.1A), 
both essential for targeting Jmjd2c to the nucleus (Shin and Janknecht, 2007) and for recognition 
of H3K4me2/3 histone modifications in vitro and hence its recruitment at H3K4 methylated sites 
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in ESCs (Pedersen et al., 2014; Shin and Janknecht, 2007). In particular, it is here proposed that 
Jmjd2c, could prevent the acquisition of repressive epigenetic marks at the promoter regions of 
pluripotency and poised differentiation-associated genes in pluripotent stem cells. As a control, 
ESCs expressing an empty version of the same construct were also generated (Control; Fig.5.1A).  
The expression of the FLAG epitope was firstly validated by immunofluorescence in stable 
pools of transfected ESCs with FV-Jmjd2c-WT and control vectors (Fig.5.1B). Moreover, both cell 
populations were found to grow normally, and similarly maintained high levels of Oct4 protein 
expression (Fig.5.1B, bottom panel). Individual FV-Jmjd2c-WT ESC clones were picked and 
expanded, and the expression of Jmjd2c and the V5 epitope was confirmed by western blot on six 
established clones (Fig.5.1C), revealing variable expression levels of this construct. To avoid 
clone-dependent bias, two clones expressing similar levels of Jmjd2c (approximately 4-fold 
higher than endogenous levels) were selected and used in subsequent experiments. Hence, FV-
Jmjd2c-WT clone 8 was used in ChIP-seq, whereas clone 3 was used for further validation by ChIP-
qPCR at a panel of selected Jmjd2c-bound sites (Section 5.2.7).  Moreover, both FV-Jmjd2c-WT 
clones 3 and 8 were exploited for FLAG pull-down studies to be described in section 5.2.8 of this 
Chapter. Similarly, ESCs were transfected with the mutant vector FV-Jmjd2c-ΔT and individual 
clones picked and expanded. Here, the expression of a 108KDa truncated Jmjd2c fragment was 
confirmed by western blot (Fig.5.1D-E), and FV-Jmjd2c-ΔT clone1 selected to be used in ChIP-
qPCR validation (Section 5.2.7).  
 To investigate Jmjd2c binding sites in naïve and differentiating conditions, FV-Jmjd2c-WT 
ESC clone 8, established and routinely cultured in serum/LIF, was first adapted to serum-free 
2i/LIF conditions for at least 7 days prior to chromatin collection for ChIP-seq, as indicated by the 
acquisition of a dome shape-like colony morphology (Fig.5.2A). These 2i/LIF cultures were then 
induced to differentiate into early epiblast-like cells (EpiLCs) upon Activin, bFgf and KSOR 
(knockout serum replacement) treatment for 48h (Buecker et al., 2014), which similarly to cells 
grown in serum/LIF displayed a more flattened colony morphology (Fig.5.2A).  
Chapter V – Results 
160 
 
 
Figure 5.1 Characterization of FV-Jmjd2c expressing ESCs 
A. Schematic representation of the generated FLAG(x2)-V5 tagged wild-type Jmjd2c construct (FV-Jmjd2c-
WT) and mutated Jmjd2c construct where the Tudor domains were deleted (FV-Jmjd2c-ΔT). Both 
constructs were used to generate stable ESC lines. An empty version of the same construct (without Jmjd2c) 
was used to generate a control ESC line.  B. Immunofluorescent labelling of DNA (DAPI), Oct4 protein and 
FLAG epitope in ESC cultures stably transfected with Control vector or F2V5-Jmjd2c-WT (Clone#8). Bars, 
100µm. C. Western blot showing Jmjd2c protein levels, together with the expression of the V5 epitope in 
individual FV-Jmjd2c-WT ESC clones and pool of transfected cells. Endogenous levels of Jmjd2c were 
determined using protein lysates from control ESCs, which was loaded at two different amounts. Detection 
of α-Tubulin was used as a loading control. D. Western blot showing protein levels of mutant Jmjd2c in FV-
Jmjd2c-ΔT ESC clones. Control ESC lysates were loaded as negative control, but an unspecific band was 
detected with similar size (*). α-Tubulin was used as a loading control. E. Western blot showing protein 
levels of the FLAG epitope in FV-Jmjd2c-WT clone 3 (132KDa) and FV-Jmjd2c-ΔT clone 1 (108KDa) ESC 
lines. α-Tubulin was used as a loading control.  
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These differentiation conditions were previously reported to promote genomic re-
distribution of key transcription factors such as Oct4 and Otx2 at newly formed enhancer regions, 
and this was consistently accompanied by gene expression changes with the acquisition of a 
typical epiblast-like phenotype (Buecker et al., 2014). Accordingly, levels of induction of the 
Epiblast markers Fgf5 and Otx2 were found to be up-regulated in induced cultures, as compared 
to 2i/LIF or Serum/LIF ESCs (Fig.5.2.B). As expected, the levels of Nanog were conversely down-
regulated upon induction of the EpiLC state, whereas the levels of Oct4 remained unchanged as 
expected (Fig.5.2B).  
 
Figure 5.2 Generation of naïve and primed FV-Jmjd2c-WT ESC cultures  
A. Morphology of FV-Jmjd2c-WT ESC clone 8 when routinely cultured in 2i/LIF, serum/LIF, and after 48h 
of Activin/Fgf2/KOSR induction (EpiLC). Bars, 100µm. B. Western blot showing Jmjd2c protein levels of in 
control and FV-Jmjd2c-WT ESCs cultured in 2i/LIF (2i), serum/LIF (FBS), and upon 48h in EpiLC (EpiLC) 
conditions. α-Tubulin was used as a loading control. C. Quantification of the mRNA levels of epiblast 
markers Fgf5 and Otx2, and pluripotency markers Nanog and Oct4, in control and FV-Jmjd2c-WT ESCs 
routinely cultured in 2i/LIF, serum/LIF, and after 24h and 48h of EpiLC induction. Data were multiplied by 
100 normalized to housekeeping genes (S17 and L19) and represented as average of 3 biological replicates 
±SEM. P<0.05 (*), Mann-Whitney U test. 
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Interestingly, Jmjd2c protein level appeared higher in ESC priming (serum/LIF) conditions 
than in naïve (2i/LIF) conditions, and remained high in epiblast-like cultures, as determined by 
western blot (Fig.5.2C). An increase of Jmjd2c expression with the acquisition of a primed 
pluripotent state reiterates a possible role for Jmjd2c at the onset of differentiation. 
 
5.2.2 Genome-wide distribution of Jmjd2c during ESC priming for multi-lineage 
differentiation 
 Chromatin was extracted from 2 biological replicates of FV-Jmjd2c-WT ESC cultures 
respectively grown in serum/LIF and 2i/LIF conditions, or upon 48h induction into epiblast-like 
cells, and protein-bound DNA fragments immunoprecipitated with anti-FLAG antibody. To 
generate genome-wide maps of Jmjd2c-DNA interactions, DNA libraries were generated with the 
purified fragments and these were sequenced and analysed in collaboration with Dr Ignacio del-
Vale Torres and Dr Kathy Niakan (NIMR Francis Crick Institute, London). Fragmented DNA 
samples were also collected prior to ChIP (input) for each culture condition, and used as 
background controls for sequencing. Reads were aligned to the reference mouse genome (mm9) 
and converted into a bigwig format for visualization in the Genome Browser. Given the high 
correlation score obtained for each pair of duplicates (Fig.A-V – Appendix A), data from both 
replicates was merged in BAM format, and then treated as one in order to identify significantly 
tagged-Jmjd2c enriched regions over inputs.  
 For this, a peak-finding algorithm was employed (MACS2) (Zhang et al., 2008) with a False 
Discovery Rate (FDR) lower than 0.0001, resulting in the identification of 20.377 and 45.485 
peaks for Jmjd2c ChIP in 2i/LIF and serum/LIF respectively, and 22.985 peaks in differentiating 
(EpiLC) conditions. Peaks were annotated relative to the nearest TSS and the great majority 
annotated to protein-coding TSS in all conditions, with a small percentage annotated to non-
coding RNAs, and under 1% to other such as small nuclear and nucleolar RNAs, ribosomal RNAs 
and pseudogenes (Fig.5.3A). Peaks were sorted into 2 groups according to their distance to the 
nearest TSS and assigned as “TSS peaks” if located within 1KB of the nearest TSS, and as “distal 
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peaks” if falling outside this interval. Concordant with previous reports, Jmjd2c peaks were 
consistently found within the defined TSS interval in 2i/LIF and serum LIF conditions (Fig.5.3B). 
However, the proportion of TSS peaks amongst total peaks detected was clearly altered between 
these conditions with a majority of Jmjd2c peaks in serum/LIF conditions being located outside 
the defined TSS interval and hence assigned as distal peaks (60% compared to 40% in 2i/LIF 
conditions). In contrast, analyzing the location of Jmjd2c peaks detected under differentiating 
(EpiLC) conditions did not revealed similar enrichment for distal sites (Fig. 5.3B), but instead 
retained a prevalence of TSS peaks as seen in 2i/LIF conditions.  
Notably, a greater number of peaks identified in priming serum/LIF conditions, as opposed 
to naïve 2i/LIF conditions, supported the hypothesis that the binding pattern of Jmjd2c is changed 
upon priming. Hence, to unravel the extent of the re-distribution of Jmjd2c upon priming, the 
peaks identified in 2i/LIF conditions were separately compared to the priming and differentiating 
culture conditions here tested (Fig.5.3C).  In both comparisons, a similar number of conserved 
TSS peaks were identified, with about 13,500 peaks overlapping between 2i/LIF versus 
serum/LIF,  or 2i/LIF versus EpiLC (Fig.5.3C, left panel), which corresponded to the majority of 
the TSS peaks identified in all conditions. Furthermore, a proportion of distal peaks were 
conserved between 2i/LIF and serum/LIF conditions (4,700), and between 2i/LIF and EpiLC 
conditions (4,000), (Fig.5.3C). Notably, around 22,600 new peaks were acquired in the metastable 
serum/LIF state, while only about 2,700 peaks were acquired upon transition from a naive to an 
EpiLC state (Fig.5.3C, middle panel), highlighting the higher levels of re-distribution of Jmjd2c 
binding in the presence of serum. Comparison of the annotated genes associated with the total 
set of peaks identified in each condition revealed that the majority of peaks detected were in fact 
located within the same gene locus and, hence, associated with the same gene (Fig.5.3C). The 
notable different degree of re-distribution found in serum/LIF, as opposed to EpiLC conditions, 
proposed that the short-term conversion here applied might have been insufficient to fully 
promote a re-organization of Jmjd2c binding. Hence, the characterization of Jmjd2c peaks was 
focused on the serum/LIF dataset.    
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Figure 5.3 Genome-wide distribution of Jmjd2c in naïve and priming culture conditions 
A. Class of genes annotated for the peaks identified in the three culture conditions tested (2i/LIF, 
serum/LIF, EpiLC). B. Percentage of peaks located within 1Kb of the TSS (TSS) or outside this interval 
(Distal) in the different culture conditions tested. C. Peak overlaps (minimum overlap = 1bp) for peaks 
identified as TSS or Distal between the three conditions: naïve (2i/LIF), primed (serum/LIF) and EpiLC 
(Activin/bFgf/KOSR). D. Overlap of gene names associated with all the peaks in 2i/LIF dataset against 
either serum/LIF or EpiLC datasets.  
 
 Taken together, these data suggest that Jmjd2c is preferentially found in the vicinity of a 
relatively large cohort of genes (about 13,500 genes).  As previously reported, Jmjd2c peaks are 
consistently located at the TSS regions of these genes in both 2i/LIF and serum/LIF conditions. 
Yet additional enrichment peaks are observed in serum/LIF at distal sites that might overlap with 
distal regulatory regions associated with the same set of genes. 
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5.2.3 Jmjd2c TSS and distal peaks coincide with H3K4me3 and H3K4me1/me2 
deposition  
The association of Jmjd2c with CpG islands and H3K4me3-bound TSS was previously 
reported (Das et al., 2014; Pedersen et al., 2014). The identification of a large number of 
additional Jmjd2c distal binding sites in priming (serum/LIF) conditions, located more than 1kb 
apart from TSS regions, suggests that Jmjd2c might also be recruited at H3K4me1/me2 decorated 
sites possibly encompassing enhancer regulatory regions (Creyghton et al., 2010; Zentner et al., 
2011). To determine whether distal Jmjd2c peaks preferentially coincide with H3K4me1/me2 
enriched regions, rather than H3K4me3, heatmaps and average density plots were generated to 
examine the presence of each of these histone modifications across sorted Jmjd2c TSS and distal 
peaks identified in serum/LIF conditions (Fig.5.4A). As expected, a clear overlap between 
H3K4me3 enrichment at the Jmjd2c TSS peaks was observed (Fig.5.4A; green), with very little or 
no enrichment at distal regions (Fig.5.4A; blue). H3K4me2 marks occupied both sets of regions, 
whereas H3K4me1 deposition was selectively found at Jmjd2c-bound distal sites in contrast to 
TSS regions (Fig.5.4A). As hypothesized, these observations unveil novel association between 
Jmjd2c and H3K4me1/2-rich sites, in addition to H3K4me3-rich TSS as previously described.    
 
5.2.4 G9a and Jmjd2c binding profiles intersect at Jmjd2c distal peaks in ESCs. 
 Jmdj2c was previously identified as a histone H3K9me2/me3 demethylase (Katoh and 
Katoh, 2004; Klose et al., 2006b; Whetstine et al., 2006). Accordingly, constitutive depletion of 
Jmjd2c protein in ESCs correlates with a marked increase in bulk levels of H3K9me2, with a 
milder effect on H3K9me3 (Section 3.2.3), proposing an active and prominent role for Jmjd2c in 
the removal of di-methyl groups from H3K9 residues in ESCs. Hence, it would be expected that no 
deposition of H3K9me2/me3 and/or enrichment for their cognate histone H3K9-
methyltransferases are detected at Jmjd2c-bound regions in ESCs. To validate this, enrichment 
profiles for these histone modifications together with the H3K9me2 (G9a) and H3K9me3 
(Suv39h1) methyltransferases were examined at Jmjd2c-bound TSS and distal regions using 
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average density plot analysis (Fig.5.4B). As hypothesized, no H3K9me2/3 enrichment was 
detected at either set of Jmjd2c peaks. Moreover, G9a was found mutually exclusive with Jmjd2c 
at TSS peaks (Fig.5.4B-C). This was in agreement with previously reported G9a enrichment 
patterns in ESCs where G9a peaks was seen closely surrounding, but not overlapping with the 
TSS of PRC2-bound genes (Mozzetta et al., 2014), strictly mirroring H3K9me2 enrichment 
patterns (Lienert et al., 2011).  
 
Figure 5.4 Jmjd2c associates with H3K4me1/2 and G9a at distal sites   
A. Average density plots and heatmaps showing enrichment levels for Jmjd2c, H3K4me3, H3K4me2 and 
H3K4me1 across a ±5Kb window around the centre of Jmjd2c peaks regions defined as TSS (green) and 
distal (blue) in serum/LIF conditions. Scale was adjusted automatically to maximum intensity in each ChIP-
seq data. B. Average density plots showing the enrichment levels of H3K9me2, H3K9me3, G9a, and 
Suvh39h1 across a 5Kb window around the centre of Jmjd2c peaks defined as TSS and Distal. Scale was 
adjusted for each ChIP-seq data individually. C. Average density plots and heatmaps for the level of 
enrichment of Jmjd2c and G9a cross a ±5Kb window around the centre of Jmjd2c TSS and Distal peaks. Scale 
was adjusted automatically to maximum intensity in each ChIP-seq data.  
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equally absent at both Jmjd2c-bound TSS and distal sites (Fig.5.5B, bottom panel). Taken 
together, these observations unexpectedly revealed that G9a and Jmjd2c are selectively co-
enriched at H3K9me2-depleted, Jmj2c-bound distal sites in ESCs, suggesting that Jmjd2c might 
counteract the H3K9 methyltransferase activity of G9a at distal, H3K4me1-enriched regions 
rather than TSS gene regions. 
 
5.2.5 Jmjd2c and G9a are co-enriched at both active and poised enhancers in ESCs  
 H3K4me1 was previously recognized as an epigenetic marker of enhancers, demarking 
both active enhancers when combined with H3K27ac, and inactive (poised) enhancers that might 
also carry the repressive H3K27me3 and/or H3K9me3 marks (Bonn et al., 2012; Creyghton et al., 
2010; Zentner et al., 2011). To determine whether H3K4me1-enriched Jmjd2c distal peaks might 
encompass enhancer regions in ESCs, H3K27ac and p300 enrichment profiles were plotted 
against Jmjd2c at distal peaks (Fig.5.5A). While H3K27ac deposition was present at these sites, 
this mark distinctly delineated two groups of Jmjd2c-bound distal regions based on high (green) 
and low or absent (blue) H3K27ac enrichment levels (Fig.5.5A; left panel). Additionally, the p300 
enzyme, which is responsible for depositing H3K27ac in ESCs, (Holmqvist and Mannervik, 2013) 
was consistently found enriched at Jmjd2c distal H3K27ac-high peaks, with lower enrichment at 
H3K27-low regions, as expected (Fig.5.5A; middle panel).  Strikingly, the vast majority (85%) of 
H3K4me1-enriched Jmjd2c distal peaks showed low or no H3K27ac enrichment (Fig.5.5A; right 
panel), suggesting that Jmjd2c might preferentially bind to poised or inactive enhancers in ESCs 
when cultured in serum conditions. The remaining Jmjd2c peaks both exhibited high levels of 
H3K4me1 and H3K27ac enrichment, reiterating that Jmjd2c is also found at active ESC-specific 
enhancers presumably in conjunction with Jmjd2b as previously reported (Das et al., 2014).  
 The enrichment of Jmjd2c, together with G9a, and known enhancer-related factors 
including Oct4, Med1 and Smc1a (Kagey et al., 2010; Whyte et al., 2013) were furthermore plotted 
against the Jmjd2c-distal H3K27-high and low groups (Fig.5.5B). Remarkably, the level of G9a co-
occupancy at distal regions clearly correlated with H3K27ac levels, with greater G9a binding 
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intensity being found at H3K27ac-high, and a reduced but still prominent enrichment detected at 
H3K27ac-low Jmjd2c sites (Fig.5.5B). A strong enrichment for Oct4 and the mediator component 
Med1 also correlated with high levels of H3K27ac at G9a and Jmjd2c co-bound sites, with a 
diminished but still noticeable binding being observed at nearly all H3K27ac-low sites (Fig5.5B). 
This suggested that G9a and Jmj2c might co-exist within protein complexes assembled at both 
active and poised enhancers in ESCs. In contrast to G9a, Oct4 and Med1, the cohesion factor Smc1 
appeared similarly enriched at both H3K27ac-high and H3K27ac-low distal regions, although 
with a broader distribution in the first group (Fig.5.5B; right panel). Further validating these 
findings, Jmjd2c and G9a co-bound regions significantly overlapped with regions substantially 
occupied by Med1, p300 and/or Smc1a as represented in Venn diagrams (Fig.5.5C). 
 Taken together, these observations reveal that nearly all H3K4me1-enriched Jmjd2c distal 
sites are co-occupied by G9a alongside the enhancer-related factors Oct4, Med1 and Smc1, which 
show enrichment levels that strictly correlate with H3K27ac intensity. This, however, excludes 
Smc1a that appears evenly enriched at both active and poised Jmjd2c-bound enhancer regions.  
 
5.2.6 Poised Jmjd2c-bound enhancers are associated with lineage-affiliated genes   
  Jmjd2c distal H3K27ac-high and low sites were next screened for known transcription 
factor binding motifs. Here, motifs for the ESC-associated nuclear receptors Esrrb and Nr5a2 
were amongst the most significantly detected at H3K27ac highly enriched peaks (top panel; 
Fig.5.5D; Table B-VI – Appendix B). Conversely, motifs for a variety of differentiation-associated 
transcription factors such as Brachyury, Gata3 and Atoh1 were prominently identified at 
H3K27ac-low peaks, which also included the motif for the pioneer enhancer-associated factor 
Oct4 (bottom panel; Fig.5.5D, Table  B-VII – Appendix B). Concordantly, GREAT gene ontology 
analysis revealed distinct biological processes associated with H3K27ac-high and H3K27ac-low 
Jmjd2c-bound regions. While H3K27ac highly enriched enhancers were mostly associated with 
genes involved in essential ESC functions (regulation of gene expression, metabolic process, 
translation) (Fig.5.5E; left panel), H3K27ac-low associated genes were predominantly involved 
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in developmental processes and differentiation pathways (germ layer formation and critical 
signalling pathways) (Fig.5.5E; right panel).   
 
Figure 5.5 Jmjd2c and G9a co-occupy active and poised enhancers in ESCs   
A. Jmjd2c distal peaks were sorted in H3K27ac-high and low with a kmeans cluster algorithm. Average 
density plots and heatmaps showing the level of enrichment for H3K27ac, p300 and H3K4me1 across a 
±5Kb window around the centre of Jmjd2c distal peaks defined as high (green) and low (blue), in serum/LIF 
conditions. B. Average density plots and heatmaps showing the level of enrichment for Jmjd2c, G9a, Oct4, 
Med1 and Smc1a across a ±5Kb window around the centre of Jmjd2c distal peaks defined high (green) and 
low (blue).  Heatmap and density plot scales were adjusted automatically to maximum intensity in each 
ChIP-seq data.  C. Distal Jmjd2c peaks were intersected with and G9a peaks and overlapped with Med1 and 
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p300, or Med1 and Smc1a. A miminum overlap interval of 1bp and maximum gap of 500 bp were used. P-
value obtained with a hypergeometric test. D. Representative motifs identified in H3K27ac-high peaks 
against low (top panel) or in H3K27ac-low peaks against high (bottom panel). E. Top 10 most significant 
biological functions of genes associated with H3K27ac-high (green) and H3K27ac-high low (blue) Jmjd2c 
peaks. 
 
5.2.7 Validation of Jmjd2c binding at candidate regions 
 Mapping of genome-wide Jmjd2c binding sites here presented revealed that Jmjd2c is not 
only recruited at H3K4me3-rich TSSs of active and bivalent genes as previously reported (Das et 
al., 2014; Pedersen et al., 2014), but also at H3K4me1-rich, active and poised enhancer regions of 
the same genes, in ESCs grown in serum/LIF conditions. To further validate these findings at the 
locus level, ChIP-qPCR analysis was next performed in ESCs expressing wild type (FV-Jmjd2c-WT) 
or a mutant (FV-Jmjd2c-ΔT) form of Jmjd2c that lacks both Tudor domains (Section 5.2.1).  For 
this, five candidate genes were selected encompassing two active genes in ESCs (Esrrb, Klf4), and 
three bivalently marked genes that are poised for future activation upon ESC differentiation (Fgf5, 
Brachyury, Foxa2).  Levels of Jmjd2c binding were examined both at the TSS of these genes as well 
as at cognate enhancer regions previously identified based on Oct4, H3K27ac and H4K4me1 
enrichment peaks in ESCs and induced epiblast-like (EpiLC) cells (Figure 5.6A) (Buecker et al., 
2014). A high and low enrichment for Jmjd2c at the selected TSS and distal regions was detected 
in the generated ChIP-seq serum/LIF dataset (Fig.A-VI.A – Appendix A). Moreover, the 
enrichment of G9a together with the enhancer factors (Med1, p300, Oct4) and histone marks 
(H3K4me1 and H3K27ac) at these candidate regions was also verified in the publicly available 
ChIP-seq profiles (Fig.A-VI.A – Appendix A).  
 Jmjd2c enrichment was quantified following anti-FLAG ChIP on chromatin extracted from 
ESC clones that were stably transfected FV-Jmjd2c-WT, the mutated FV-Jmjd2c-ΔT, or the Control 
(empty) vector used to assess background levels (Section 5.2.1). PCR quantification of the 
recovered ChIP DNA revealed indeed a significant enrichment for Jmjd2c at the TSS of active and 
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bivalent genes, which is lost upon deletion of both Jmjd2c Tudor domains as expected (Fig. 5.6B, 
left panel). Furthermore, a relatively lower but significant enrichment for Jmjd2c was detected at 
the selected active and poised enhancer regions (Fig. 5.6B; right panel). Similarly, loss of Jmjd2c 
enrichment was observed in ESCs expressing FV-Jmjd2c-ΔT at the poised enhancer regions 
analyzed, confirming H3K4-dependent Jmjd2c DNA-binding. Unexpectedly, Jmjd2c appeared to 
be recruited to active enhancers in a Tudor-independent manner (Fig. 5.6B; right panel), possibly 
through interaction with Jmjd2b (Das et al., 2014).  
 
Figure 5.6 Jmjd2c binds to TSS of active and poised enhancers in ESCs 
A. Snapshots showing the location of binding sites for Oct4 and enrichment levels for H3K27ac and 
H3K4me1 at enhancers in ESCs (2i/LIF) or in EpiLCs (Act/bFgf/KOSR), at Esrrb, Klf4, Fgf5, Brachyury/T 
and Foxa2 loci, as previously described (Buecker et al., 2014). The position of selected enhancer primer 
pairs used in B are indicated by (*). B. Jmjd2c enrichment at the TSS of the selected active and bivalent 
genes, and enhancer regions as indicated. Levels were normalized to the control (empty vector) and 
represented as average ±SEM. An intergenic (Interg) region was included to confirm background levels. 
ChIP templates used in C were produced by Tony Bou-Kheir.   
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Overall, this analysis established that Jmjd2c is bound to poised enhancers of genes whose 
expression was here found to be impaired upon induction of differentiation (Section 3.2.4; Section 
4.2.4), proposing a role for Jmjd2c in the activation of these enhancers.  
 
5.2.8 Identification of Jmjd2c protein partners  
As described above (Sections 5.2.4-5), Jmjd2c was found to co-localise with G9a alongside 
the known enhancer-associated factors p300, Oct4, Med1 and Smc1a at both active and poised 
enhancers, suggesting that Jmjd2c and G9a might be physically associated and/or be co-recruited 
at these sites within multi-protein complexes. To test whether Ga9 and Jmjd2c indeed interact 
and furthermore determine whether this interaction takes place in Med1-containing complexes, 
HA-tagged G9a was exogenously transfected in HeLa cells, and immunoprecipitated using anti-
HA antibody in both soluble and chromatin nuclear fractions extracted from control and HA-G9a 
expressing cells, in collaboration with Dr Lauriane Fritsch (Paris VII University, France) (Fritsch 
et al., 2010). Immunoblotting using antibodies raised against Jmjd2c and Med1 as well as Cdyl – 
a control molecule known to interact with G9a, identified that G9a and Med1 are physically 
associated in the chromatin fractions of HA-FLAG-tagged (HF) G9a expressing cells (Fig.5.7A). 
Similarly, Jmjd2c was found to interact with G9a as detected in both soluble and chromatin 
fractions, though a stronger signal was seen in the later (Fig.5.7A).  
Moreover, in nuclear extracts from ESC transfected with an empty vector (Control; Section 
5.2.1), by immunoprecipitation of Med1 an interaction could be identified between Med1 and 
Jmjd2c, whereas in ESCs overexpressing FV-Jmjd2c-WT (Section 5.2.1) an interaction could also 
be detected between G9a, GLP and Jmjd2c (Fig.5.7B). Furthermore, in a separate experiment 
Med1 could also be pulled-down with G9a and with GLP in nuclear extracts from ESCs (Fig.5.7C), 
therefore establishing that in ESCs, Med1 can interact with Jmjd2c and with the G9a-GLP complex. 
Surprisingly, the antagonistic molecules G9a and Jmjd2c can also interact, proposing that Med1-
Jmjd2c-G9a interaction might occur at the same complex.  
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Figure 5.7 Jmjd2c interacts with G9a-GLP and Med1 
A. HF-G9a was immunoprecipitated in in both the soluble and chromatin nuclear fractions of HeLa cells. 
Pulled proteins were visualised by western blot with antibodies for Med1, Jmjd2c and Cdyl. HeLa cells 
expressing an empty HF vector were used as control. B. Endogenous Med1, G9a and GLP were 
immunoprecipitated in nuclear extracts from ESCs expressing an empty vector (control) or the FV-Jmjd2c-
WT construct. Interactions were visualized with antibodies against Med1, Jmjd2c, G9a and GLP. C. 
Endogenous G9a and GLP were immunoprecipitated in nuclear extracts of ESCs expressing an empty vector 
and immunobloted with G9a, GLP and Med1 antibodies. Results in A and B were generated by Dr Lauriane 
Fritsch.  
 
 To further explore the composition of Jmjd2c-containing protein complexes, FLAG pull-
down was performed in two independently derived FV-Jmjd2c-WT clones (Section 5.2.1). Here, 
nuclear extracts rich in Jmjd2c, were isolated from both FV-Jmjd2c-WT and control ESC cultures 
(Fig.5.8A), and incubated with FLAG-bound sepharose beads. Bound protein complexes were 
then eluted from the beads, and the efficiency of pull-down and elution tested by anti-FLAG 
immunoblotting. This showed no residual FLAG signal in the supernatant (SN) fractions, and little 
residual signal associated with stripped beads. In contrast, a strong signal was detected in the 
In
p
u
t 
5
%
IgG G9a GLP
IP:
IB:G9a
IB:GLP
IB:Med1
Input                 IP:Control IP: HF-G9a 
soluble chromatin solube chromatin soluble chromatin
IB: Med1
IB: Jmjd2c
IB: Cdyl
A.
C.
In
p
u
t 
3
%
IgG Med1 Jmjd2c G9a GLP    
ESCControl IP:
IB: Med1
IB: Jmjd2c
IB: G9a
IB: GLP
IgG Med1 Jmjd2c G9a GLP    
ESCFV-Jmjdc-WT IP:
B.
Chapter V – Results 
174 
 
eluted fractions from FV-Jmjd2c-WT cells but not from control cells, as expected (Fig.5.8B). Eluted 
proteins were further precipitated, separated on a polyacrilamyde gel and then analysed by mass 
spectrometry in collaboration with Dr Raymond Poot (Erasmus MC, Rotterdam).  
Identified proteins with a Mascot Score higher that 40, and at least 3-fold higher in FV-
Jmjd2c-WT samples as compared to control pull-down in each of the three independent 
experiments performed were considered as positive hits (Fig.5.8C). The proteins identified in 
each experiment were overlapped, resulting in 93 proteins being identified as positive hits in at 
least two out of three experiments (Fig.5.8C). Cytoskeletal and cytoplasmic proteins were 
removed from this list, resulting in a total of 28 proteins with a nuclear location and roles 
associated with chromatin remodelling, RNA processing, cell cycle, DNA repair, mitosis and 
apoptosis (Fig.5.8D; Fig. A-VII – Appendix A). Chromatin modifier proteins identified included 
Jmjd2b - another member of the Jmjd2 histone demethylase family (Das et al., 2014), and Jmjd1a 
– a known functional H3K9me2 demethylase in ESCs (Loh et al., 2007), L3mbtl2 – a PRC1 protein 
found at H3K9me2 regions (Qin et al., 2012b), and the H3K9me2 methyltransferase GLP/Ehmt1 
(Shinkai and Tachibana, 2011) (Fig.5.8E). However, none of the enhancer-related factors Med1, 
p300, Oct4, Smc1a, could be identified with this approach, possibly due to the complexity and size 
of enhancer-promoter bound complexes. Yet, Jmjd2c pull-down could identified novel interactors 
and the biological function of these complexes in ESCs remains to be further investigated.      
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Figure 5.8 Identification of Jmjd2c binding partners by pull down and mass spectrometry 
A. Efficiency of nuclear extraction was confirmed by immunobloting nuclear (nuc) and cytoplasmic (cyto) 
extracts with antibodies against FLAG, Jmjd2c and α-tubulin. B. Elution of FLAG-bound complexes was 
validated by immunobloting the IP supernatant (SN), boiled beads (Beads), and eluted fractions (Elutions) 
with FLAG antibody. C. Overlap between positive hits identified in each of the three independent 
experiments. Mascot Score cut-off = 40; hits were considered positive if the score was 3-fold higher in FLAG 
compared to control samples. D. Function of proteins identified as positive hits in 2 out of 3 experiments 
with known nuclear locations. E. List of Jmjd2c-bound proteins with functions associated with chromatin 
remodelling and transcription. 
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V.3 Summary and Conclusions 
Altogether, the experiments herein described unveil a novel link between Jmjd2c binding and 
enhancer regions in ESCs grown in ‘priming’ culture conditions. In this chapter genome-wide 
Jmjd2c DNA-binding sites were characterized using ChIP-sequencing in ESCs cultured in naïve 
(2i/LIF) and priming (serum/LIF) conditions. As previously reported, Jmjd2c occupies 
H3K4me3-rich TSS sites encompassing both active and poised/bivalent genes (Das et al., 2014; 
Pedersen et al., 2014). Here, this association appears consistently conserved in ESCs regardless 
of culture conditions used. Remarkably, alteration of the Jmjd2c binding profile is observed in 
serum/LIF, with the acquisition of additional Jmjd2c peaks at non-TSS (distal) sites. The approach 
here utilised involved overexpression of a FLAG-tagged version of Jmjd2c in WT ESCs, which 
could have resulted in non-specific binding of Jmjd2c. However, comparison of the resulting ChIP-
seq profiles with a previously published dataset using an antibody against the endogenous 
protein in 2i/LIF conditions (Pedersen et al., 2014), revealed highly similar binding profiles 
(Fig.A-VI.B – Appendix A). This suggests that FLAG-Jmjd2c binding sites identified might indeed 
mimic the endogenous binding pattern.  
Surprisingly, distal Jmjd2c-bound regions are co-occupied by G9a as further validating by co-
immunoprecipitation analysis, and overlap with several known enhancer-associated factors such 
as p300, Oct4, Mediator/Med1 and Cohesin/Smc1a in ESCs (Kagey et al., 2010; Whyte et al., 
2013). Moreover, these regions are distinctively decorated with the enhancer-associated 
H3K4me1 and H3K27ac marks together or H3K4me1 alone, most likely representing active and 
poised regulatory enhancer regions in ESCs. Taken together, these data point to a novel and 
selective role for Jmjd2c in delineating and/or regulating poised enhancer regions associated 
with somatic, lineage-affiliated genes in ESCs as further investigating upon Jmjd2c depletion in 
the following result Chapter.  
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VI.1 Introduction 
 PRC-bound, differentiation-associated genes in ESCs harbor bivalent chromatin structures 
with inactive (H3K27me3) and active (H3K4me2/3) marks at their promoter regions, which have 
been proposed to prevent untimely gene expression while keeping these genes primed for future 
activation (or repression) upon differentiation (Azuara et al., 2006; Bernstein et al., 2006; Boyer 
et al., 2006; Lee et al., 2006b). Similarly, enhancer regions of differentiation-associated genes can 
also occur in a primed state typically harboring the active H3K4me1 mark alone, or in 
combination with repressive marks (H3K27me3, H3K9me3) (Bonn et al., 2012; Creyghton et al., 
2010; Zentner et al., 2011).  Upon differentiation, chromatin re-organization at regulatory regions 
ensures that the appropriate gene expression programs are activated, repressed or remain poised 
(Chen and Dent, 2014). In particular, acquisition of H3K9me3 marks and/or de novo DNA 
methylation at gene promoters are two mechanisms previously shown to be responsible for 
silencing inappropriate gene expression in extra-embryonic and neuronal lineages (Alder et al., 
2010; Meissner et al., 2008; Senner et al., 2012). 
 In Chapter III, a noticeable increase in the bulk level of H3K9me2, and a moderate increase 
in H3K9me3, were detected in the absence of Jmjd2c in ESCs. Furthermore, when challenged to 
differentiate, Jmjd2c-knockout (KO) ESCs and cEpiSCs showed impaired abilities to up-regulate 
the appropriate gene expression programs upon somatic differentiation. Instead, Jmjd2c-
depleted cells showed skewed differentiation abilities towards extra-embryonic endoderm-like 
phenotypes as tested upon retinoic acid induction in ESCs and under mesodermal permissive 
conditions in cEpiSCs. In Chapter IV, detailed analysis of Jmjd2c genome-wide DNA-binding sites 
showed strong  binding at the TSS of active and poised (bivalent) genes as previously reported in 
two independent studies (Das et al., 2014; Pedersen et al., 2014). This was here confirmed in both 
naïve (2i/LIF) and primed (serum/LIF) ESC states, yet additional distal peaks were readily 
detected nearby the same set of genes in “priming” culture conditions only. Moreover, further 
bioinformatics analysis of newly generated (Chapter IV) and publicly available ChIP-seq datasets 
uncovered a co-enrichment for Jmjd2c and the H3K9me2 methyltransferase G9a at enhancer 
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regions that either harbor an active (H3K4me1, H3K27ac) or a poised (H3K4me1) epigenetic 
signature. These Jmjd2c and G9a co-bound regions furthermore overlap with known enhancer-
associated factors including Oct4, p300, Med1 and Smc1a (Kagey et al., 2010; Whyte et al., 2013), 
as seen in primed (serum/LIF) ESC cultures.   
 Altogether, these observations propose a possible role for Jmjd2c in the protection of 
poised regulatory regions - promoters and/or enhancers - from acquisition of G9a-mediated 
H3K9me2 and de novo DNA methylation. To test this hypothesis, enrichment levels of H3K9me2, 
DNA methylation, G9a, and enhancer-related factors were assessed in Jmjd2c-depleted ESCs and 
cEpiSCs. Here, candidate gene loci were selected to include representative examples of epiblast 
(Fgf5), mesoderm (Brachyury) and endoderm (Foxa2) markers, who were found to be bound by 
Jmjd2c (Chapter V) and whose expression was found to be consistently impaired upon embryoid 
body formation, epiblast and/or mesodermal induction in Jmjd2c-KO pluripotent stem cells 
(Chapter III).  
 
VI.2 Results 
6.2.1 Jmjd2c-depleted ESCs do not harbour aberrant H3K9me2 and DNA methylation 
at gene regulatory regions.  
 H3K9me2 is enriched at low levels across large genomic regions, being mutually exclusive 
with H3K4me2-rich sites (Lienert et al., 2011) commonly associated with TSS but also enhancer 
regions(Chen and Dent, 2014) . To test whether, in the absence of Jmjd2, the silencing marks 
H3K9me2 and DNA methylation might be aberrantly acquired at Jmjd2c-bound TSS and enhancer 
regions upon lineage priming, H3K9me2 ChIP-qPCR analyses were performed using chromatin 
lysates extracted from both WT and Jmjd2c-KO ESCs and cEpiSCs.  Candidate locations included 
poised TSS and enhancers associated with Fgf5, Brachyury and Foxa2 loci where Jmjd2c binding 
was validated by ChiP-qPCR in FV-Jmjd2c-ESCs (Section 5.2.7). Primers amplifying control 
regions closely located to each of the three analyzed loci were additionally selected based on the 
absence of Jmjd2c binding at these sites as identified in ChIP-seq datasets. Moreover, the levels of 
Chapter VI – Results 
180 
 
H3K9me2 at Magea2 promoter region (Tachibana et al., 2002) were also used as a positive 
control. In these experiments, no increase in H3K9me2 enrichments was identified both at TSSs 
and enhancer regions of these genes in Jmjd2c-KO ESC and cEpiSCs relative to WT cells (Fig.6.1A). 
Moreover, a consistent decrease in H3K9me2 enrichment levels at these TSS and enhancer 
regions relative to their flanking regions was observed (Fig.6.1A), in agreement with mutually 
exclusive deposition of H3K4me2 and H3K9me2 marks at regulatory regions(Lienert et al., 2011). 
In contrast, H3K9me2 was substantially enriched at Magea2 TSS in all ESC and cEpiSC 
populations examined, indicative of efficient ChIP recovery (Fig.6.1A, right panel). These data 
point to a role for Jmjd2c at bound target sites independent of its histone demethylase activity.  
 Additionally, the levels of DNA methylation were examined and quantified at the same 
genomic regions using a previously described enzymatic assay (Ficz et al., 2011). Briefly, pre-
treated WT and Jmjd2c-KO cell genomic DNA was digested with either MspI or HpaII, which 
recognize the same sequence (CCGG). As a measure for total DNA amount an enzyme-free reaction 
with the same input DNA was performed in parallel.  DNA was quantified with primers 
surrounding at least one CCGG site, where the amplification of HpaII-resistant and MspI-resistant 
DNA fractions was directly proportional to methylated (5mC) plus hydroxymethylated (5hmC) 
DNA, or 5hmC alone, respectively. Hence, levels of 5mC DNA were determined by subtracting the 
MspI-resistant DNA amount from the HpaII-resistant fraction, and represented as percentage of 
total (undigested) DNA (Fig6.1B). Note that primers for both H3K9me2 ChIP and DNA 
methylation assay were designed within regions that selectively acquire DNA methylation in XEN 
cells but not in embryo-derived EpiSCs (Senner et al., 2012)(Fig.A-VIII – Appendix A) as 
confirmed in these experiments (Fig. 6.1B, bottom panel). Conversely Chrna3 promoter region 
was used as a positive control for detection of 5mC in WT and Jmjd2c-KO cEpiSCs, as well as in 
embryo-derived EpiSCs (Veillard et al., 2014) (Fig.6.1B; right panel).  
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Figure 6.1 Levels of H3K9me2 and DNA methylation at TSS and enhancers of differentiation-
associated genes are unchanged in Jmjd2c-depleted ESCs and cEpiSCs 
A. ChIP-qPCR analysis showin H3K9me2 enrichment levels at enhancer, TSS and control (Jmjd2c-free) 
regions in the gene locui of Fgf5, Brachyury/T and Foxa2, in WT and Jmjd2c-KO ESCs (blue) and WT and 
Jmjd2c-KO cEpiSCs (green). Magea2 was used as a positive control for enrichment of H3K9me2. Levels at 
each locus were normalized to the respective control regions (dotted lines), and levels of Magea2 
normalized to a TSS H3K9-depleted region (dotted lines). Data was represented as average of 3 
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independent experiments ±SEM. B. DNA methylation levels were quantified by subtracting MspI-resistant 
(5hmC) from HpaII-resistant (5hmC+5mC) fractions. Levels were normalized to a control region without a 
MspI/HpaII restriction site and represented relative to total/undigested DNA (100%). The average of 2 
experiments ± SD is plotted. Primers across all regions (enhancer and TSS) were selectively designed in 
regions known to be methylated in XEN cells (orange) (Fig.A-VIII – Appendix A), with an additional region 
(Chrna3) known to be methylated in EpiSC (purple). 
 
Similarly to H3K9me2, higher levels of 5mC were found in the flanking regions of each of the 
studied loci. 5mC levels were, however, strongly reduced (or undetectable) at the TSS and 
enhancer regions of Fgf5, Brachyury and Foxa2 (Fig.6.1B). This pattern appeared to be conserved 
between WT and Jmjd2c-KO ESC/cEpiSC populations, as also observed when additionally looking 
at 5hmC levels across the same regions (Fig.IX – Appendix A). While higher levels of 5mC were 
found at the Fgf5 poised enhancer region in Jmjd2c-KO ESC, these were lost upon EpiSC induction 
(Fig.6.1B), and thus are unlikely to account for the reduced Fgf5 expression observed in Jmjd2c-
KO cEpiSCs.  
 
6.2.2 Jmjd2c is required for the stable recruitment of G9a at active and poised 
enhancers in ESCS. 
 Mapping of genome-wide Jmjd2c DNA-binding sites in ESCs (Section 5.2.6) revealed that 
Jmjd2c is recruited at both active (H3K4me1, H3K27ac) and poised (H3K4me1) enhancer regions 
that are also co-bound by known enhancer proteins: Oct4, p300, Med1 and Smc1a. Remarkably, 
a concomitant binding of the antagonistic enzyme G9a at Jmjd2c distal/enhancer peaks was also 
identified. Nevertheless, no aberrant H3K9me2 levels were acquired at active and poised 
enhancers as well as at TSSs of associated genes in the absence of Jmjd2c. Interestingly, and in 
addition to G9a, Jmjd2c was also found to physically interact with Med1 in ESCs (Section 5.2.8), 
pointing to a functional role for Jmjd2c at enhancer regions independent of its H3K9 demethylase 
activity. To explore this further, the effect of Jmdj2c removal in the loading of enhancer protein 
complexes was here examined at both active (Esrrb, Klf4) and poised (Fgf5, T, Foxa2) enhancers 
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in ESCs, specifically looking by ChIP-qPCR at the enrichment levels of Oct4, p300, H3K27ac, Med1, 
the Cohesin factor Smc1a as well as G9a itself . A comparative analysis of Oct4, p300, H3K27ac 
and Med1 occupancies revealed higher enrichment levels at Esrrb and Klf4 as compared to Fgf5, 
T and Foxa2 enhancers, reflecting differences in the activity of these enhancers in ESCs. 
Interestingly, and as previously observed through interrogations of ChIP-seq datasets (Section 
5.2.6), the Cohesin factor (Smc1a) appeared similarly recruited at both active and poised 
enhancers. These patterns remained unchanged at both sets of regions in the absence of Jmjd2c 
in ESCs.  
 
Figure 6.2 Formation of the enhancer complexes is retained in Jmjd2c-depleted ESCs  
Enrichment levels for Oct4, p300, H3K27ac, Med1, Smc1a and G9a as assessed by ChIP-qPCR in WT and 
Jmjd2c-KO ESCs (ESCWT and ESCKO) at active (Esrrb and Klf4) and poised (Fgf5, Brachuyry/T and Foxa2) 
enhancers in ESCs. Levels at each region were normalized to an intergenic control region (dotted lines), 
where none of these factors bind to. Data was represented as average of 3 independent experiments ±SEM.  
 
G9a has been previously shown to have a widespread distribution across the genome 
(Mozzetta et al., 2014), similarly to H3K9me2 (Lienert et al., 2011). Not surprisingly, G9a ChIP 
experiments proved to be technically challenging, and required a double chromatin cross-linking 
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approach, with titration of the chromatin amount used (Methods Section 2.2.9.1) as well as ChIP 
efficiency validations. Analysis of published G9a ChIP-seq profile revealed that G9a enrichment 
specifically accumulates at regions closely located to, but not overlapping, the TSS of a defined set 
of genes (Mozzetta et al., 2014). Thus, to validate the efficiency of anti-G9a ChIP, Vstm2l and Npas4 
were selected as G9a positive control targets regions as described. Conversely, the Nnat locus, 
where G9a was barely detected, was used as negative control genes (Mozzetta et al., 2014). 
Accordingly, G9a was found highly enriched at Vstm2l and Npas4 and virtually absent at Nnat TSS 
regions in WT ESCs (Fig.A-X – Appendix A). Similarly, high G9a enrichment levels were detected 
at active enhancers in WT ESCs (Fig.6.2). G9a detection at poised enhancers was only marginal in 
these experiments. In contrast, in the absence of Jmjd2c, G9a binding appeared consistently 
reduced at Esrrb, Klf4, Fgf5 and T enhancers, which were all demonstrated to be bound by Jmjd2c 
in ESCs (Section 5.2.7). These data indicate that Jmjd2c might be required for the stable 
recruitment of G9a at these sites in ESCs. 
 
6.2.3 Jmjd2c facilitates the assembly of protein complexes at poised enhancers upon 
ESC-to-EpiSC transition. 
 In WT cEpiSCs, Fgf5 was highly expressed relative to Brachyury and Foxa2, which only show 
low and very low gene expression, respectively (Section 4.2.3). In contrast, Fgf5 mRNA levels 
were found to be reduced, and Brachyury and Foxa2 undetectable in Jmjd2c-KO cEpiSCs. 
Regardless of transcriptional output, however, all enhancer regions analysed here were similarly 
occupied by the pioneer factor Oct4 in WT and KO cEpiSCs (Fig. 6.3; upper panel), indicative of 
active chromatin remodelling at these sites during ESC to EpiSC conversion. Indeed, during this 
transition, Oct4 binding was shown to undergo global re-distribution with increased loading at 
previously bound (poised) enhancers in ESCs, but also at newly defined enhancer regions in 
EpiLCs associated with expression of post-implantation epiblast markers (Buecker et al., 2014). 
Hence, these results also suggest that EpiSC-specific enhancer regions can be specified in the 
absence of Jmj2dc as further indicated by high H3K27ac and p300 enrichment levels, despite 
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lessened levels of p300 being detected at the Fgf5 locus in Jmjd2c-KO cEpiSCs (Fig. 6.3; upper 
panel).  In contrast, G9a and Med1 both failed to be properly recruited at Fgf5 and Brachyury 
enhancers during ESC-to-EpiSC conversion as evidenced by G9a and Med1 enrichment levels 
close to background in Jmjd2c-KO as opposed to WT cEpiSCs, despite no changes being observed 
in the levels of this proteins (Fig.A-X – Appendix A). This corroborates with the impaired 
expression of these genes in the absence of Jmjd2c (Section 3.2.4; Section 4.2.4). Collectively, 
these data show that Jmjd2c is required for the proper assembly of enhancer protein complexes 
as seen at active (Fgf5) and poised (Brachury and Foxa2) enhancers during pluripotency 
maturation towards a primed, post-implantation EpiSC state. 
 
Figure 6.3 Assembly of enhancer complexes is destabilized in the absence of Jmjd2c in cEpiSC 
Enrichment levels for Oct4, p300, Med1 and G9a as assessed by ChIP-qPCR in WT and Jmjd2c-KO cEpiSCs 
(cEpiSCWT and cEpiSCKO) at active (Fgf5) and poised (Brachuyry/T and Foxa2) enhancers in EpiSCs. Levels 
at each region were normalized to an intergenic control region (dotted lines), where none of these factors 
bind to. Data was represented as average of 3 independent experiments ±SEM. P<0.5(*), Mann-Whitney U 
test. 
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 To further strengthen this conclusion, detailed analyses across the Fgf5 locus was 
performed by assessing the recruitment of enhancer-associated factors at the poised enhancer 
constituent (PE) and two downstream EpiSC-specific sites (E1 and E3) as identified through Oct4, 
H3K27ac and H3K4me1 profiling in ESCs and EpiLCs (Fig.6.4A)(Buecker et al., 2014).  
 
Figure 6.4 Recruitment of enhancer factors at EpiSC enhancers is impaired in the absence of Jmjd2c 
A. Location of poised (PE) and EpiSC-specific enhancers (E1-4) acquired at the Fgf5 locus upon transition 
of ESC (2i/LIF) to a primed EpiLC (Act/Fgf/KOSR) state as previously defined on the basis of Oct4, H3K27ac 
and H3K4me1 ChIP-seq profiles (Buecker et al., 2014). B. Enrichment levels for Oct4, p300, Med1, Smc1a 
and G9a at PE, E1 and E3 Fgf5 enhancer contituents as determined by ChIP-qPCR in WT and Jmjd2c-KO 
cEpiSCs (cEpiSCWT and cEpiSCKO). Levels at each region were normalized to an intergenic control region 
(dotted lines), where none of these factors bind to. Data was represented as average of 3 independent 
experiments ±SEM. P<0.05 (*), Mann-Whitney U test.  
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In agreement with the data presented above, all three Fgf5 enhancer constituents showed 
evidence of epigenetic programming as indicated by equally high enrichment levels for Oct4, 
p300 and also H3K27ac deposition in WT and Jmjd2c-KO cEpiSCs (Fig. 6.4B; upper panel). These 
sites were furthermore confirmed as genomic targets for the enhancer and DNA looping factors 
Med1 and Smc1a, as well as G9a, in the presence of Jmjd2c. Yet Med1, Smc1a and G9a binding was 
consistently abrogated at both poised and newly defined EpiSC-specific enhancer constituents in 
the absence Jmjd2c (Fig. 6.4; bottom panel). 
 
 Collectively, these data uncover an important role for Jmjd2c in recruiting and/or 
facilitating the assembly of selective enhancer protein components as demonstrated for Med1, 
Smc1a and G9a but not for Oct4 and p300.  
     
VI.3 Summary and Conclusions 
In summary, the results described in this Chapter unveil a novel function for Jmjd2c in the 
recruitment and/or stable assembly of enhancer protein complexes upon lineage priming in 
pluripotent stem cells. Depletion of Jmjd2c was found to result in impaired gene activation upon 
differentiation into epiblast-derived lineages (Chapters III, IV). The strong binding of Jmjd2c at 
TSS regions, its concomitant detection with G9a at enhancer regions (Chapter V), together with 
the identified increase in bulk levels of H3K9me2 (Chapter III), pointed to a possible role for 
Jmjd2c in regulating and/or protecting TSS and enhancer sites against H3K9 methylation via its 
histone demethylase activity.  
Here, aberrant acquisition of H3K9me2 (and de novo DNA methylation) at regulatory regions 
of poised (bivalent) genes in ESCs, in the absence of Jmjd2c, was hypothesised as a silencing 
mechanism underlying the identified defective expression upon differentiation. However, no 
increase in H3K9me2 deposition and DNA methylation was detected at the candidate loci studied 
both in Jmjd2c-knockout ESC and cEpiSC. Instead, defective loading of the enhancer and DNA-
looping factors Med1 and Cohesin/Smc1a was selectively identified upon the transition from a 
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ESC state to a primed, post-implantation EpiSC-like state, as seen at the epiblast Fgf5 and 
differentiation-associated gene loci Brachyury and Foxa2 whose expression was found 
compromised in Jmjd2c-KO cEpiSC (Chapter IV).  
Interestingly, the recruitment of the pioneer enhancer factor Oct4, and acquisition of 
H3K27ac/p300 – markers of active enhancers, were, in contrast, not impaired, suggesting that 
rather than the de novo establishment of enhancers per se, the assembly of the Mediator-Cohesin 
complex involved in looping events between enhancers and promoters (Kagey et al., 2010), might 
require the action of Jmjd2c. Furthermore, co-binding of Jmdj2c and G9a was identified at Med1-
enriched regions, and these three proteins were furthermore found to physically interact in ESCs 
(Chapter V), suggesting that Jmj2dc-G9a interaction could take place in activating, Med1-enriched 
enhancer complexes. In line with this, in the absence of Jmjd2c, loading of G9a was also impaired 
at both active and poised enhancer regions as seen in ESCs and cEpiSCs. Altogether, these 
observations suggest that, rather than counteracting the deposition of G9a-mediated H3K9 
methyaltion, Jmjd2c-G9a interaction at enhancers could instead be an essential feature of Med1 
and Cohesin-mediated enhancer activity and DNA looping. 
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VII.1 Discussion 
In this project, the role of Jmjd2c in embryonic stem cell (ESC) biology was explored using a 
Jmjd2c-knockout (KO) ESC model system. Depletion of Jmjd2c in the ESC state correlated with 
overall lessened expression of pluripotency markers. However, this was insufficient to impair ESC 
self-renewal capacity. Concordant with Jmjd2c previously reported H3K9-demethylase activity, 
Jmjd2c-KO ESCs harboured higher H3K9me2/3 bulk levels relative to wild-type (WT) cells. 
Interestingly, when challenged to differentiate upon embryoid body formation, Jmjd2c-depleted 
ESCs displayed impaired up-regulation of lineage-affiliated markers, and this seemingly resulted 
into a blockage at an epiblast-like stage of differentiation. Although Jmjd2c-KO ESCs could 
successfully generate self-renewing cEpiSCs, these epiblast cells, however, expressed reduced 
levels of Fgf5 and failed to show any evidence of transcriptional priming for germ layer markers, 
as typically expected in primed pluripotent stem cells (Han et al., 2010). In contrast, 
differentiation into extra-embryonic endoderm was uncompromised and, furthermore emerged 
as a default pathway upon mesodermal induction in mutant cEpiSCs.  
Dissection of the molecular mechanism underlying this phenotype uncovered a role for 
Jmjd2c in the transcriptional regulation of somatic, lineage-associated genes together with G9a. 
This action was found be independent of Jmjd2c H3K9-demethtylase activity but rather through 
the stabilization of activating protein complexes at poised and EpiSC-specific enhancer regions 
upon ESC differentiation.  
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Figure 7.1 Summary of Jmjd2c-knockout ESCs phenotype 
A. Schematic representation of early mouse embryonic development between pre-implantation (E.3.5-4.5) 
and post-implantation stages (E5.5), with highlighted key early embryonic and extra-embryonic lineage 
populations emerging at these stages: inner cell mass (ICM), Trophectoderm (TE), primitive endoderm 
(PrE), epiblast (Epi), visceral endoderm (VE), parietal endoderm (PE),  extra-embryonic ectoderm (ExE) 
and ectoplacental cone (EPC). B. Summary representation of the different outcomes observed upon 
differentiation induction in Jmjd2c-knockout pluripotent stem cells.  
 
7.1.1 Targeting of Jmjd2c in embryonic stem cells  
Over decades the mouse has been exploited as a key model organism for the study of 
mammalian gene function and development. The isolation and propagation of pluripotent mouse 
ESCs has since provided a platform for in vitro study of molecular events occurring in the early 
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embryo. This has also laid the foundations for large-scale gene engineering, where virtually any 
gene function can be interrogated by targeted mutagenesis. The wide range of targeted mutations 
generated in ESCs by the EUCOMM/IKMC programs represents, up to now, the largest effort in 
providing tools for the scientific community to decipher gene function (Skarnes et al., 2011). 
Hence, for the purpose of this work, genetically engineered Jmjd2c-knockout mouse ESCs 
obtained from the EUCOMM repository were used as a primary tool to uncover the role of Jmjd2c 
in ESC self-renewal state and beyond. Previous efforts to investigate the function of Jmjd2c in 
ESCs via transient RNAi approaches reported that knockdown of Jmjd2c mRNA leads to 
spontaneous differentiation, with concomitant repression of the ESC-specific gene network and 
de-repression of PRC2-bound differentiation markers, highlighting this as an essential marker of 
ESC identity (Das et al., 2014; Loh et al., 2007) . In striking contrast, ESCs stably depleted in Jmjd2c 
protein in this study maintain efficient self-renewal ability in culture, grow normally and express 
variable but high levels of pluripotency markers (Section 3.2.2). A concordant study using a 
conditional Jmjd2c-null ESC line generated from the same original EUCOMM cell line, similarly 
reported that these cells retain normal growth rate upon Jmjd2c depletion and maintain high 
expression levels of the pluripotency markers Oct4, Sox2 and Nanog (Pedersen et al., 2014). 
In RNAi systems, reagents such as shRNA or siRNAs are designed to target mRNA transcripts 
and are delivered to cells (Mohr et al., 2014), carrying a drug-resistant gene commonly used to 
select for successful transfection. This process ultimately relies on the specificity on the target 
sequence and efficiency of gene delivery. Here, gene trapping technology provided a stable and 
drug-free alternative system to interrogate the function of Jmjd2c in an in vitro embryo-derived 
ESC model. Although the gene trap system permitted some level of residual expression of Jmjd2c 
transcript, an occurrence previously found in genetrap systems (Pedersen et al., 2014; White et 
al., 2013), this appeared to robustly abolish expression of a full-length Jmjd2c protein (Fig.3.1). 
Moreover, a putative truncated Jmjd2c protein arising as a result of the inserted cassettes would 
lack both Jmjd2c PHD and Tudor domains and its nuclear localization signal leading to altered 
cellular location as experimentally demonstrated by combining mutagenesis and staining in 
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previous studies where Jmjd2c N-terminal domains were selectively deleted (Pedersen et al., 
2014; Shin and Janknecht, 2007). Overall, the gene trap approach utilised to target Jmjd2c was 
validated and successfully generated a stable and robust knockout ESC model.  
 
7.1.2 Possible redundancy between histone demethylases in embryonic stem cells 
and in vivo 
The striking differences between the phenotype identified upon transient knockdown of 
Jmjd2c with shRNA vectors and in stable Jmjd2c-KO ESC lines used in this work, motivated a re-
assessment of the state of ESCs upon shRNA knockdown. Thus, using Jmjd2c shRNA vectors 
previously validated and reported by Loh and colleagues (Loh et al., 2007), careful interrogation 
of the phenotype of these cells revealed that despite prominent spontaneous differentiation, 
alkaline phosphatase positive (undifferentiated) colonies with compact morphology could be 
readily identified in culture up to 4 days post-transfection and selection. Upon manual isolation 
and expansion of these colonies, a significant down-regulation of Jmjd2c transcript could be 
validated with concomitant maintenance of normal ESC self-renewal abilities (Fig.3.8). Notably, 
shRNA depleted ESCs displayed reduced expression of the pluripotency factors Nanog, Esrrb and 
Tbx3, concomitant with modest down-regulation of Jmjd2b (Fig.3.8D). Indeed, Jmjd2b was found 
to cooperate with Nanog in an interconnected regulatory loop, influencing the expression of 
Nanog’s downstream targets such as Klf4, Esrrb and Tbx3. Moreover, the same study uncovered 
that both Jmjd2b and Jmjd2c co-occupy TSS regions of active genes, with Jmjd2b being also found 
at active ESC-specific enhancers (Das et al., 2014). In this work, Jmjd2c was also detected at a 
subset of distal regulatory regions that encompassed active (H3K4me1/H3K27ac-rich) 
enhancers in ESCs (Fig.5.4). Thus, it is possible that in active TSS and enhancers, Jmjd2c and 
Jmjd2b cooperate in a redundant manner to maintain the tight regulation of gene expression of 
self-renewal genes.  
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Concordantly, experimental evidence generated in this study suggested that Jmjd2c might in 
fact form a complex with the H3K9me2/3-demethylases such as Jmjd2b and Jmjd1a (Fig.5.9), 
further supporting that these could be able to cooperate and/or compensate for loss of function.    
Further evidence for redundancy comes from the discrepancy of results in regards to the 
impact of depleting Jmjd2c in target histone modifications. One study documented an increase in 
H3K9me3, but not H3K9me2 bulk levels upon transient shRNA-mediated depletion of Jmjd2c in 
ESCs (Loh et al., 2007), whereas another study using a similar RNAi approach reported no obvious 
changes in global histone modifications (Das et al., 2014). Similarly, in constitutive Jmjd2c-null 
ESCs described by Pedersen and colleagues, no change in H3K9me2/3 levels were identified 
(Pedersen et al., 2014). Moreover, in this project, an initial titration of acid-extracted histone 
lysates and antibody dilutions was performed, allowing the detection of an increase in bulk levels 
of H3K9me2, with a modest increase in H3K9me3, in constitutive Jmjd2c-KO ESCs (Fig.3.4). Thus, 
it remains to be elucidated whether different levels of redundancy, or limitations on the detection 
of small changes of these histone modification due to antibody specificity and/or saturation of 
the detection method, explain the discrepancy of published results.  
 
7.1.3 An essential role for Jmjd2c at the onset of embryonic stem cell differentiation  
A key finding in this project was the identification of a requirement for Jmjd2c in epibast-
derived lineage differentiation upon formation of embryoid bodies (EBs); a functional assay 
commonly used to investigate the developmental potential of ESCs in vitro (Fig.3.6; Fig.3.9). In 
this procedure, ESCs are cultured in suspension and in the absence of LIF to allow the generation 
of three-dimensional cellular aggregates that progress to form cystic structures comprising a 
mixture of differentiated cells from the three embryonic germ layers. Although heterogeneous, 
this system is able to recapitulate the early differentiation events occurring in early embryo.       
When challenged to form EBs, Jmjd2c-depleted ESCs were unable to efficiently express the 
differentiation-associated markers tested from each of the three germ layers (mesoderm, 
endoderm and ectoderm), and concomitantly showed a reduced size of formed EBs as compared 
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to WT cells (Fig.3.6). Importantly, in both depletion systems tested (knockout and knockdown), 
weak but detectable expression levels of the early epiblast marker Fgf5 were aberrantly retained 
in later differentiation time-points, similarly to Oct4 (Fig.3.6; Fig.3.9). This suggested that 
differentiation of Jmjd2c-depleted ESCs could be impaired and possibly stalled in vitro at an early 
post-implantation equivalent epiblast-like stage of the mouse embryo. This was further 
supported by an impaired induction of neuronal progenitors in Jmjd2c-KO ESCs (Fig.3.8), in which 
the poor survival rate observed beyond the transiently reached epiblast-like state in normal 
differentiation pathway revealed that, under specific permissive conditions (Ying et al., 2003b), 
ESCs could not efficiently progress and acquire a neuronal–like phenotype.  
In contrast, converted EpiSC populations could nevertheless be derived from Jmjd2c-KO ESCs 
upon provision of activin and fibroblast growth factor (Guo et al., 2009). Yet these cells strikingly 
proved unable to differentiate towards somatic lineages, as assessed in this study upon 
mesodermal induction (Fig.4.4). This confirmed that the observed differentiation defect in 
mutant cells arises from the emerging epiblast-like progenitors, as further revealed upon lack of 
lineage priming. Despite the ability of Jmjd2c-KO converted EpiSCs to be maintained in prolonged 
culture, these cells exhibited key phenotypic differences with their WT counterparts, suggestive 
of an underlying defect in transcriptional regulation. Indeed, these cells expressed diminished 
levels of Fgf5, and also displayed no primed expression of mesoderm (Brachyury) or endoderm 
(Foxa2) markers, as seen in WT cEpiSC (Fig.4.3). The absence of transcriptional gene priming for 
germ layer markers suggested that Jmjd2c-depleted cEpiSCs might have adopted an immature 
phenotype, failing to progress further as also evidenced by the lack of spontaneous differentiation 
typically occurring at the edge of WT EpiSC colonies. The existence of distinct EpiSCs have indeed 
been proposed based on the preferential use of distal (ESC-specific) versus proximal (EpiSC-
specific) enhancers to drive Oct4 expression, concomitant with differential gene expression and 
developmental potency (Han et al., 2010). In this published report, gene expression profiling of 
high Oct4-GFP expressing EpiSCs was found to correlate with E5.5 embryos, and hence with an 
early (immature) stage of epiblast maturation, whereas profile of low or negative Oct4-GFP 
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EpiSCs resembled that of late-stage epiblast cells on the verge of differentiation. Moreover, early 
epiblast-like Oct4-high populations consistently express lower levels of Fgf5 and Brachyury 
markers (Han et al., 2010). Based on these observations, it is proposed that Jmjd2c-KO cEpiSCs 
most likely represent a homogeneous, early epiblast stage.   
 
7.1.4 Jmjd2c is expendable for the acquisition of extra-embryonic endoderm-like 
identity  
The formation of the mouse blastocyst coincides with the first cell fate decisions to take 
place: the emergence of the pluripotent ICM and extra-embryonic trophoectoderm lineages. 
Around the time of implantation, the ICM further segregates into the extra-embryonic primitive 
endoderm (PrE) and the epiblast that will give rise to the embryo proper (Zernicka-Goetz et al., 
2009). ESCs are derived from the pluripotent ICM of pre-implantation blastocysts, and in self-
renewing culture conditions displayed some level of transcriptional priming for PrE markers 
(Artus et al., 2010; Canham et al., 2010; Capo-Chichi et al., 2005; Niakan et al., 2010), indicating 
that these cells retain the potential to differentiate towards extra-embryonic cells. Accordingly, 
conditions that allow the generation of extra-embryonic endoderm (XEN) stem cell populations 
from ESCs without gene manipulation have now been defined (Niakan et al., 2013).  
In striking contrast with the outcome of EB induction experiments, Jmjd2c-KO ESCs could 
readily up-regulate the expression of PrE markers when treated with atRA in the absence of LIF, 
with faster kinetics of induction as seen for Gata6, Gata4 and Dab2 relative to WT cells (Fig.4.1.). 
Moreover, converted Jmjd2c-null XEN cells could be successfully generated, expressing XEN 
markers to similar levels than converted WT and embryo-derived XEN cells (Fig.4.2). These 
experiments suggested that Jmjd2c might be dispensable for the formation of extra-embryonic 
lineages, as further supported by the reduced or absence of Jmjd2c expression in embryo-derived 
XEN (Fig.4.2) and trophoblast stem cells (TS) cells (Alder et al., 2010), respectively. Hence, 
Jmjd2c-KO ESCs could similarly be expected to convert into TS-like cells (Ng et al., 2008), though 
this hypothesis remains to be tested.  
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Experiments described in this study further indicated that differentiation in Jmjd2c-KO 
pluripotent stem cells might be skewed towards extra-embryonic endoderm-like phenotypes. 
Here, Jmjd2c-KO cEpiSCs were induced to differentiate into early mesodermal progenitors by 
treatment with BMP4, Fgf4 and a Pi3K inhibitor in chemically defined media. At this stage, 
expression of Brachyury was found to be impaired in the absence of Jmjd2c as previously found 
upon EB-induced ESC differentiation. Moreover, following subsequent treatment with either, 
BMP4 and Fgf2, for lateral plate mesoderm induction, or with BMP4 and Pi3K inhibitors, Fgf2 and 
Wnt3a, for paraxial mesoderm induction (Fig.7.2), Jmjd2c-depleted cells consistently acquired a 
pronounced extra-embryonic endoderm-like identity, with only a small proportion of cells 
gaining expression of mesoderm markers and correct morphology (Fig.4.4). The extra-embryonic 
phenotype was identified by the polarized epithelial-like appearance with concomitant 
expression of visceral/parietal endoderm markers Lrp2 and Sparc, similarly to BMP4-treated 
XEN cells (Fig.4.5).  
Indeed, BMP4 treatment of XEN cells has been found to induce a VE identity (Artus et al., 
2012; Paca et al., 2012; Soares et al., 2008) concordant with a role established for this signalling 
molecule in the regulation of anterior VE (Soares et al., 2008) and in proper development of extra-
embryonic lineages in the early embryo (Graham et al., 2014). Furthermore, BMP4 treatment of 
embryo-derived EpiSCs has been shown to promote expression of PrE and trophectoderm 
markers (Brons et al., 2007; Vallier et al., 2009b) (Fig.7.1). Mesoderm differentiation of Jmjd2c-
KO cEpiSCs was here induced by an initial treatment with BMP4 and selectively displayed a 
skewed differentiation into an extra-embryonic endoderm rather than a trophoblast fate 
indicated by the absence of Cdx2 expression in day 4 differentiated cells (not shown). 
Interestingly while a low proportion of cells acquired expression of Cxcr4 under mesodermal 
induction, marking the emergence of definitive endoderm-like cells, this occurred similarly in WT 
and Jmjd2c-KO cultures. Thus, these results suggest that absence of Jmjd2c could compromise the 
expression of somatic differentiation-associated factors, favouring the emergence extra-
embryonic endoderm-like cells as a major default pathway. Of note, this same default pathway 
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was not seemingly occurring upon neuronal induction of Jmjd2c-KO ESCs (Fig.3.7), possibly due 
to the lack of permissiveness growth factors in the culture conditions used in this assay. Overall, 
this highlights key differences in the transcriptional regulation mechanisms in embryonic versus 
extra-embryonic lineages, which remain largely unexplored.  
 
 
Figure 7.2  Signalling Pathways involved in differentiation of hESCs and mEpiSCs 
Schematic representation of conditions used for in vitro differentiation of human embryonic stem cells 
(hESCs) and mouse Epiblast stem cells (mEpiSCs) into the indicated lineages (Bernardo et al., 2009; Vallier 
et al., 2009b). 
 
7.1.5 Exploring a role for Jmjd2c in early cell fate decisions 
The identification of a default extra-embryonic identity upon ineffective differentiation of 
Jmjd2c-depleted cells raised the question of whether the presence of Jmdj2c could be an essential 
factor in early cell fate decisions in the developing blastocyst. To explore this further, hanging-
drop EBs (HD-EBs) were generated as an in vitro model to specifically study the impact of Jmjd2c 
depletion on the segregation of the epiblast and PrE lineages. Here, generation of HD-EBs from 
Jmjd2c-KO ESCs was hypothesised to favour the formation of a PrE-like outer layer. However, and 
despite enhanced expression of PrE transcripts as assessed by RT-qPCR (Fig.4.6B), when staining 
whole EBs against Oct4 and Gata4 no proper segregated outer layer could be identified in Jmjd2c-
KO HD-EBs in these experiments (Fig.6.C). Staining agarose-embedded sectioned EBs could have, 
however, greatly improved the resolution of this confocal analysis and hence the readout of these 
experiments as previously described (Lavial et al., 2012). As an alternative approach, Jmjd2c-KO 
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and WT ESCs were labelled and co-cultured in suspension to induced the formation of chimeric 
HD-EBs, and cell allocation between outer versus inner layers investigated by 
immunofluorescence (Fig.4.7). Nevertheless, distribution of Jmjd2c-KO cells across the HD-EB did 
not show any preferential cell allocation bias into the PrE outer layer. Interestingly and 
concordantly with these preliminary analyses, in vivo expression data previously generated from 
single blastomeres harvested from E3.5 and E4.5 embryos revealed that indeed Jmjd2c transcript 
is expressed at variable levels being found in both PrE and epiblast blastomeres. However, 
consistently high levels of Jmjd2c correlated with E4.5 Epiblast blastomeres, the stage where 
expression of ICM/PrE factors such as Nanog/Gata6, respectively, is clearly segregated (Ohnishi 
2014) (Fig.7.3).  
 
Figure 7.3 Single-cell in vivo expression in dissected ICMs of E3.5 and E4.5 mouse embryos 
Single-cell expression analysis from single blastomeres harvested from the ICM of E3.5 and E4.5. Each dot 
in scatter plots represents mRNA levels detected in individual blastomere. The prospective blastomere 
identity, as depicted in the schematic representation of E3.5 and E4.5 embryos, was assigned based on the 
expression of the PrE Gata4 marker as previously reported. Data from (Ohnishi et al., 2014).  
 
Ultimately, the most stringent approach to uncover if presence of Jmjd2c would indeed 
impact on cell allocation would be by injecting labelled Jmjd2c-KO ESCs into morula embryos and 
subsequently implant these embryos into foster female host to examine the preferential 
distribution into extra-embryonic versus embryonic lineages of depleted cells at later embryonic 
stages. Nevertheless, Jmjd2c-null mice have been previously generated from inter-crossed 
heterozygous mice and were reported to be viable and fertile (Pedersen et al., 2014; White et al., 
2013). Thus, abolishment of Jmjd2c function in whole-organism context does not appear to 
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impact on early embryo development as judged by the lack of gross phenotype in born mice, 
despite these studies lacking careful dissection of early development in Jmjd2c-null embryos. The 
evidence described in this project proposes a role for Jmjd2c as scaffolding molecule facilitating 
gene activation upon exit of the pluripotent state, as further discussed below. Hence, it is possible 
that functional redundancy takes place with other demethylases during embryo development in 
order to robustly sustain the expression of essential genes. Notably, cell competition has been 
described as a mechanism of elimination of “unfit” or “defective” cells during the post-
implantation epiblast formation (Sancho et al., 2013). Thus, it still remains to be elucidated 
whether instead single-cell Jmjd2c depletion in an in vivo competitive environment would indeed 
impact on Epi/PrE allocation, or whether redundancy would also allow normal differentiation 
and development of injected mutant cells.  
 
7.1.6 Genome-wide re-distribution of Jmjd2c between naïve and priming conditions 
Comprehensive analysis of the pluripotent abilities of Jmjd2c-KO ESCs revealed inefficient 
lineage-associated gene activation upon induced differentiation, proposing a role for Jmjd2c in 
transcriptional regulation of poised genes. Previous reports described a predominant occupancy 
of Jmjd2c at H3K4me3-rich TSS sites of both poised and active genes in ESCs cultured under naïve 
(2i/LIF) condition (Pedersen et al., 2014) or priming (serum/LIF) conditions (Das et al., 2014). 
In priming conditions a larger number of non-TSS binding sites was also identified, though the 
function of Jmjd2c at these sites and its possible link with the acquisition of transcriptional gene 
primed remained to be fully investigated. 
Therefore, Jmjd2c genome-wide binding sites were here directly compared in naïve and 
priming conditions using the same experimental setting, as well as upon induction of an epiblast-
like (EpiLC) state (Buecker et al., 2014). It was hypothesised that upon lineage priming, Jmjd2c 
might be re-distributed into distal sites, possibly overlapping with EpiLC-specific enhancer 
regions. These sites indeed become dynamically targeted by the pioneer factor Oct4 at the exit of 
the pluripotent ground state, and this re-distribution of Oct4 binding is associated with co-
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occupancy with the epiblast transcription factor Otx2 and acquisition of enhancer activity 
(Buecker et al., 2014; Yang et al., 2014). In this study, higher numbers of additional peaks were 
identified in priming (serum/LIF) ESC conditions as compared to the ESC ground-state also 
referred as naïve (2i/LIF) conditions (Fig.5.3B). Analysis of peak location revealed that nearly 
13,500 TSS sites were similarly bound by Jmjd2c in both culture conditions, and that major re-
distribution of Jmjd2c binding occurred at distal sites in serum/LIF conditions only (Fig.5.3). This 
was also accompanied by higher Jmjd2c protein expression being detected in priming conditions 
(Fig.5.2).  
Induction of the EpiLC state did not, however, result into any significant genome-wide re-
distribution of Jmjd2c binding as seen in serum/LIF conditions. Although the activation of 
epiblast markers was confirmed following 48h post-induction, this short time window may have 
not been sufficient for the acquisition of an homogenous EpiLC state in induced cultures and 
hence re-location of Jmjd2c binding sites in the ESC line and genetic background used in this 
study. Alternatively, the acquisition of distal binding sites could solely depend on intrinsic factors 
present in serum/LIF conditions.  
Hence, Jmjd2c binding sites in efficiently induced EpiLC populations or embryo-derived 
EpiSCs still remains to be identified to fully elucidate the extent of Jmjd2c re-distribution to distal 
sites. Due to the lack of commercially available ChIP-grade antibodies raised against Jmjd2c, 
FLAG-tagged Jmjd2c expressing stable cEpiSCs would be best used for this purpose (Fig.5.2). This 
system, however, implies enforced expression of Jmjd2c, which may impact on the generation of 
self-renewing cEpiSCs as lower endogenous Jmjd2c expression levels are detected in EpiSCs 
relative to ESCs (Fig.4.3). In a preliminary attempt to generate stable cEpiSCs expressing FV-
Jmjd2c construct consistently proved difficult, as the cells failed to acquire a proper EpiSC 
morphology instead displaying high incidence of cell differentiation. Alternatively, tagging of 
endogenous Jmjd2c with the recently developed CRISPR/Cas9 technology (Mali et al., 2013; Ratz 
et al., 2015) would overcome this effect and allow the generation of stable cEpiSC populations, in 
order to map Jmjd2c binding sites in an unbiased manner.  
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7.1.7 Jmjd2c associates with all H3K4 methylation states at TSS and distal genomic 
sites  
Interestingly, the re-distribution of Jmjd2c in priming serum/LIF conditions selectively 
occurred at H3K4me1/me2-rich distal sites, in addition to H3K4me3-rich TSS sites. Concordantly, 
Jmjd2c has been proposed to recognise H3K4me3 and H3K4me2 via its Tudor domains, although 
a link with H3K4me1 had not been previously recognized (Pedersen et al., 2014). Moreover, a 
small proportion of distal sites were also highly co-enriched with H3K27ac, defining two distinct 
groups of Jmjd2c-distal peaks encompassing active (H3K27ac-high) enhancers, and poised 
(H3K27-ac low) enhancers (Fig.5.5). In line with this observation, Jmjd2c was recently identified 
in pull-down of histone modifications H3K4me3 and H3K4me1, and to a lesser extent H3K27ac 
in serum/LIF ESCs (Engelen et al., 2015). ChIP-qPCR at known active and poised enhancers 
furthermore unveiled that, although Jmjd2c binding could be confirmed at both sets of enhancers, 
recruitment at active enhancers appeared to occur independently of its Tudor domains (Fig.5.6). 
Thus, these observations extend the previously characterized link between Jmjd2c recruitment 
and H3K4me3 recognition, to all H3K4 methylation states (Fig.7.4), and furthermore proposed 
that Jmjd2c might be recruited through distinct mechanisms at poised and active enhancers in 
serum/LIF conditions. 
 
Figure 7.4 Jmjd2c associates with all H3K4-methylation states 
Representative snapshot of Jmjd2c binding at H3K4me3/2/1-rich locations in a region spanning 100Kb of 
the Hoxa-cluster loci at chromosome 6, in serum/LIF conditions. 
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Epigenetic programming of enhancers is an important component of gene regulation during 
development. The pre-marking of enhancers by H3K4me1 and H3K4me2 has been proposed to 
facilitate the binding of pioneer transcription factors and hence, stimulate the establishment of 
an open chromatin environment (Zaret and Carroll, 2011). Thus, synergistic action of chromatin 
modifications and pioneer factor binding are likely to have a key role in the establishment of 
permissive conditions for transcription. Profiling of the epigenetic landscape of ground-state 
(2i/LIF) ESC cultures revealed reduced transcriptional gene priming as indicated by lower 
transcript levels of differentiation-associated genes and reduced enrichment for H3K27me3 at 
gene promoters, hence resulting into less bivalent chromatin domains being detected (Marks et 
al., 2012), a chromatin structure that was previously associated with poised gene expression in 
serum/LIF ESCs (Azuara et al., 2006; Bernstein et al., 2006; Boyer et al., 2006; Lee et al., 2006b) . 
Thus, it is reasonable to envisage that in naïve conditions the pre-marking of enhancers by 
H3K4me1 and H3K4me2 could also be reduced. Altogether, the re-distribution of Jmjd2c between 
naïve and primed states could mimic the distribution of H3K4-methylation states, being 
prominently bound to H3K4me3-rich TSS in naïve conditions and further re-distributed to 
H3K4me1/2-rich distal sites upon enhancer pre-marking in the serum/LIF ESC state.     
 
7.1.8 Jmjd2c and G9a are co-enriched at both active and poised enhancers in ESCs 
Remarkably, the majority of Jmjd2c distal sites detected were associated with epigenetic 
signature typical of poised (H3K27ac-low) enhancers. These H3K27ac-low peaks were similarly 
co-occupied by reduced levels of Med1, Cohesin and Oct4, as compared to H3K27ac-high peaks. 
Moreover, H3K27ac-low, Jmjd2c-bound regions encompassed a great variety of sequence motifs 
significantly associated with differentiation-affiliated transcription factors, including also the 
pioneer factor Oct4 (Fig.5.5C; Table B-VII – Appendix B). Gene ontology analysis further 
confirmed that the nearest genes associated to H3K27ac-low peaks were functionally involved in 
embryonic development and differentiation processes (Fig.5.5D). This corroborates with a role 
for Jmjd2c in epiblast lineage priming. 
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An interesting finding that arose from the analysis of Jmjd2c-distal peaks was the co-
occupancy of H3K9me2-demethylase G9a at these sites (Fig.5.4C). Strikingly, and in contrast to 
its well-established role in gene silencing, G9a highest enrichment levels were detected at 
H3K27ac-high peaks and hence active enhancer regions in ESCs (Fig. 5.5A), proposing that Jmjd2c 
and G9a co-enrichment might coincide with the formation of activating Mediator complexes at 
these sites. In line with this, Jmjd2c, G9a and Med1 interactions were confirmed exogenously in 
HeLa cells and endogenously in ESCs by co-immunoprecipitation (Fig.5.7). Yet Med1 failed to be 
identified upon FLAG-Jmjd2c pull-down in ESCs (Fig.5.8). While validation that these proteins 
form a trimeric complex is still missing, Jmjd2c, G9a and Med1 co-occupancy at the chromatin 
strongly suggests that they physically interact as part of the same complex at the chromatin. 
However, despite unlikely, the possibility that these are forming two distinct complexes in 
heterogeneous cell populations cannot be discarded.   
 
7.1.9 Jmjd2c and G9a - counteracting roles in the modification of H3K9? 
The co-occupancy of the antagonistic enzymes Jmjd2c and G9a at poised enhancer regions 
proposed a counteracting role in activation versus repression of these sites, possibly as a 
mechanism for fine-tuning primed gene expression. Similarly, histone acetyltransferases (HATs) 
and deacetylases (HDACs) were, for example, found to co-occupy both active and poised gene 
promoters in human T cells (Wang et al., 2009). In this published report, transient binding of 
HAT/HDAC at H3K4-methylated poised genes was demonstrated to be essential for keeping 
genes in a primed/inactive state through an active cycle of acetylation and deacetylation. 
However, in Jmjd2c-depleted ESCs and cEpiSCs, no acquisition of H3K9me2 and de novo DNA 
methylation - two silencing marks associated with gene repression in extra-embryonic tissues 
(Alder et al., 2010; Senner et al., 2012), were detected at regions co-bound by Jmjd2c and G9a 
(enhancers) or Jmjd2c alone (TSS) (Fig.6.1). Thus, despite the acquisition of enriched bulk levels 
of H3K9 methylated histones in the absence of Jmjd2c (Fig.3.4), these did not correlate with an 
increase at selected target regions. Here, reduced H3K9me2 enrichment levels at regulatory 
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regions versus flanking regions were consistently observed regardless of Jmjd2c expression, and 
furthermore corroborates with the previously reported widespread genomic location of 
H3K9me2 marks with the notable exception of H3K4me2-rich regions (Lienert et al., 2010). 
Notably, H3K4me2 and the H3K9me2-depositing enzyme G9a co-occur at the same sites. 
However, H3K4me2-rich sites appear to remain depleted of H3K9me2 in the absence of Jmjd2c, 
proposing histone-independent roles for G9a and Jmjd2c in H3K4me2-rich locations. Thus, it 
remains to be clarified how regulatory sites are indeed protected from acquisition of H3K9me2.        
 
7.1.10 Jmjd2c-G9a association favours stable recruitment of enhancer-associated 
protein complexes  
Unexpectedly Jmjd2c-depleted ESCs displayed reduced G9a enrichment levels at active and 
poised enhancer sites that appear to be normally co-bound by these two molecules in ESCs. This 
further highlights a cooperative rather than competitive interplay between Jmjd2c and G9a. 
Interestingly, impaired G9a binding was here observed at not only Fgf5 poised enhancer in 
Jmjd2c-KO ESCs, but also at newly formed Fgf5 enhancer constituents as defined by Oct4 and 
p300 occupancy in mutant cEpiSCs (Fig.6.3). Strikingly, at this stage, loss of Jmjd2c led to 
compromised Fgf5 expression in cEpiSCs that was mirrored by the destabilized G9a-Med1-Smc1a 
complex formation as seen at all Fgf5 enhancers. Taken together, these findings suggest that 
Jmjd2c and G9a could synergistically promote the recruitment and/or stable assembly of the 
Mediator-Cohesin complex at enhancers (Fig.7.5). 
The Mediator complex as emerged as a central co-activator of transcription, which by 
interaction with key transcription factors, enables recruitment of RNA polymerase II to 
promoters (Conaway et al., 2005; Kornberg, 2005; Malik and Roeder, 2005) . Cooperation 
between the Mediator complex and the Cohesin ring has been shown to bridge interactions 
between transcription factors at enhancers and the transcription machinery at core promoters in 
ESCs (Kagey et al., 2010). Thus, cell-specific DNA looping formation between enhancer-bound 
transcription factors and promoters is a fundamental process in gene activation, and inefficient 
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loading or assembly of these factors could lead to impaired gene expression. Although the 
Mediator subunit Med1 and Cohesin subunit Smc1a genome-wide profiles have not yet been 
reported in EpiSCs, here it was found that Med1 and Smc1a remain similarly expressed in EpiSCs 
as in ESCs (Fig.A-X – Appendix A), implying that these proteins could play conserved regulatory 
roles in gene activation at both developmental stages. Hence, it would be important to validate 
genome-wide their re-location to newly formed enhancer regions upon pluripotency maturation 
that is the transition from an ESC to a primed EpiSC state. 
Collectively, this study provides novel insights into the role of Jmjd2c-G9a as molecular 
scaffolding for the assembly of the Mediator-Cohesin complexes, hence potentially contributing 
to the formation of DNA loops between newly activated enhancers and promoters upon triggering 
of ESC differentiation.  In this model, removal of Jmjd2c would both impact on the loading of G9a 
of the Mediator-Cohesin complexes leading to inefficient gene activation during somatic, lineage 
priming. To further validate this hypothesis, it would be interesting to assess the impact of 
depletion of Jmjd2c and/or G9a in assembly of DNA looping events between the candidate genes 
using chromosome conformation capture (3C) technology (Dekker et al., 2002).  
 
Figure 7.5 Model of assembly of active Jmjd2c-G9a centred enhancer protein complex  
Proposed model for Jmjd2c and G9a action in the assembly of the Mediator-Cohesin Complex. Jmjd2c and 
G9a co-bind enhancer sites, promoting and/or stabilizing the recruitment of the Mediator complex and 
Cohesin (ring) necessary for the formation of DNA loops and potent activation of poised genes upon 
triggering of differentiation and exit of the pluripotent state.  
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7.1.11 Identification of novel roles for the chromatin modifiers Jmjd2c and G9a  
A role for Jmjd2c as a co-activator via H3K9me3-demethylation of promoters has been 
reported in different cell contexts, where abolishing Jmjd2c led to impaired differentiation 
(Cascante et al., 2014; Lu et al., 2012; Wu et al., 2015). Moreover, Jmjd2c has also been described 
as a co-repressor through interaction with HDAC inhibiting PPARγ-mediated transcriptional 
pathways in preadipocyte differentiation (Lizcano et al., 2011) as well as SCR-1/NCOA1-
dependent gene activation in breast cancer cells (Walsh et al., 2014), suggesting that Jmjd2c might 
endorse various functions that are either linked or not with its catalytic activity.  
Conversely, the G9a protein exists in a heteromeric complex with GLP, and has been widely 
associated with gene repression via its H3K9me2-methylase activity (Collins and Cheng, 2010).  
However, a growing number of reports have documented that G9a can act as an activator in a 
context dependent-manner (Chaturvedi et al., 2009; Chaturvedi et al., 2012; Lee et al., 2006a; 
Lehnertz et al., 2010; Oh et al., 2014). Interestingly, an activating interaction between the 
Mediator complex and G9a had been previously identified in hematopoietic (erythroid) 
progenitor cells. Here, G9a was found to participate in two distinct protein complexes: as an 
activator with the Mediator complex and as a repressor with the H3K4me3-demethylase Jarid1a, 
both regulating the differential activation of globin genes (Chaturvedi et al., 2012). In particular, 
depletion of G9a was shown to de-stabilize the recruitment of Mediator complex at the βmaj globin 
(adult) locus, whose expression was then abrogated, while concomitantly re-activating the Ey 
globin (embryonic) gene.  
In ESCs, an interplay between G9a/GLP and PRC2 has been shown to safeguard repression 
of developmental-associated genes (Mozzetta et al., 2014). In that context, depletion of G9a 
resulted into an up-regulation of many differentiation markers, including Fgf5. However, a large 
proportion of PRC2-bound genes were not de-repressed. These findings together with the 
findings described in this project suggest that G9a could also be part of two different complexes 
in ESCs: an activator complex with Jmjd2c-Mediator-Cohesin at active and poised enhancers, and 
a repressor complex with PRC2 at bivalent promoter regions. Thus depletion of G9a might 
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compromise the loading of both complexes, where the balance between activator and repressive 
actions might set the extent of repression versus de-repression of developmental associated 
genes. 
The repressive function of G9a has been associated with its auto-methylation ability, which 
mediates the co-binding of other repressive factors such as HP1 or CDYL (Sampath et al., 2007), 
although the same link with recruitment of PRC2 has not been explored (Mozzetta et al., 2014). 
Interestingly, non-histone targets have been identified in vitro for the Jmjd2 family, and these 
included the tri-methylated sites of proteins such as WIZ, CDYL, CSB and the auto-methylation 
site of G9a (Ponnaluri et al., 2009). Here, the precise molecular mechanism underlying the 
identified Jmjd2c-G9a functional interplay remains to be fully uncovered. Yet one possibility 
could be that the integration of G9a into distinct complexes in ESCs relies on its methylation state. 
Thus, interaction of G9a with an activator complex could require demethylation by Jmjd2c, 
whereas its methylated form creates a platform for recruitment of repressive complexes (Fig.7.6). 
Investigating the methylated state of G9a in Med1-bound versus PRC2 or HP1-bound complexes 
would be fundamental to address this question.  
Moreover, in a recent report it was uncovered that G9a induced the degradation of MyoD – a 
transcription factor involved in skeletal muscle differentiation, through methylation of this 
protein. In addition, Jmjd2c was found to demethylate G9a-mediated methylation resulting in 
stabilization of the MyoD protein, thus enhancing its transcriptional ability (Jung et al., 2015). 
Hence, another possibility would be that the same regulatory mechanism is necessary for 
stabilization of proteins that integrate the enhancer complexes in ESCs and at the onset of 
differentiation.  
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Figure 7.6 Hypothesised outcomes of different methylation states of G9a 
In this model, G9a is proposed to be part of both co-activator and co-repressor complexes. Methylation 
activity of G9a (auto-methylation and H3K9me2 methylation) might provide a platform for recruitment of 
repressive complexes. Demethylation of G9a by Jmjd2c could allow G9a to bind activating complexes, hence 
precluding the recruitment of repressor complexes at regulatory regions.    
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Figure A-I Titration of histone lysates and validation of antibody sources for detection of 
H3K9me2/3 levels in Jmjd2c-knockout ESCs  
A. 1 and 2µg of acid-extracted histone lysates collected from WT and Jmjd2c-knockout clones E2 and E3 
were used for detection of H3K9me2/3 levels by western blot (source of antibodies: Abcam). The two 
panels represent two different concentration so antibody as indicated. H3K4me2 were used as a loading 
control. B. Detection of H3K9me2 and H3K9me3 with three different antibody sources as indicated. 
Western blots were performed in 2µg of acid-extracted histone lysates collected from WT, the Jmjd2c 
heterozygous-knockout clone D3 and the Jmjd2c-knockout clones E2 and E3. Total H3 was used as a loading 
control. 
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Figure A-II Morphology of neuronal progenitors at day 5  
The three panels of phase-contrast images represent the cell morphology observed at the final time point 
(day 5) of three independent neuronal differentiation experiments performed in WT (ESCWT) and KO 
(ESCJmjd2c-KO) ESCs. Images labelled as experiment 2 correspond to different sections of the same well of the 
experiment shown in Fig.3.7B. Bars, 100µm. 
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Figure A-III Optimization of ESC-to-EpiSC conversion 
A. Representative images of WT ESCs after 4 days of ESC-to-EpiSC conversion, with the indicated 
conditions: WT ESCs were routinely cultured in serum/LIF or in 2i/LIF (N2B27/2i/LIF) conditions and 
plated in wells coated with either Fibronectin or FBS. Cells were plated in either the aforementioned 
medium routinely used in ESC culture for 24h before swapping into EpiSC conditions (N2B27/Act/bFGF), 
or directly in EpiSC conditions. B. Fgf5 transcript levels quantified after 4 days of conversion in the different 
tested conditions as indicated below the graph (n=1). Where indicated, conversion experiments were 
tested with different starting cell numbers. The arrow indicates the conversion conditions selected to 
perform the experiments depicted in Fig.4.3.  
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Figure A-IV Mesoderm induction in parental EpiSC 
A. Representative phase-contrast images of embryo-derived EpiSC cultured in CDM-PVA and day 4 
differentiated EpiSCs in FB40 (PM) or FlyWL (LPM) conditions. Bars, 100µm. B. Transcript levels of Fgf5, 
Brachyury/T, Nanog, Oct4 in cEpiSC (day 0) differentiated with FlyB for 1 and 1.5 days, and FB40 at day 4. 
Transcript levels of Flk-1, and Isl1; and Pdgfra and Meox1, in EpiSC prior and after 4 day LPM and PM 
differentiation, respectively. Data were normalized to housekeeping genes (Hmbs, Ywak and Gpdh) and 
represented as average of at least 3 independent experiments ±SEM. P<0.01 (**), t-test. Results in this 
figure were produced by Jennifer Harman.  
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Figure A.V Correlation heatmap for ChIP-seq biological replicates 
Pearson correlation was performed using the BAM files for each replicate and input files, with a genome 
bin size of 1000bp. Scale represents the degree of correlation with 0 being no correlation and 1 
representing perfect correlation.  
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Figure A.VI Enrichment profiles across enhancers and peak location in published datasets 
A. Enrichment profiles for p300, Oct4, Smc1a, Med1, G9a, H3K4me1, H3K27ac from published datasets 
(outlined in Section 2.2.9.3), and the Jmjd2c serum/LIF dataset generated in this work. Active and poised 
enhancers are distinguished by the presence of H3K27ac. Grey (*) indicates the candidate regions analysed 
in Fig.5.6B, whereas red (*) indicates a second poised enhancer regions noticeable at the Foxa2 locus, which 
was not analysed in this work.  B. Location of annotated peaks identified in this work and in published 
datasets. Peak calling in published datasets was performed with MACS 1.4 using default parameters.  
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Figure A.VII List of peptides identified in FLAG-Jmjd2c pull-down 
A. Full list of peptides recovered after Jmjd2c pull-down, with known location in the nucleus. B. Multiple 
hits identified for the proteins highlighted with (*) in A.  
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Figure A-VIII DNA methylation profiles of EpiSC, ESCs, TS and XEN cells and primer locations 
Screenshots of methylation DNA immunoprecipitation (MeDIP)-seq profiles of EpiSC, ESC, TS and XEN cells 
across Fgf5, Brachyury/T and Foxa2 gene loci. Horizontal red and blue lines show the number of reads 
indicative of methylation levels detected in the sense and antisense strands, respectively. Primers designed 
in TSS, enhancer or control regions are depicted in green, orange and blue. Data from Senner et al., 2012; 
screenshots obtained with the software SeqMonk (Babraham Institute, Cambridge). 
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Figure A-IX Levels of DNA hydroxymethylation at TSS and enhancers of differentiation-associated 
genes 
DNA hydroxymethylation correspond to the MspI-resistant fraction in WT and Jmjd2c-KO ESCs (ESCWT and 
ESCKO; blue) and WT and Jmjd2c-KO cEpiSCs (cEpiSCWT and cEpiSCKO; green). Levels were normalized to a 
control region without an MspI/HpaII restriction site and represented relative to total/undigested DNA 
(100%). The average of 2 experiments ± SD is plotted. Regions represented (enhancer and TSS) are the 
same as described in Fig.6.1B.  
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Figure A-X Validation of G9a ChIP efficiency and quantification of enhancer proteins in Jmjd2c-
depleted pluripotent cells 
A. Enrichment levels for G9a as assessed by ChIP-qPCR in in WT and Jmjd2c-KO ESCs (ESCWT and ESCKO; 
blue) and WT and Jmjd2c-KO cEpiSCs (cEpiSCWT and cEpiSCKO; green) in positive controls regions enriched 
in G9a (Vstm2l, Npas4) and a negative control region not enriched in G9a (Nnat). Levels at each region were 
normalized to an intergenic control region. Data was represented as average of 3 independent experiments 
±SEM. B. Snapshots of the ChIP-seq enrichment profiles for G9a and Jmjd2c at the regions assessed in A. 
Primer locations are indicated by (*). C. Western blot showing the levels of Jmjd2c, G9a, GLP, Med1, Smc1a, 
Oct4a and p300 in on whole cell extracts from WT and Jmjd2c-knockout ESC and cEpiSC cultures. α-Tubulin 
was used as a loading control.
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Table B – I. Sequenced of primer used in genotyping of Jmjd2c-knockout 
 
 
 
 
 
Table B – II. Sequences of primers used for cloning of Jmjd2c  
Name Sequence (5’ – 3’)  
XhoI-Jmjd2c-F ATACATTCTCGAGATGGAGGTGGT 
PacI-Jmjd2c3-R CTCTTAATTAACTACTGTCTCTTCTGACACT 
BamHI-Jmjd2c-F ATTAGGATCCGAGGTGGTGGAGGTG 
SalI-Jmjd2c-R TAATGTCGACCTACTGTCTCTTCTGACACTT 
SalI-Del-Tudor-R TAATGTCGACCTACGCGTTTGAGTTGAC 
 
 
Table B – III. Sequences of primers used for RT-qPCR 
Gene  Forward (5’ – 3’) Reverse (5’ – 3’) 
Oct4  CGTGGAGACTTTGCAGCCTG GCTTGGAAACTGTTCTAGCTCCT 
Oct4*  ACCTCAGGTTGGACTGGGCCTA GCCTCGAAGCGACAGATGGT 
Brachyury CCGGTGCTGAAGGTAAATGT CCTCCATTGAGCTTGTTGGT 
Brachyury* TCAGCAAAGTCAAACTCACC TCATTCTGGTAGGCAGTCAC 
Cdx2 TCAACCTCGCCACAACCTTCCC TGGCTCAGCCTGGGATTGCT 
Cxcr4  CGGGATGAAAACGTCCATTT ATGACCAGGATCACCAATCCA 
Dab2 GGCAACAGGCTGAACCATTAGT TTGGTGTCGATTTCAGAGTTTAGAT 
Dnmt3b TTCAGTGACCAGTCCTCAGACACGAA TCAGAAGGCTGGAGACCTCCCTCTT 
Eset GAGGCCGGGGAGAGGCTGAA TAGCTGGTCGGCGAAGCCCT 
Esrrb GCACCTGGGCTCTAGTTGC TACAGTCCTCGTAGCTCTTGC 
Fgf5 TGTGTCTCAGGGGATTGTAGG AGCTGTTTTCTTGGAATCTCTC 
Fgf5* ACGTTTTCTTCGTCTTCTGC TTCCTACAATCCCCTGAGAC 
Flk-1 GACGGAGAAGGAGTCTGTGC TTTCTGTGTGCTGAGCTTGG 
Foxa2 CCATCAGCCCCACAAAATG CCAAGCTGCCTGGCATG 
Foxa2* ACTGGAGCAGCTACTACGC AGGATGACATGTTCATGGAG 
G9a TCACCCTGACTGACAATGAG AGACAGGAACAACAGAACAC 
Gapdh AGA AGG TGG TGA AGC AGG CA CGA AGG TGG AAG AGT GGG AG 
Gata4 GAACACCCTGAGCAGGCCTC TTTCTGGGAAACTGGAGCTGG 
Gata6 GAGCTGGTGCTACCAAGAGG TGCAAAAGCCCATCTCTTCT 
GLP CAGATGGAGAAACAAATGGGTCT TTTGCTTCCCCACTTCTGTGT 
Name Sequence (5’ – 3’) 
tm1a-F GAAGTAGGAGGAGAACCATAGTTCCAGAG 
tm1a-R GCCTCTTCGCTATTACGCCAGCTG 
tm2-F AAGAGGTAAGAAGCCCATCACATC 
tm2-R GCAGCTATTTACCCGCAGGA 
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Hmbs ACTGGTGGAGTATGGAGTCTAGATGGC GCCAGGCTGATGCCCAGGTT 
Isl1 AGACCCTCTCAGTCCCTTG CGTCATCTCCACTAGTTGCTC 
Jmjd2a TTCTGTGAATCCTGCGTCTG TAGCTGTGCACGGTGAGAAC 
Jmjd2b CATGTGGAAGACCACGTTTG AAGGGGATGCCGTACTTCTT 
Jmjd2c(ex14-15) CCAAATGCCTTCCTTGAAGA CACAGCCATCCATCACAGAC 
Jmjd2c(ex18-20) GATGACTGGCCTTACGTGGT CTTCACACAGTTTCGGCTCA 
Jmjd2c(ex5-7) ACACGGAGGACATGGATCTC TCACAGCCTTGGGAGCTACT 
Klf4 GTGCCCCGACTAACCGTTG GTCGTTGAACTCCTCGGTCT 
L19 TGATCTGCTGACGGAGTTG GGAAAAGAAGGTCTGGTTGGA 
Lrp2 CCTTGCCAAACCCTCTGAAAAT CACAAGGTTTGCGGTGTCTTTA 
LSD1 GATGATGTCTGGGAAACAGG GGGCCAAGGTAGAATACAGAG 
Math1 GGAGAAGCTTCGTTGCACGC GGGACATCGCACTGCAATGG 
Meox1 ACGGAGAAGAAATCATCCAG GTAGTTGTGGTGGGCAAAC 
Mixl1 GACAGACCATGTACCCAGAC GCTTCAAACACCTAGCTTCAG 
Nanog CTTACAAGGGTCTGCTACTGA TCTGCTTCCTGGCAAGGACC 
Otx2 TATCTAAAGCAACCGCCTTACG AAGTCCATACCCGAAGTGGTC 
Pax3 GGGAACTGGAGGCATGTTTA GTTTTCCGTCCCAGCAATTA 
Pax6 ACACGCCCTGGTTGGTATC CATCTGAGCTTCATCCGAGTC 
Pdgfra GGTCCCAACCTGTAATGAAG GTAAATGGGACCTGACTTGG 
S17 ATGACTTCCACACCAACAAGC GCCAACTGTAGGCTGAGTGAC 
Sox17 GGAATCCAACCAGCCCACTG  GGACACCACGGAGGAAATGG 
Sox2 AAAACCACCAATCCCATCCA CGAAGCGCCTAACGTACCAC 
Sox7 CAAGGATGAGAGGAAACGTCTG  TCATCCACATAGGGTCTCTTCTG 
Sparc AGGGCCTGGATCTTCTTTCTC  CAAATTCTCCCATTTCCACCT 
Suv39h1 TGTCAACCATAGTTGTGATCC ATTCGGGTACTCTCCATGTC 
Suv39h2 ATCTACGAATGCAACTCAAGGTG CCACAGCCATTGCTAGTTCTAA 
Tbx3 GAACCTACCTGTTCCCGGAAA CAATGCCCAATGTCTCGAAAAC 
Ywhaz  CGTTGTAGGAGCCCGTAGGTCAT TCTGGTTGCGAAGCATTGGG 
* Primers used in Fig.4.4D 
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Table B – IV. Sequences of primers used for ChIP 
Gene  Forward (5’ – 3’) Reverse (5’ – 3’) Region 
Intergenic AAGGGGCCTCTGCTTAAAA AGAGCTCCATGGCAGGTAGA Control 
Vstm2l GCACGGCTCACAGTACCTAAAGT CAGCAAGCACGGTGTGTCA TSS 
Npas4 CTATGGCCATTTCAGCACCG AGCTGTTCGACGTCCTGAAG TSS 
Nnat CCCTACCCAACCCATCCTATC CCACCGCGGCACTTTG TSS 
Esrrb  GGAAGTGGGAAGTGTTGCTAT GAGCTCCAGATCCCCTACAC Enhancer 
Esrrb  CTCCCACTCCGCCTTCTC GGCAAATCACGCGGAAGA TSS 
Klf4 AAGGAAGGCGTTCCAGATTT TTGAGATCCCTGGTGAAAGG TSS 
Klf4 CGCCTGCCTGTACCTTCTAA GGGCCTGGGAGAGATTGTAA Enhancer 
Foxa2  GCTATCACAGGGCCAGGAA CTGTGGGCGAGCTAACAATG Enhancer 
Foxa2  GAGTAGAGGTGTCTGCGACCA CAGAGGCCTAGGGAGAGACC TSS 
Brachyury  CTCTGTCTCAGTTTGCCATTCTC TGTACCGACCACTGGAATCC  Enhancer 
Brachyury   GGCCGACTTTGTTTCTTCCC GAATGCCTCCTTCCTCCTCA TSS 
Fgf5  GTGCATGCATGGGACTGTAG AACCCGACCTGAACCTAGTG Enhancer 
Fgf5  CTCACCAGTCGCAGCTTCT  GAAGGGCTCCACTGGAAACT TSS 
Fgf5  TTGGACTGCTGGGGATAGTG CACGGGGTAAGGTGCTTCTA Enhancer 1 
Fgf5  GGGGCTTGGAGAGTTCAGAT AAAGCTCACCTGGCAGTCTA Enhancer 3 
 
 
Table B – V. Sequences of primers used for DNA methylation assay and H3K9me2 ChIP 
Gene  Forward (5’ – 3’) Reverse (5’ – 3’) Region 
Foxa2  CAGTACCACCTGGGAGTGTTT TGGATTCCCTAGGCATCTTC Enhancer 
Foxa2  GAGTAGAGGTGTCTGCGACCA CAGAGGCCTAGGGAGAGACC TSS 
Foxa2  CCTCTGGGAAACAGAGGACA TTTCTGCGGTCAAGGGTATT Control 
Brachyury   GGATTCCAGTGGTCGGTACA AGGCTCTTGGCTCCAGCTAGT Enhancer 
Brachyury  ACCAAGAACGGCAGGTAGGT GCTGTTAACTCAGCGGGAAG TSS 
Brachyury  CAAGCCTCCCTGCTGACTT GGTTCAGCCACTGACACTCA Control 
Fgf5  GCCGACCAGTCTCTTTCATT TTGCTTCTCCTTCTGCACCT Enhancer 
Fgf5  GGCTCGGAACATAGCAGTTT GCCCAAAGGAATCTTGACC TSS 
Fgf5  GTGTCCCATGGTAACCTGCT GCAGCCCTGTACAAGATCCA Control 
Magea2 TTGGTGGACAGGGAAGCTAGGGGA CGCTCCAGAACAAAATGGCGCAGA TSS 
Chrna3 AGGAGGCAGATGCTGGAAG TCCCAGTCCCTACCACTGAG TSS 
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Table B – VI. Motifs identified in H3K27-high versus H3K27ac-low Jmjd2c peak dataset 
 
Table B – VII. Motifs identified in H3K27-low versus H3K27ac-high Jmjd2c peak dataset 
Motif Name P-value 
# Target 
Sequences 
with Motif 
% Targets 
Sequences 
with Motif 
# 
Background 
Sequences 
with Motif 
% 
Background 
Sequences 
with Motif 
 
E2F1 1e-29 818.0 3.53% 87.8 2.34% 
 REST 1e-21 43.0 0.19% 0.6 0.02% 
 
SFP1 1e-16 37.0 0.16% 0.9 0.02% 
Motif Name P-value 
# Target 
Sequences 
with Motif 
% Targets 
Sequences 
with Motif 
# 
Background 
Sequences 
with Motif 
% 
Background 
Sequences 
with Motif 
 
Esrrb 1e-9 428.0 10.45% 1797.6 7.72% 
 
Nr5a2 1e-6 363.0 8.86% 1605.4 6.89% 
 
MITF 1e-4 434.0 10.59% 2055.4 8.82% 
 
ZFX 1e-3 798.0 19.48% 4016.0 17.24% 
 
ZNF711 1e-3 1064.0 25.97% 5485.0 23.54% 
 
KLF5 1e-3 883.0 21.55% 4530.7 19.45% 
 
BMAL1 1e-2 772.0 18.84% 3993.2 17.14% 
 
ELF1 1e-2 362.0 8.84% 1776.8 7.63% 
 CRE 1e-2 93.0 2.27% 388.8 1.67% 
 Nur77 1e-2 79.0 1.93% 322.0 1.38% 
 PPARE 1e-2 549.0 13.40% 2783.2 11.95% 
 
Sox10 1e-2 691.0 16.87% 3557.6 15.27% 
 
Sox4 1e-2 373.0 9.10% 1840.9 7.90% 
 
Sox3 1e-2 708.0 17.28% 3653.7 15.68% 
 
Gata4 1e-2 329.0 8.03% 1617.1 6.94% 
 
Sox2 1e-2 366.0 8.93% 1817.3 7.80% 
 NF-E2 1e-2 37.0 0.90% 133.6 0.57% 
 NF1 1e-2 235.0 5.74% 1136.5 4.88% 
 EKLF 1e-2 139.0 3.39% 644.8 2.77% 
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NF1 1e-16 5508.0 23.75% 808.3 21.50% 
 
E2F7 1e-15 386.0 1.66% 40.9 1.09% 
 
MyoD 1e-12 2524.0 10.88% 355.7 9.46% 
 Brachyury 1e-11 449.0 1.94% 52.3 1.39% 
 
Pbx3 1e-11 507.0 2.19% 60.9 1.62% 
 
MyoG 1e-9 3328.0 14.35% 488.3 12.99% 
 
Atf4 1e-9 369.0 1.59% 43.3 1.15% 
 GATA3 1e-8 138.0 0.60% 13.7 0.36% 
 
Ascl1 1e-8 5028.0 21.68% 757.9 20.16% 
 
Atoh1 1e-7 3324.0 14.33% 494.1 13.14% 
 
Hoxc9 1e-7 606.0 2.61% 79.4 2.11% 
 
SCL 1e-6 12866.0 55.48% 2022.9 53.81% 
 
Nkx6.1 1e-6 3699.0 15.95% 555.7 14.78% 
 
Chop 1e-5 289.0 1.25% 35.5 0.95% 
 
Myf5 1e-5 1997.0 8.61% 292.7 7.79% 
 
PAX3 1e-5 238.0 1.03% 28.1 0.75% 
 
E2F4 1e-5 1508.0 6.50% 217.9 5.80% 
 
SUT1? 1e-5 19300.0 83.23% 3085.2 82.07% 
 
E2F6 1e-5 1740.0 7.50% 253.2 6.74% 
 
CES-1 1e-5 495.0 2.13% 65.8 1.75% 
 
Nkx2.5 1e-4 5165.0 22.27% 795.1 21.15% 
 
Oct4 1e-4 485.0 2.09% 65.0 1.73% 
 
CTCF 1e-4 572.0 2.47% 79.1 2.10% 
 
Olig2 1e-3 4779.0 20.61% 738.2 19.64% 
 
LIN-39 1e-3 1285.0 5.54% 188.8 5.02% 
 FOXA1 1e-3 61.0 0.26% 6.8 0.18% 
 
PRDM14 1e-3 631.0 2.72% 89.2 2.37% 
The top 30 results are shown in this table. 
